<<<<<<< HEAD
ID,Source,Compound,CID,Class,Label,MW,XLOGP,TPSA,H-Bond ACC,H-Bond Donor,Heavy_Atom_Count,Canonical SMILES,Metabolism,Note
3765,Liew,Nimesulide,4495,positive,1,308.31,2.6,110.0,6,1,21,CS(=O)(=O)NC1=C(C=C(C=C1)[N+](=O)[O-])OC2=CC=CC=C2,Liver,
1661,LIverTox,Rolapitant,10311306,E,0,500.5,4.4,50.4,9,2,35,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OCC2(CCC3(CCC(=O)N3)CN2)C4=CC=CC=C4,CYP3A4,
3835,Liew,Phenacemide,4753,positive,0,178.19,0.9,72.2,2,2,13,C1=CC=C(C=C1)CC(=O)NC(=O)N,,
1637,LIverTox,Reserpine,5770,E,0,608.7,4.0,118.0,10,1,44,COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC,"Liver, Gut",
966,LIverTox,Capreomycin,3000502,E,0,1321.4,,737.0,23,27,93,CC1C(=O)NC(C(=O)NC(=CNC(=O)N)C(=O)NC(C(=O)NCC(C(=O)N1)N)C2CCN=C(N2)N)CNC(=O)CC(CCCN)N.C1CN=C(NC1C2C(=O)NCC(C(=O)NC(C(=O)NC(C(=O)NC(=CNC(=O)N)C(=O)N2)CNC(=O)CC(CCCN)N)CO)N)N,.,
259,DILIrank,terbinafine,1549008,vMost-DILI-Concern,1,291.4,5.6,3.2,1,0,22,CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21,liver,
2659,Xu,Fluvastatin,446155,Negative,1,411.5,3.5,82.7,5,3,30,CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F,"	Liver: CYP2C9 75%, CYP3A4 20%, CYP2C8 5%",
1015,LIverTox,Citalopram,2771,C,1,324.4,3.2,36.3,4,0,24,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,"CYP3A4,CYP2C19",
3510,Liew,Flumequine,3374,positive,1,261.25,2.9,57.6,5,1,19,CC1CCC2=C3N1C=C(C(=O)C3=CC(=C2)F)C(=O)O,,
1650,LIverTox,Rilpivirine,6451164,D,1,366.4,4.5,97.4,6,2,28,CC1=CC(=CC(=C1NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C)C=CC#N,CYP3A4,
3036,Liew,Morphine,5288826,positive,0,285.34,0.8,52.9,4,2,21,CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,,
70,DILIrank,pentamidine,4735,vLess-DILI-Concern,1,340.4,2.6,118.0,4,4,25,C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N,.,
2883,Liew,Carbinoxamine,2564,negative,0,290.79,2.9,25.4,3,0,20,CN(C)CCOC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2,,
1028,LIverTox,Clopidogrel,60606,B,1,321.8,3.8,57.8,4,0,21,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,Liver,
1450,LIverTox,Naldemedine,54732242,E,0,570.6,3.2,141.0,9,4,42,CC(C)(C1=NC(=NO1)C2=CC=CC=C2)NC(=O)C3=C(C4C56CCN(C(C5(C3)O)CC7=C6C(=C(C=C7)O)O4)CC8CC8)O,primarily CYP3A4,
4047,Liew,Toremifene,3005573,positive,1,406.0,7.2,12.5,2,0,29,CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3,CYP3A4,
687,DILIrank,trazodone,5533,vLess-DILI-Concern,1,371.9,2.8,42.4,4,0,26,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl,"CYP3A4, CYP2D6, CYP1A2",
4076,Liew,Tropisetron,72165,positive,0,284.35,3.8,45.3,3,1,21,CN1C2CCC1CC(C2)OC(=O)C3=CNC4=CC=CC=C43,"CYP3A4, CYP1A2, CYP2D6",
2561,Xu,Ciprofloxacin HCl,2764,Positive,1,331.34,-1.1,72.9,7,2,24,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,	Liver incl. CYP1A2,
1402,LIverTox,Metformin,4091,B,1,129.16,-1.3,91.5,1,3,9,CN(C)C(=N)N=C(N)N,Not by liver,
1816,LIverTox,Trospium,107979,E,0,428.0,,46.5,4,1,30,C1CC[N+]2(C1)C3CCC2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O.[Cl-],.,
1870,Greene,"1,3 dinitrobenzene",7452,HH,1,168.11,1.5,91.6,4,0,12,C1=CC(=CC(=C1)[N+](=O)[O-])[N+](=O)[O-],.,
1735,LIverTox,Tadalafil,110635,D,1,389.4,2.3,74.9,4,1,29,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36,Liver predominantly CYP3A4,
4047,Liew,Toremifene,3005573,positive,1,406.0,7.2,12.5,2,0,29,CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3,CYP3A4,
4004,Liew,Tenidap,60712,positive,1,320.8,3.8,114.0,4,2,21,C1=CSC(=C1)C(=O)C2=C(N(C3=C2C=C(C=C3)Cl)C(=O)N)O,,
3231,Liew,Benzthiazide,2343,negative,0,431.9,1.7,161.0,7,2,26,C1=CC=C(C=C1)CSCC2=NS(=O)(=O)C3=CC(=C(C=C3N2)Cl)S(=O)(=O)N,,
3173,Liew,Aminocaproic acid,564,positive,0,131.17,-3.0,63.3,3,2,9,C(CCC(=O)O)CCN,,
3988,Liew,Suprofen,5359,positive,0,260.31,3.3,82.6,4,1,18,CC(C1=CC=C(C=C1)C(=O)C2=CC=CS2)C(=O)O,,
3746,Liew,Naphazoline,4436,negative,0,210.27,2.1,24.4,1,1,16,C1CN=C(N1)CC2=CC=CC3=CC=CC=C32,,
2764,Xu,Pinacidil,4826,Negative,0,245.32,2.7,73.1,3,2,18,CC(C(C)(C)C)N=C(NC#N)NC1=CC=NC=C1,.,
614,DILIrank,mefloquine,40692,vLess-DILI-Concern,1,378.31,3.6,45.2,9,2,26,C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O,Extensive liver; main metabolite is inactive,
438,DILIrank,desloratadine,124087,vLess-DILI-Concern,1,310.8,4.5,24.9,2,1,22,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4,"UGT2B10, CYP2C8",
938,LIverTox,Boceprevir,10324367,B,1,519.7,3.1,151.0,5,4,37,CC1(C2C1C(N(C2)C(=O)C(C(C)(C)C)NC(=O)NC(C)(C)C)C(=O)NC(CC3CCC3)C(=O)C(=O)N)C,.,
1803,LIverTox,Triamterene,5546,D,1,253.26,1.0,130.0,7,3,19,C1=CC=C(C=C1)C2=NC3=C(N=C(N=C3N=C2N)N)N,hydroxylation to para-hydroxytriamterene,
2088,Greene,Estrone,5870,HH,1,270.4,3.1,37.3,2,1,20,CC12CCC3C(C1CCC2=O)CCC4=C3C=CC(=C4)O,.,
2452,Greene,tianeptine,68870,HH,1,437.0,1.2,95.1,6,2,29,CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O,Liver by ??-oxidation,
3856,Liew,Pirarubicin,3033521,positive,0,627.6,2.7,204.0,13,5,45,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)OC6CCCCO6,,
833,LIverTox,Amoxicillin-Clavulanate,6435924,A,1,564.6,,245.0,12,6,39,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C.C1C2N(C1=O)C(C(=CCO)O2)C(=O)O,.,
3620,Liew,Lacidipine,5311217,positive,0,455.5,4.5,90.9,7,1,33,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2C=CC(=O)OC(C)(C)C)C(=O)OCC)C)C,,
1145,LIverTox,Enasidenib,89683805,E*,0,473.4,3.5,109.0,14,3,33,CC(C)(CNC1=NC(=NC(=N1)C2=NC(=CC=C2)C(F)(F)F)NC3=CC(=NC=C3)C(F)(F)F)O,.,
3199,Liew,Arbutamine,60789,negative,0,317.4,0.9,93.0,5,5,23,C1=CC(=CC=C1CCCCNCC(C2=CC(=C(C=C2)O)O)O)O,,
3335,Liew,Clofarabine,119182,positive,1,303.68,0.9,119.0,8,3,20,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N,,
1263,LIverTox,Guanfacine,3519,E,0,246.09,2.0,81.5,1,2,15,C1=CC(=C(C(=C1)Cl)CC(=O)N=C(N)N)Cl,CYP3A4,
518,DILIrank,colistimethate,5311054,vNo-DILI-Concern,0,1155.4,-3.3,491.0,18,18,81,CCC(C)CCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC(C)C)CC(C)C)CCN)CCN)C(C)O,.,
2186,Greene,Loperamide HCl,3955,NE,0,477.0,5.0,43.8,3,1,34,CN(C)C(=O)C(CCN1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,	Liver extensive,
4063,Liew,Trimeprazine,5574,positive,0,298.4,4.7,31.8,3,0,21,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)CN(C)C,Liver,
3057,Liew,Pamidronate,4674,negative,0,235.07,-6.9,161.0,8,6,13,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O,,
3503,Liew,Flomoxef,65864,positive,0,496.5,-1.3,220.0,14,3,32,COC1(C2N(C1=O)C(=C(CO2)CSC3=NN=NN3CCO)C(=O)O)NC(=O)CSC(F)F,,
1018,LIverTox,Clemastine,26987,E,0,343.9,5.0,12.5,2,0,24,CC(C1=CC=CC=C1)(C2=CC=C(C=C2)Cl)OCCC3CCCN3C,Liver,
4087,Liew,Vardenafil,110634,positive,0,488.6,2.5,118.0,7,1,34,CCCC1=NC(=C2N1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC)C,CYP3A4,
3396,Liew,Dibucaine,3025,negative,0,343.5,4.4,54.5,4,1,25,CCCCOC1=NC2=CC=CC=C2C(=C1)C(=O)NCCN(CC)CC,,
3374,Liew,Delapril,5362116,positive,0,452.5,1.7,95.9,6,2,33,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N(CC(=O)O)C2CC3=CC=CC=C3C2,,
1669,LIverTox,Ruxolitinib,25126798,C,1,306.4,2.1,83.2,4,1,23,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,CYP3A4,
2153,Greene,indacrinone,42266,HH,1,365.2,4.5,63.6,4,1,24,CC1(CC2=CC(=C(C(=C2C1=O)Cl)Cl)OCC(=O)O)C3=CC=CC=C3,.,
2494,Greene,Zomepirac,5733,NE,0,291.73,2.8,59.3,3,1,20,CC1=C(N(C(=C1)CC(=O)O)C)C(=O)C2=CC=C(C=C2)Cl,.,
2452,Greene,tianeptine,68870,HH,1,437.0,1.2,95.1,6,2,29,CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O,Liver by ??-oxidation,
331,DILIrank,dichlorphenamide,3038,vNo-DILI-Concern,0,305.2,0.3,137.0,6,2,16,C1=C(C=C(C(=C1S(=O)(=O)N)Cl)Cl)S(=O)(=O)N,.,
3242,Liew,Bitolterol,35330,negative,0,461.5,5.2,84.9,6,2,34,CC1=CC=C(C=C1)C(=O)OC2=C(C=C(C=C2)C(CNC(C)(C)C)O)OC(=O)C3=CC=C(C=C3)C,,
3703,Liew,Methylprednisolone,6741,positive,1,374.5,1.9,94.8,5,3,27,CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,,
638,DILIrank,nitroglycerin,4510,vNo-DILI-Concern,0,227.09,1.6,165.0,9,0,15,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-],	Liver,
492,DILIrank,ramelteon,208902,vNo-DILI-Concern,0,259.34,2.7,38.3,2,1,19,CCC(=O)NCCC1CCC2=C1C3=C(C=C2)OCC3,"Liver CYP1A2 major, CYP2C,CYP3A4 minor",
2050,Greene,Didanosine,135398739,HH,1,236.23,-1.2,88.7,5,2,17,C1CC(OC1CO)N2C=NC3=C2N=CNC3=O,.,
4070,Liew,Tripelennamine,5587,negative,0,255.36,3.3,19.4,3,0,19,CN(C)CCN(CC1=CC=CC=C1)C2=CC=CC=N2,Liver,
2537,Xu,Biotin,171548,Negative,0,244.31,0.3,104.0,4,3,16,C1C2C(C(S1)CCCCC(=O)O)NC(=O)N2,.,
3315,Liew,Chlorprothixene,667467,positive,1,315.9,5.2,28.5,2,0,21,CN(C)CCC=C1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,,
449,DILIrank,benztropine,1201549,vNo-DILI-Concern,0,307.4,4.5,12.5,2,0,23,CN1C2CCC1CC(C2)OC(C3=CC=CC=C3)C4=CC=CC=C4,Liver,
473,DILIrank,ceftriaxone,5479530,vLess-DILI-Concern,1,554.6,-1.3,288.0,13,4,36,CN1C(=NC(=O)C(=O)N1)SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O,Negligible,
437,DILIrank,gemifloxacin,9571107,vLess-DILI-Concern,1,389.4,-0.7,121.0,10,2,28,CON=C1CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F,Limited metabolism by the liver to minor metabolites,
242,DILIrank,methimazole,1349907,vMost-DILI-Concern,1,114.17,-0.3,47.4,1,1,7,CN1C=CNC1=S,Liver,
3912,Liew,Raloxifene,5035,positive,0,473.6,6.1,98.2,6,2,34,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,Liver,
3764,Liew,Nilvadipine,4494,positive,0,385.4,2.9,134.0,8,1,28,CC1=C(C(C(=C(N1)C#N)C(=O)OC)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OC(C)C,,
226,DILIrank,dimenhydrinate,10660,vNo-DILI-Concern,0,470.0,,81.8,5,1,33,CN1C2=C(C(=O)N(C1=O)C)NC(=N2)Cl.CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2,Liver,
302,DILIrank,phenoxypropazine,71467,vMost-DILI-Concern,1,166.22,1.1,47.3,3,2,12,CC(COC1=CC=CC=C1)NN,.,
234,DILIrank,sunitinib,5329102,vMost-DILI-Concern,1,398.5,2.6,77.2,4,3,29,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,CYP3A4,
2764,Xu,Pinacidil,4826,Negative,0,245.32,2.7,73.1,3,2,18,CC(C(C)(C)C)N=C(NC#N)NC1=CC=NC=C1,.,
3334,Liew,Clocortolone Pivalate,5282493,negative,0,495.0,4.5,80.7,6,1,34,CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1C(=O)COC(=O)C(C)(C)C)C)O)Cl)C)F,,
509,DILIrank,cyclofenil,2898,vMost-DILI-Concern,1,364.4,5.5,52.6,4,0,27,CC(=O)OC1=CC=C(C=C1)C(=C2CCCCC2)C3=CC=C(C=C3)OC(=O)C,.,
443,DILIrank,dutasteride,6918296,vNo-DILI-Concern,0,528.5,5.4,58.2,8,2,37,CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C,CYP3A4,
84,DILIrank,sulfadiazine,5215,vLess-DILI-Concern,1,250.28,-0.1,106.0,6,2,17,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N,Liver acetylation,
692,DILIrank,ebrotidine,65869,vMost-DILI-Concern,1,477.4,1.5,198.0,7,3,26,C1=CC(=CC=C1S(=O)(=O)NC=NCCSCC2=CSC(=N2)N=C(N)N)Br,.,
1132,LIverTox,Edoxaban,10280735,D,1,548.1,1.4,165.0,8,3,37,CN1CCC2=C(C1)SC(=N2)C(=O)NC3CC(CCC3NC(=O)C(=O)NC4=NC=C(C=C4)Cl)C(=O)N(C)C,"minimal CES1, CYP3A4/5, hydrolysis, glucuronidation",
3559,Liew,Glutethimide,3487,negative,0,217.26,1.9,46.2,2,1,16,CCC1(CCC(=O)NC1=O)C2=CC=CC=C2,,
3838,Liew,Phenindione,4760,positive,1,222.24,2.9,34.1,2,0,17,C1=CC=C(C=C1)C2C(=O)C3=CC=CC=C3C2=O,,
634,DILIrank,esomeprazole Sodium,9579578,vLess-DILI-Concern,1,345.4,2.2,96.3,6,1,24,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,"	Liver CYP2C19, CYP3A4",
3401,Liew,Diethylcarbamazine,3052,negative,1,199.29,0.3,26.8,2,0,14,CCN(CC)C(=O)N1CCN(CC1)C,,
1917,Greene,Ascorbate,54670067,NE,0,176.12,-1.6,107.0,6,4,12,C(C(C1C(=C(C(=O)O1)O)O)O)O,.,
3797,Liew,Oxprenolol,4631,negative,0,265.35,2.1,50.7,4,2,19,CC(C)NCC(COC1=CC=CC=C1OCC=C)O,Liver,
1121,LIverTox,Droxidopa,92974,E,0,213.19,-3.2,124.0,6,5,15,C1=CC(=C(C=C1C(C(C(=O)O)N)O)O)O,Liver,
194,DILIrank,sodium thiosulfate,24477,vNo-DILI-Concern,0,158.11,,104.0,4,0,7,[O-]S(=O)(=S)[O-].[Na+].[Na+],.,
1405,LIverTox,Methocarbamol,4107,E,0,241.24,0.6,91.0,5,2,17,COC1=CC=CC=C1OCC(COC(=O)N)O,Liver,
3950,Liew,Sapropterin,135398654,negative,0,241.25,-1.9,132.0,6,6,17,CC(C(C1CNC2=C(N1)C(=O)NC(=N2)N)O)O,,
4084,Liew,Valrubicin,454216,negative,0,723.6,4.0,215.0,16,5,51,CCCCC(=O)OCC(=O)C1(CC(C2=C(C1)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4OC)O)OC5CC(C(C(O5)C)O)NC(=O)C(F)(F)F)O,,
3670,Liew,Mepenzolate,4057,negative,0,340.4,3.2,46.5,3,1,25,C[N+]1(CCCC(C1)OC(=O)C(C2=CC=CC=C2)(C3=CC=CC=C3)O)C,,
1063,LIverTox,Dalfampridine,1727,E*,0,94.11,0.3,38.9,2,1,7,C1=CN=CC=C1N,.,
1015,LIverTox,Citalopram,2771,C,1,324.4,3.2,36.3,4,0,24,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,"CYP3A4,CYP2C19",
1474,LIverTox,Nintedanib,9809715,E*,0,539.6,3.3,94.2,7,2,40,CN1CCN(CC1)CC(=O)N(C)C2=CC=C(C=C2)NC(=C3C4=C(C=C(C=C4)C(=O)OC)NC3=O)C5=CC=CC=C5,"Esterases, glucuronidation",
4001,Liew,Temocillin,171758,negative,0,414.5,1.1,187.0,9,3,27,CC1(C(N2C(S1)C(C2=O)(NC(=O)C(C3=CSC=C3)C(=O)O)OC)C(=O)O)C,,
3990,Liew,Talinolol,68770,positive,0,363.5,2.6,82.6,4,4,26,CC(C)(C)NCC(COC1=CC=C(C=C1)NC(=O)NC2CCCCC2)O,,
2278,Greene,perhexiline,4746,HH,1,277.5,6.8,12.0,1,1,20,C1CCC(CC1)C(CC2CCCCN2)C3CCCCC3,	Saturable Liver,
3204,Liew,Atenolol,2249,negative,1,266.34,0.2,84.6,4,3,19,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,,
2186,Greene,Loperamide HCl,3955,NE,0,477.0,5.0,43.8,3,1,34,CN(C)C(=O)C(CCN1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,	Liver extensive,
3575,Liew,Halofantrine,37393,positive,0,500.4,8.6,23.5,5,1,33,CCCCN(CCCC)CCC(C1=C2C=CC(=CC2=C3C=C(C=C(C3=C1)Cl)Cl)C(F)(F)F)O,,
3285,Liew,Ceforanide,43507,positive,0,519.6,-3.2,244.0,12,4,35,C1C(=C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3CN)C(=O)O)CSC4=NN=NN4CC(=O)O,,
672,DILIrank,riluzole,5070,vMost-DILI-Concern,1,234.2,3.6,76.4,7,1,15,C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N,CYP1A2,
760,DILIrank,apomorphine,6005,vNo-DILI-Concern,0,267.32,2.3,43.7,3,2,20,CN1CCC2=C3C1CC4=C(C3=CC=C2)C(=C(C=C4)O)O,"Liver, phase II",
149,DILIrank,busulfan,2478,vMost-DILI-Concern,1,246.3,-0.5,104.0,6,0,14,CS(=O)(=O)OCCCCOS(=O)(=O)C,Liver,
818,LIverTox,Altretamine,2123,E*,0,210.28,2.7,48.4,6,0,15,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,Extensive liver,
2180,Greene,Lidocaine,3676,NE,0,234.34,2.3,32.3,2,1,17,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,"	Liver, 90% CYP3A4",
3708,Liew,Metocurine,21233,negative,0,652.8,6.7,55.4,6,0,48,C[N+]1(CCC2=CC(=C3C=C2C1CC4=CC=C(C=C4)OC5=C6C(CC7=CC(=C(C=C7)OC)O3)[N+](CCC6=CC(=C5OC)OC)(C)C)OC)C,,
1755,LIverTox,Teriflunomide,54684141,D,1,270.21,3.3,73.1,6,2,19,CC(=C(C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F)O,.,
3513,Liew,Flunisolide,82153,negative,0,434.5,2.5,93.1,7,2,31,CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C,,
619,DILIrank,methazolamide,4100,vLess-DILI-Concern,1,236.3,0.1,139.0,6,1,14,CC(=O)N=C1N(N=C(S1)S(=O)(=O)N)C,.,
3321,Liew,Cilnidipine,5282138,positive,0,492.5,4.4,120.0,8,1,36,CC1=C(C(C(=C(N1)C)C(=O)OCC=CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OCCOC,,
79,DILIrank,indocyanine green,5282412,vNo-DILI-Concern,0,775.0,,137.0,7,0,54,CC1(C(=[N+](C2=C1C3=CC=CC=C3C=C2)CCCCS(=O)(=O)[O-])C=CC=CC=CC=C4C(C5=C(N4CCCCS(=O)(=O)[O-])C=CC6=CC=CC=C65)(C)C)C.[Na+],.,
349,DILIrank,cosyntropin,16132265,vNo-DILI-Concern,0,4541.0,-19.7,1860.0,68,63,322,CC(C)CC(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)O)NC(=O)C2CCCN2C(=O)C(CC3=CC=CC=C3)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)CNC(=O)C(CC(=O)N)NC(=O)C4CCCN4C(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(C(C)C)NC(=O)C(CCCCN)NC(=O)C(C(C)C)NC(=O)C6CCCN6C(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(C(C)C)NC(=O)C7CCCN7C(=O)C(CCCCN)NC(=O)CNC(=O)C(CC8=CNC9=CC=CC=C98)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC1=CN=CN1)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CO)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(CO)N,.,peptide
31,DILIrank,bupropion,444,vLess-DILI-Concern,1,239.74,3.2,29.1,2,1,16,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,"Liver, intestines",
2507,Xu,Amantadine HCl,64150,Negative,0,187.71,,26.0,1,2,12,C1C2CC3CC1CC(C2)(C3)N.Cl,	Minimal mostly to acetyl metabolites,
1857,LIverTox,Yohimbine,8969,E,0,354.4,2.9,65.6,4,2,26,COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O,.,
2718,Xu,Methysergide Maleate,9681,Negative,0,353.5,2.3,57.5,3,2,26,CCC(CO)NC(=O)C1CN(C2CC3=CN(C4=CC=CC(=C34)C2=C1)C)C,.,
3437,Liew,Droperidol,3168,negative,0,379.4,3.5,52.6,4,1,28,C1CN(CC=C1N2C3=CC=CC=C3NC2=O)CCCC(=O)C4=CC=C(C=C4)F,,
1667,LIverTox,Rucaparib,9931954,E*,0,323.4,2.5,56.9,3,3,24,CNCC1=CC=C(C=C1)C2=C3CCNC(=O)C4=C3C(=CC(=C4)F)N2,Liver primarily CYP2D6; 1A2 and 3A4 to a lesser extent,
3505,Liew,Floxuridine,5790,positive,1,246.19,-1.2,99.1,6,3,17,C1C(C(OC1N2C=C(C(=O)NC2=O)F)CO)O,,
2144,Greene,Hydrochlorothiazide,3639,HH,1,297.7,-0.1,135.0,7,3,17,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,	Not significant,
2410,Greene,Ribavirin,37542,E*,0,244.2,-1.8,144.0,7,4,17,C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,liver and intracellularly,
4007,Liew,Tenoxicam,5282194,positive,0,337.4,2.2,136.0,8,2,22,CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=C(S1(=O)=O)C=CS3,,
3915,Liew,Ramipril,5362129,positive,1,416.5,1.4,95.9,6,2,30,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,Liver,
2261,Greene,Orphenadrine Citrate,4601,NE,0,269.4,3.8,12.5,2,0,20,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,	Liver demethylation,
3294,Liew,Celecoxib,2662,positive,1,381.4,3.4,86.4,7,1,26,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,,
1057,LIverTox,Dabrafenib,44462760,E*,0,519.6,4.8,148.0,11,2,35,CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F,.,
482,DILIrank,atazanavir,148192,vLess-DILI-Concern,1,704.9,5.6,171.0,9,5,51,CC(C)(C)C(C(=O)NC(CC1=CC=CC=C1)C(CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)C(C(C)(C)C)NC(=O)OC)O)NC(=O)OC,CYP3A4,
3145,Liew,Adapalene,60164,negative,0,412.5,7.7,46.5,3,1,31,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5,,
3967,Liew,Sparfloxacin,60464,positive,0,392.4,0.1,98.9,9,3,28,CC1CN(CC(N1)C)C2=C(C(=C3C(=C2F)N(C=C(C3=O)C(=O)O)C4CC4)N)F,Liver,
2431,Greene,Sulfanilamide,5333,HH,1,172.21,-0.6,94.6,4,2,11,C1=CC(=CC=C1N)S(=O)(=O)N,.,
435,DILIrank,levothyroxine,5819,vLess-DILI-Concern,1,776.87,2.4,92.8,5,3,24,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,"	Mainly in liver, kidneys, brain and muscles",
3925,Liew,Retapamulin,6918462,negative,0,517.8,6.1,92.1,6,1,36,CC1CCC23CCC(=O)C2C1(C(CC(C(C3C)O)(C)C=C)OC(=O)CSC4CC5CCC(C4)N5C)C,CYP3A4,
1556,LIverTox,Phentermine,4771,E,0,149.23,1.9,26.0,1,1,11,CC(C)(CC1=CC=CC=C1)N,Liver,
3848,Liew,Pimecrolimus,16051947,negative,0,810.4,3.8,158.0,11,2,56,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C,CYP3A5,
3901,Liew,Pyrazinamide,1046,positive,1,123.11,-0.6,68.9,3,1,9,C1=CN=C(C=N1)C(=O)N,Liver,
133,DILIrank,pemoline,4723,vMost-DILI-Concern,1,176.17,0.9,64.7,2,1,13,C1=CC=C(C=C1)C2C(=O)N=C(O2)N,	Liver,
3650,Liew,Loteprednol,444025,negative,0,466.9,3.9,99.1,7,1,32,CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl,,
711,DILIrank,valdecoxib,119607,vLess-DILI-Concern,1,314.4,2.6,94.6,5,1,22,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N,"CYP3A4,2C9",
1639,LIverTox,Resveratrol,445154,E,0,228.24,3.1,60.7,3,3,17,C1=CC(=CC=C1C=CC2=CC(=CC(=C2)O)O)O,.,
2663,Xu,Furosemide,3440,Positive,1,330.74,2.0,131.0,7,3,21,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,	liver and kidney glucuronidation,
1551,LIverTox,Pexidartinib,25151352,B,1,417.8,4.5,66.5,7,2,29,C1=CC(=NC=C1CC2=CNC3=C2C=C(C=N3)Cl)NCC4=CN=C(C=C4)C(F)(F)F,.,
4013,Liew,Testolactone,13769,negative,0,300.4,3.0,43.4,3,0,22,CC12CCC3C(C1CCC(=O)O2)CCC4=CC(=O)C=CC34C,Liver,
2718,Xu,Methysergide Maleate,9681,Negative,0,353.5,2.3,57.5,3,2,26,CCC(CO)NC(=O)C1CN(C2CC3=CN(C4=CC=CC(=C34)C2=C1)C)C,.,
693,DILIrank,aceclofenac,71771,vLess-DILI-Concern,1,354.2,4.3,75.6,5,2,23,C1=CC=C(C(=C1)CC(=O)OCC(=O)O)NC2=C(C=CC=C2Cl)Cl,.,
492,DILIrank,ramelteon,208902,vNo-DILI-Concern,0,259.34,2.7,38.3,2,1,19,CCC(=O)NCCC1CCC2=C1C3=C(C=C2)OCC3,"Liver CYP1A2 major, CYP2C,CYP3A4 minor",
1334,LIverTox,Lacosamide,219078,D,1,250.29,0.3,67.4,3,2,18,CC(=O)NC(COC)C(=O)NCC1=CC=CC=C1,.,
753,DILIrank,simethicone,6433516,vNo-DILI-Concern,0,238.46,,52.6,4,0,13,CO[Si](C)(C)O[Si](C)(C)C.O=[Si]=O,	Not metabolized,
1922,Greene,Auranofin,6333901,HH,1,679.5,,115.0,10,0,32,CC[PH+](CC)CC.CC(=O)OCC1C(C(C(C(O1)[S-])OC(=O)C)OC(=O)C)OC(=O)C.[Au+],	Plasma membrane of the cell removes the acetyl groups of the glucose moiety.,
1895,Greene,Allyl alcohol,7858,HH,1,58.08,0.2,20.2,1,1,4,C=CCO,,
2760,Xu,Phenylbutazone,4781,Positive,1,308.4,3.2,40.6,2,0,23,CCCCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3,,
3200,Liew,Argatroban,440542,positive,0,508.6,1.3,189.0,8,5,35,CC1CCN(C(C1)C(=O)O)C(=O)C(CCCN=C(N)N)NS(=O)(=O)C2=CC=CC3=C2NCC(C3)C,,
3567,Liew,Guanabenz,5702063,positive,0,231.08,1.7,76.8,2,2,14,C1=CC(=C(C(=C1)Cl)C=NN=C(N)N)Cl,,
4101,Liew,Xanomeline,60809,positive,0,281.42,3.3,66.5,5,0,19,CCCCCCOC1=NSN=C1C2=CCCN(C2)C,,
388,DILIrank,porfimer,57166,vNo-DILI-Concern,0,1179.4,5.2,314.0,15,10,87,CC1=C(C2=CC3=NC(=CC4=NC(=CC5=C(C(=C(N5)C=C1N2)C(C)OC(C)C6=C(C7=CC8=C(C(=C(N8)C=C9C(=C(C(=N9)C=C1C(=C(C(=N1)C=C6N7)C)CCC(=O)O)CCC(=O)O)C)C)C(C)O)C)C)C(=C4CCC(=O)O)C)C(=C3C)CCC(=O)O)C(C)O,.,no small molecule
714,DILIrank,pyridoxine,1054,vNo-DILI-Concern,0,169.18,-0.8,73.6,4,3,12,CC1=NC=C(C(=C1O)CO)CO,.,
738,DILIrank,l-arginine,6322,vNo-DILI-Concern,0,174.2,-4.2,128.0,4,4,12,C(CC(C(=O)O)N)CN=C(N)N,.,
3125,Liew,Valganciclovir,135413535,negative,1,354.36,-1.5,167.0,8,4,25,CC(C)C(C(=O)OCC(CO)OCN1C=NC2=C1N=C(NC2=O)N)N,,
3263,Liew,Carbachol,5831,negative,0,182.65,,52.3,3,1,11,C[N+](C)(C)CCOC(=O)N.[Cl-],,
126,DILIrank,testosterone,6013,vMost-DILI-Concern,1,288.4,3.3,37.3,2,1,21,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C,	Liver mainly reduction and conjugation,
480,DILIrank,chloramphenicol,5959,vNo-DILI-Concern,1,323.13,1.1,115.0,5,3,20,C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-],Liver,
709,DILIrank,telithromycin,5462516,vMost-DILI-Concern,1,812.0,4.2,172.0,13,1,58,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C,Liver 50% CYP3A4,
2498,Xu,Acetazolamide,1986,Positive,1,222.3,-0.3,152.0,7,2,13,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,	None,
3183,Liew,Amonafide,50515,positive,0,283.32,1.5,66.6,4,1,21,CN(C)CCN1C(=O)C2=CC=CC3=CC(=CC(=C32)C1=O)N,,
3688,Liew,Methenolone,3037705,positive,1,302.5,3.9,37.3,2,1,22,CC1=CC(=O)CC2C1(C3CCC4(C(C3CC2)CCC4O)C)C,,
4062,Liew,Trilostane,656583,negative,0,329.4,2.9,76.8,4,2,24,CC12CCC3C(C1CCC2O)CCC45C3(CC(=C(C4O5)O)C#N)C,Liver,
1547,LIverTox,Pergolide,47811,E*,0,314.5,4.2,44.3,2,1,22,CCCN1CC(CC2C1CC3=CNC4=CC=CC2=C34)CSC,Extensively Liver,
1657,LIverTox,Rivaroxaban,6433119,A,1,435.9,2.5,116.0,6,1,29,C1COCC(=O)N1C2=CC=C(C=C2)N3CC(OC3=O)CNC(=O)C4=CC=C(S4)Cl,"CYP3A4, CYP2J2",
4024,Liew,Thiopental,3000714,positive,0,264.32,,96.6,3,1,17,CCCC(C)C1(C(=O)NC(=S)N=C1[O-])CC.[Na+],Liver,
1969,Greene,carbamazepine,2554,HH,1,236.27,2.5,46.3,1,1,18,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,CYP3A4,
1891,Greene,aflatoxin B1,14403,HH,1,312.27,1.6,71.1,6,0,23,COC1=C2C3=C(C(=O)CC3)C(=O)OC2=C4C5C=COC5OC4=C1,.,
1917,Greene,Ascorbate,54670067,NE,0,176.12,-1.6,107.0,6,4,12,C(C(C1C(=C(C(=O)O1)O)O)O)O,.,
3311,Liew,Chlorphenesin,2724,negative,0,245.66,1.2,81.8,4,2,16,C1=CC(=CC=C1OCC(COC(=O)N)O)Cl,,
2883,Liew,Carbinoxamine,2564,negative,0,290.79,2.9,25.4,3,0,20,CN(C)CCOC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2,,
3745,Liew,Nandrolone,9904,positive,0,274.4,2.6,37.3,2,1,20,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34,,
3183,Liew,Amonafide,50515,positive,0,283.32,1.5,66.6,4,1,21,CN(C)CCN1C(=O)C2=CC=CC3=CC(=CC(=C32)C1=O)N,,
1071,LIverTox,Daunorubicin,30323,E*,0,527.5,1.8,186.0,11,5,38,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O,Liver,
692,DILIrank,ebrotidine,65869,vMost-DILI-Concern,1,477.4,1.5,198.0,7,3,26,C1=CC(=CC=C1S(=O)(=O)NC=NCCSCC2=CSC(=N2)N=C(N)N)Br,.,
3425,Liew,Dolasetron,60654,positive,0,324.4,3.4,62.4,4,1,24,C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,,
1309,LIverTox,Irbesartan,3749,C,1,428.5,4.1,87.1,5,1,32,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,CYP2C9,
3474,Liew,Ethionamide,2761171,positive,1,166.25,1.1,71.0,2,1,11,CCC1=NC=CC(=C1)C(=S)N,,
3980,Liew,Sulfamethizole,5328,positive,1,270.3,0.5,135.0,7,2,17,CC1=NN=C(S1)NS(=O)(=O)C2=CC=C(C=C2)N,,
1708,LIverTox,Solifenacin,154059,D,1,362.5,4.0,32.8,3,0,27,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5,CYP3A4,
732,DILIrank,telmisartan,65999,vLess-DILI-Concern,1,514.6,6.9,72.9,4,1,39,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,Minimal liver glucuronidation,
1210,LIverTox,Fluorouracil,3385,A,1,130.08,-0.9,58.2,3,2,9,C1=C(C(=O)NC(=O)N1)F,Intracellular and liver CYP-mediated,
291,DILIrank,alclofenac,30951,vMost-DILI-Concern,1,226.65,2.5,46.5,3,1,15,C=CCOC1=C(C=C(C=C1)CC(=O)O)Cl,.,
602,DILIrank,isradipine,3784,vLess-DILI-Concern,1,371.4,4.3,104.0,8,1,27,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC,100% Liver,
1072,LIverTox,Decitabine,451668,E*,0,228.21,-1.2,121.0,4,3,16,C1C(C(OC1N2C=NC(=NC2=O)N)CO)O,.,
1957,Greene,buspirone,2477,NE,0,385.5,2.6,69.6,6,0,28,C1CCC2(C1)CC(=O)N(C(=O)C2)CCCCN3CCN(CC3)C4=NC=CC=N4,CYP3A4,
3612,Liew,Josamycin,5282165,positive,0,828.0,2.9,206.0,16,3,58,CC1CC=CC=CC(C(CC(C(C(C(CC(=O)O1)OC(=O)C)OC)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)OC(=O)CC(C)C)(C)O)N(C)C)O)CC=O)C)O,,
1923,Greene,Aurothioglucose,6104,HH,1,392.18,,91.2,6,4,13,C(C1C(C(C(C(O1)[S-])O)O)O)O.[Au+],.,
3938,Liew,Rocuronium,441351,negative,0,609.7,,59.0,6,1,39,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C.[Br-],,
172,DILIrank,sincalide,32800,vNo-DILI-Concern,0,1143.3,-2.6,486.0,19,13,78,CSCCC(C(=O)NCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CCSC)C(=O)NC(CC(=O)O)C(=O)NC(CC3=CC=CC=C3)C(=O)N)NC(=O)C(CC4=CC=C(C=C4)OS(=O)(=O)O)NC(=O)C(CC(=O)O)N,.,
2466,Greene,Trientine HCl,5565,HH,0,146.23,-2.5,76.1,4,4,10,C(CNCCNCCN)N,,
1338,LIverTox,Lanreotide,71349,E*,0,1096.3,2.5,406.0,14,13,77,CC(C)C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)N)C(=O)NC(C(C)O)C(=O)N,In GI tract,
635,DILIrank,nialamide,4472,vMost-DILI-Concern,1,298.34,0.9,83.1,4,3,22,C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2,.,
36,DILIrank,chlorcyclizine,2710,vLess-DILI-Concern,1,300.8,4.5,6.5,2,0,21,CN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,.,
1650,LIverTox,Rilpivirine,6451164,D,1,366.4,4.5,97.4,6,2,28,CC1=CC(=CC(=C1NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C)C=CC#N,CYP3A4,
139,DILIrank,nevirapine,4463,vMost-DILI-Concern,1,266.3,2.0,58.1,4,1,20,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,Liver,
4101,Liew,Xanomeline,60809,positive,0,281.42,3.3,66.5,5,0,19,CCCCCCOC1=NSN=C1C2=CCCN(C2)C,,
1280,LIverTox,Hydralazine,3637,A,1,160.18,0.7,63.8,4,2,12,C1=CC=C2C(=C1)C=NN=C2NN,Liver,
789,LIverTox,Acarbose,444254,B,1,645.6,-8.5,321.0,19,14,44,CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO,Gastrointestinal tractglucosidasemaltogenic alpha-amylase and cyclomaltodextrinase from gut microbiome,
3765,Liew,Nimesulide,4495,positive,1,308.31,2.6,110.0,6,1,21,CS(=O)(=O)NC1=C(C=C(C=C1)[N+](=O)[O-])OC2=CC=CC=C2,Liver,
3407,Liew,Digitoxin,441207,negative,0,764.9,2.3,183.0,13,5,54,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CCC7(C6(CCC7C8=CC(=O)OC8)O)C)C)C)C)O)O,,
653,DILIrank,pentostatin,439693,vMost-DILI-Concern,1,268.27,-2.1,112.0,6,4,19,C1C(C(OC1N2C=NC3=C2NC=NCC3O)CO)O,"Liver, minor",
505,DILIrank,darunavir,213039,vMost-DILI-Concern,1,547.7,2.9,149.0,9,3,38,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N,CYP3A4,
3173,Liew,Aminocaproic acid,564,positive,0,131.17,-3.0,63.3,3,2,9,C(CCC(=O)O)CCN,,
3664,Liew,Medrysone,247839,negative,0,344.5,2.7,54.4,3,1,25,CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)CC4)C)O)C)C(=O)C,,
327,DILIrank,meclizine,4034,vNo-DILI-Concern,0,390.9,5.8,6.5,2,0,28,CC1=CC(=CC=C1)CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=C(C=C4)Cl,Liver,
4076,Liew,Tropisetron,72165,positive,0,284.35,3.8,45.3,3,1,21,CN1C2CCC1CC(C2)OC(=O)C3=CNC4=CC=CC=C43,"CYP3A4, CYP1A2, CYP2D6",
523,DILIrank,polymyxin b sulfate,5702105,vNo-DILI-Concern,0,1301.6,,574.0,22,20,90,CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O,.,
1395,LIverTox,Meperidine,4058,ND,0,247.33,2.5,29.5,3,0,18,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,Liver,
201,DILIrank,triptorelin pamoate,25074470,vLess-DILI-Concern,0,1311.4,-0.3,490.0,15,17,95,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8,.,oligopeptide
636,DILIrank,nilutamide,4493,vMost-DILI-Concern,1,317.22,2.0,95.2,7,1,22,CC1(C(=O)N(C(=O)N1)C2=CC(=C(C=C2)[N+](=O)[O-])C(F)(F)F)C,"Liver CYP2C19, FMOTooltip flavin-containing monooxygenase",
4013,Liew,Testolactone,13769,negative,0,300.4,3.0,43.4,3,0,22,CC12CCC3C(C1CCC(=O)O2)CCC4=CC(=O)C=CC34C,Liver,
646,DILIrank,oxacillin,6196,vLess-DILI-Concern,1,401.4,2.4,138.0,7,2,28,CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O,.,
394,DILIrank,remifentanil,60815,vLess-DILI-Concern,1,376.4,1.9,76.2,6,0,27,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC,	cleaved by non-specific plasma and tissue esterases,
2457,Greene,Tolazamide,5503,HH,1,311.4,1.5,86.9,4,2,21,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CCCCCC2,	metabolized in the liver to active metabolites,
1123,LIverTox,Duloxetine,60835,B,1,297.4,4.3,49.5,3,1,21,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,"Liver, two P450 isozymes, CYP2D6 and CYP1A2",
3518,Liew,Fluorometholone,9878,negative,0,376.5,2.0,74.6,5,2,27,CC1CC2C3CCC(C3(CC(C2(C4(C1=CC(=O)C=C4)C)F)O)C)(C(=O)C)O,,
3222,Liew,Bendroflumethiazide,2315,positive,1,421.4,1.2,135.0,10,3,27,C1=CC=C(C=C1)CC2NC3=C(C=C(C(=C3)C(F)(F)F)S(=O)(=O)N)S(=O)(=O)N2,,
2387,Greene,Procarbazine HCl,4915,HH,1,221.3,0.1,53.2,3,3,16,CC(C)NC(=O)C1=CC=C(C=C1)CNNC,"Liver, Kidney",
288,DILIrank,tasosartan,60919,vMost-DILI-Concern,1,411.5,3.0,101.0,6,1,31,CC1=C2CCC(=O)N(C2=NC(=N1)C)CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,.,
3407,Liew,Digitoxin,441207,negative,0,764.9,2.3,183.0,13,5,54,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CCC7(C6(CCC7C8=CC(=O)OC8)O)C)C)C)C)O)O,,
2741,Xu,Norgestrel,16051930,Positive,1,312.4,3.3,37.3,2,1,23,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,.,
1321,LIverTox,Ivosidenib,71657455,E*,0,583.0,3.4,119.0,9,1,41,C1CC(=O)N(C1C(=O)N(C2=CC(=CN=C2)F)C(C3=CC=CC=C3Cl)C(=O)NC4CC(C4)(F)F)C5=NC=CC(=C5)C#N,.,
966,LIverTox,Capreomycin,3000502,E,0,1321.4,,737.0,23,27,93,CC1C(=O)NC(C(=O)NC(=CNC(=O)N)C(=O)NC(C(=O)NCC(C(=O)N1)N)C2CCN=C(N2)N)CNC(=O)CC(CCCN)N.C1CN=C(NC1C2C(=O)NCC(C(=O)NC(C(=O)NC(C(=O)NC(=CNC(=O)N)C(=O)N2)CNC(=O)CC(CCCN)N)CO)N)N,.,
3828,Liew,Perazine,4744,positive,0,339.5,4.1,35.0,4,0,24,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=CC=CC=C42,,
3804,Liew,Oxyphenisatin,31315,positive,1,317.3,3.2,69.6,3,3,24,C1=CC=C2C(=C1)C(C(=O)N2)(C3=CC=C(C=C3)O)C4=CC=C(C=C4)O,,
116,DILIrank,ergocalciferol,5280793,vNo-DILI-Concern,0,396.6,7.4,20.2,1,1,29,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,.,
1618,LIverTox,Quercetin,5280343,E,0,302.23,1.5,127.0,7,5,22,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O,.,
195,DILIrank,sirolimus,5284616,vLess-DILI-Concern,1,914.2,6.0,195.0,13,3,65,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC,Liver,
2561,Xu,Ciprofloxacin HCl,2764,Positive,1,331.34,-1.1,72.9,7,2,24,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,	Liver incl. CYP1A2,
4069,Liew,Trioxsalen,5585,negative,0,228.24,3.0,39.4,3,0,17,CC1=CC(=O)OC2=C1C=C3C=C(OC3=C2C)C,,
642,DILIrank,octreotide,448601,vLess-DILI-Concern,1,1019.2,1.0,383.0,14,13,71,CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O,Liver,
3194,Liew,Anisotropine,6647,negative,0,362.3,,26.3,3,0,21,CCCC(CCC)C(=O)OC1CC2CCC(C1)[N+]2(C)C.[Br-],,
753,DILIrank,simethicone,6433516,vNo-DILI-Concern,0,238.46,,52.6,4,0,13,CO[Si](C)(C)O[Si](C)(C)C.O=[Si]=O,	Not metabolized,
3402,Liew,Diethylpropion,7029,negative,0,205.3,2.8,20.3,2,0,15,CCN(CC)C(C)C(=O)C1=CC=CC=C1,,
922,LIverTox,Betrixaban,10275777,E*,0,451.9,3.6,107.0,5,3,32,CN(C)C(=N)C1=CC=C(C=C1)C(=O)NC2=C(C=C(C=C2)OC)C(=O)NC3=NC=C(C=C3)Cl,.,
3609,Liew,Itraconazole,55283,positive,1,705.6,5.7,101.0,9,0,49,CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,,
292,DILIrank,aplaviroc,3001322,vMost-DILI-Concern,1,577.7,3.1,119.0,7,3,42,CCCCN1C(=O)C(NC(=O)C12CCN(CC2)CC3=CC=C(C=C3)OC4=CC=C(C=C4)C(=O)O)C(C5CCCCC5)O,.,
4087,Liew,Vardenafil,110634,positive,0,488.6,2.5,118.0,7,1,34,CCCC1=NC(=C2N1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC)C,CYP3A4,
2238,Greene,Nadolol,39147,NE,0,309.4,0.7,82.0,5,4,22,CC(C)(C)NCC(COC1=CC=CC2=C1CC(C(C2)O)O)O,Not metabolised,
588,DILIrank,gemcitabine,60750,vMost-DILI-Concern,1,263.2,-1.5,108.0,6,3,18,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,.,
3563,Liew,Goserelin,5311128,negative,1,1269.4,-1.5,496.0,16,17,91,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6,,
2685,Xu,Kanamycin Sulfate,6032,Negative,0,484.5,-6.9,283.0,15,11,33,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)O)O)OC3C(C(C(C(O3)CO)O)N)O)N,	Unknown,
1895,Greene,Allyl alcohol,7858,HH,1,58.08,0.2,20.2,1,1,4,C=CCO,,
3836,Liew,Phendimetrazine,12460,negative,0,191.27,1.9,12.5,2,0,14,CC1C(OCCN1C)C2=CC=CC=C2,Liver,
3791,Liew,Oxandrolone,5878,positive,1,306.4,3.7,46.5,3,1,22,CC12CCC3C(C1CCC2(C)O)CCC4C3(COC(=O)C4)C,Kidney,
3558,Liew,Gliclazide,3475,positive,1,323.4,1.5,86.9,4,2,22,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2,,
712,DILIrank,dexpanthenol,4678,vNo-DILI-Concern,0,205.25,-0.9,89.8,4,4,14,CC(C)(CO)C(C(=O)NCCCO)O,.,
1635,LIverTox,Regorafenib,11167602,B,1,482.8,4.2,92.4,8,3,33,CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F,Hepatic UGT1A9-mediated,
817,LIverTox,Alprazolam,2118,D,1,308.8,2.1,43.1,3,0,22,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,"Liver, via cytochrome P450 3A4",
3680,Liew,Metaraminol,5906,negative,0,167.2,-0.4,66.5,3,3,12,CC(C(C1=CC(=CC=C1)O)O)N,,
3643,Liew,Lofepramine,3947,positive,1,419.0,6.8,23.6,3,0,30,CN(CCCN1C2=CC=CC=C2CCC3=CC=CC=C31)CC(=O)C4=CC=C(C=C4)Cl,,
3485,Liew,Exisulind,5472495,positive,0,372.4,3.5,79.8,5,1,26,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)(=O)C)C=CC(=C2)F)CC(=O)O,,
2441,Greene,Temafloxacin,60021,HH,1,417.4,0.6,72.9,9,2,30,CC1CN(CCN1)C2=C(C=C3C(=C2)N(C=C(C3=O)C(=O)O)C4=C(C=C(C=C4)F)F)F,.,
3101,Liew,Teriparatide,16132393,negative,0,4118.0,-18.7,1800.0,62,60,289,CCC(C)C(C(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(CCSC)C(=O)NC(CC1=CN=CN1)C(=O)NC(CC(=O)N)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CC2=CN=CN2)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)N)C(=O)NC(CO)C(=O)NC(CCSC)C(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(C(C)C)C(=O)NC(CC5=CN=CN5)C(=O)NC(CC(=O)N)C(=O)NC(CC6=CC=CC=C6)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CO)N,,
1323,LIverTox,Ixazomib,25183872,E*,0,361.0,,98.7,4,4,23,B(C(CC(C)C)NC(=O)CNC(=O)C1=C(C=CC(=C1)Cl)Cl)(O)O,"Liver CYP: 3A4 42%, 1A2 26%, 2B6 16% and others",
471,DILIrank,cefprozil,9887643,vLess-DILI-Concern,1,407.4,,159.0,8,5,28,CC=CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O.O,.,
70,DILIrank,pentamidine,4735,vLess-DILI-Concern,1,340.4,2.6,118.0,4,4,25,C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N,.,
2742,Xu,Nortriptyline HCl,4543,Positive,1,263.4,4.5,12.0,1,1,20,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,Liver,
2679,Xu,Imipramine HCl,3696,Positive,1,280.4,4.8,6.5,2,0,21,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31,"CYP1A2, CYP2C19, CYP2D6",
2113,Greene,flunoxaprofen,68869,WE,1,285.27,3.6,63.3,5,1,21,CC(C1=CC2=C(C=C1)OC(=N2)C3=CC=C(C=C3)F)C(=O)O,.,
3276,Liew,Cefamandole,456255,positive,0,462.5,-0.9,201.0,10,3,31,CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)NC(=O)C(C4=CC=CC=C4)O)SC2)C(=O)O,,
2387,Greene,Procarbazine HCl,4915,HH,1,221.3,0.1,53.2,3,3,16,CC(C)NC(=O)C1=CC=C(C=C1)CNNC,"Liver, Kidney",
265,DILIrank,clevidipine,153994,vNo-DILI-Concern,0,456.3,4.3,90.9,7,1,30,CCCC(=O)OCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,Blood and tissue esterases,
83,DILIrank,streptomycin,19649,vNo-DILI-Concern,0,581.6,-8.0,336.0,15,12,40,CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O,.,
3317,Liew,Chlorzoxazone,2733,positive,1,169.56,1.8,38.3,2,1,11,C1=CC2=C(C=C1Cl)NC(=O)O2,,
3334,Liew,Clocortolone Pivalate,5282493,negative,0,495.0,4.5,80.7,6,1,34,CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1C(=O)COC(=O)C(C)(C)C)C)O)Cl)C)F,,
1166,LIverTox,Eslicarbazepine,179344,D,1,296.32,2.0,72.6,3,1,22,CC(=O)OC1CC2=CC=CC=C2N(C3=CC=CC=C13)C(=O)N,UGT ,
3881,Liew,Procaine,4914,negative,0,236.31,1.9,55.6,4,1,17,CCN(CC)CCOC(=O)C1=CC=C(C=C1)N,,
765,DILIrank,norethindrone acetate,5832,vNo-DILI-Concern,0,340.5,3.5,43.4,3,0,25,CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C,.,
3582,Liew,Hydroxychloroquine,3652,negative,1,335.9,3.6,48.4,4,2,23,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,,
2801,Xu,Sulfasalazine,5339,Positive,1,398.4,-0.7,150.0,9,3,28,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N=NC3=CC(=C(C=C3)O)C(=O)O,.,
1127,LIverTox,Duvelisib,50905713,E*,0,416.9,4.1,86.8,5,2,30,CC(C1=CC2=C(C(=CC=C2)Cl)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5,mainly metabolized by CYP3A4,
3162,Liew,Alprostadil,5280723,positive,0,354.5,3.2,94.8,5,3,25,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,,
1243,LIverTox,Gilteritinib,49803313,E*,0,552.7,3.5,121.0,10,3,40,CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC(=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)OC)NC5CCOCC5,.,
2801,Xu,Sulfasalazine,5339,Positive,1,398.4,-0.7,150.0,9,3,28,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N=NC3=CC(=C(C=C3)O)C(=O)O,.,
3152,Liew,Alendronate,2088,positive,1,249.1,-6.5,161.0,8,6,14,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,,
3416,Liew,Diphenidol,9175,negative,0,280.4,4.0,0.0,0,0,22,C1C=C2C=C3C=CC=CC3=CC2=C4C1C=C5C=CC=CC5=C4,,
1863,LIverTox,Zidovudine,35370,B,1,267.24,0.0,93.2,6,2,19,CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-],Liver,
3893,Liew,Propofol,4943,positive,1,178.27,3.8,20.2,1,1,13,CC(C)C1=C(C(=CC=C1)C(C)C)O,Liver,
1745,LIverTox,Telbivudine,159269,E,0,242.23,-1.2,99.1,5,3,17,CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)O,Nil,
2111,Greene,Flufenamic Acid (Flufenamate),3371,WE,1,281.23,5.2,49.3,6,2,20,C1=CC=C(C(=C1)C(=O)O)NC2=CC=CC(=C2)C(F)(F)F,"	Hydroxylation, glucuronidation",
4101,Liew,Xanomeline,60809,positive,0,281.42,3.3,66.5,5,0,19,CCCCCCOC1=NSN=C1C2=CCCN(C2)C,,
1851,LIverTox,Vorinostat,5311,E,0,264.32,1.9,78.4,3,3,19,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,"Liver glucuronidation and ??-oxidation
CYP system not involved",
1921,Greene,atractyloside,442005,HH,1,726.8,1.2,267.0,16,5,48,CC(C)CC(=O)OC1C(C(C(OC1OC2CC(C3CCC45CC(CCC4C3(C2)C)C(=C)C5O)C(=O)O)CO)OS(=O)(=O)O)OS(=O)(=O)O,.,
1942,Greene,Betaine HCl,247,NE,0,117.15,0.5,40.1,2,0,8,C[N+](C)(C)CC(=O)[O-],,
2428,Greene,Sulconazole Nitrate,5318,NE,0,397.7,6.1,43.1,2,0,24,C1=CC(=CC=C1CSC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl,,
3746,Liew,Naphazoline,4436,negative,0,210.27,2.1,24.4,1,1,16,C1CN=C(N1)CC2=CC=CC3=CC=CC=C32,,
904,LIverTox,Baricitinib,44205240,E*,0,371.4,-0.5,129.0,7,1,26,CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,CYP3A4 <10%,
1127,LIverTox,Duvelisib,50905713,E*,0,416.9,4.1,86.8,5,2,30,CC(C1=CC2=C(C(=CC=C2)Cl)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5,mainly metabolized by CYP3A4,
1135,LIverTox,Elagolix,11250647,E,0,631.6,2.6,99.2,11,2,45,CC1=C(C(=O)N(C(=O)N1CC2=C(C=CC=C2F)C(F)(F)F)CC(C3=CC=CC=C3)NCCCC(=O)O)C4=C(C(=CC=C4)OC)F,CYP3A,
1546,LIverTox,Perampanel,9924495,E,0,349.4,3.4,57.0,3,0,27,C1=CC=C(C=C1)N2C=C(C=C(C2=O)C3=CC=CC=C3C#N)C4=CC=CC=N4,"Liver, mostly via CYP3A4 and/or CYP3A5",
482,DILIrank,atazanavir,148192,vLess-DILI-Concern,1,704.9,5.6,171.0,9,5,51,CC(C)(C)C(C(=O)NC(CC1=CC=CC=C1)C(CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)C(C(C)(C)C)NC(=O)OC)O)NC(=O)OC,CYP3A4,
3200,Liew,Argatroban,440542,positive,0,508.6,1.3,189.0,8,5,35,CC1CCN(C(C1)C(=O)O)C(=O)C(CCCN=C(N)N)NS(=O)(=O)C2=CC=CC3=C2NCC(C3)C,,
115,DILIrank,progesterone,5994,vLess-DILI-Concern,1,314.5,3.9,34.1,2,0,23,CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C,"	Liver CYP2C19, CYP3A4, CYP2C9, 5??-reductase, 3??-HSDTooltip 3??-hydroxysteroid dehydrogenase, 17??-hydroxylase, 21-hydroxylase, 20??-HSDTooltip 20??-hydroxysteroid dehydrogenase",
3770,Liew,Nitrofurazone,5447130,negative,0,198.14,0.2,126.0,5,2,14,C1=C(OC(=C1)[N+](=O)[O-])C=NNC(=O)N,,
3518,Liew,Fluorometholone,9878,negative,0,376.5,2.0,74.6,5,2,27,CC1CC2C3CCC(C3(CC(C2(C4(C1=CC(=O)C=C4)C)F)O)C)(C(=O)C)O,,
3988,Liew,Suprofen,5359,positive,0,260.31,3.3,82.6,4,1,18,CC(C1=CC=C(C=C1)C(=O)C2=CC=CS2)C(=O)O,,
4075,Liew,Tropicamide,5593,negative,0,284.35,1.5,53.4,3,1,21,CCN(CC1=CC=NC=C1)C(=O)C(CO)C2=CC=CC=C2,,
1407,LIverTox,Methsuximide,6476,E*,0,203.24,1.2,37.4,2,0,15,CC1(CC(=O)N(C1=O)C)C2=CC=CC=C2,Liver (demethylation and glucuronidation),
1015,LIverTox,Citalopram,2771,C,1,324.4,3.2,36.3,4,0,24,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,"CYP3A4,CYP2C19",
2725,Xu,Monocrotaline,9415,Positive,1,325.36,-0.7,96.3,7,2,23,CC1C(=O)OC2CCN3C2C(=CC3)COC(=O)C(C1(C)O)(C)O,.,
3383,Liew,Desoximetasone,5311067,negative,0,376.5,2.3,74.6,5,2,27,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1C(=O)CO)C)O)F)C,,
686,DILIrank,tranylcypromine,19493,vLess-DILI-Concern,1,133.19,1.5,26.0,1,1,10,C1C(C1N)C2=CC=CC=C2,Liver,
140,DILIrank,primidone,4909,vNo-DILI-Concern,0,218.25,0.9,58.2,2,2,16,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2,Liver,
3750,Liew,Nedocromil,50294,negative,0,371.3,2.2,121.0,8,2,27,CCCC1=C2C(=CC3=C1OC(=CC3=O)C(=O)O)C(=O)C=C(N2CC)C(=O)O,,
3815,Liew,Pefloxacin,51081,positive,0,333.36,0.3,64.1,7,1,24,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCN(CC3)C)F)C(=O)O,Liver,
3583,Liew,Hydroxyurea,3657,positive,1,76.055,-1.8,75.4,2,3,5,C(=O)(N)NO,,
1146,LIverTox,Encorafenib,50922675,E*,0,540.0,2.7,149.0,10,3,36,CC(C)N1C=C(C(=N1)C2=C(C(=CC(=C2)Cl)NS(=O)(=O)C)F)C3=NC(=NC=C3)NCC(C)NC(=O)OC,.,
3604,Liew,Isopropamide,3775,negative,0,353.5,4.3,43.1,1,1,26,CC(C)[N+](C)(CCC(C1=CC=CC=C1)(C2=CC=CC=C2)C(=O)N)C(C)C,,
2111,Greene,Flufenamic Acid (Flufenamate),3371,WE,1,281.23,5.2,49.3,6,2,20,C1=CC=C(C(=C1)C(=O)O)NC2=CC=CC(=C2)C(F)(F)F,"	Hydroxylation, glucuronidation",
1200,LIverTox,Fingolimod,107970,C,1,307.5,4.2,66.5,3,3,22,CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N,.,
3192,Liew,Aniracetam,2196,negative,0,219.24,1.6,46.6,3,0,16,COC1=CC=C(C=C1)C(=O)N2CCCC2=O,,
1072,LIverTox,Decitabine,451668,E*,0,228.21,-1.2,121.0,4,3,16,C1C(C(OC1N2C=NC(=NC2=O)N)CO)O,.,
1334,LIverTox,Lacosamide,219078,D,1,250.29,0.3,67.4,3,2,18,CC(=O)NC(COC)C(=O)NCC1=CC=CC=C1,.,
3563,Liew,Goserelin,5311128,negative,1,1269.4,-1.5,496.0,16,17,91,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6,,
785,LIverTox,Abemaciclib,46220502,E*,0,506.6,3.8,75.0,9,1,37,CCN1CCN(CC1)CC2=CN=C(C=C2)NC3=NC=C(C(=N3)C4=CC5=C(C(=C4)F)N=C(N5C(C)C)C)F,.,
1427,LIverTox,Mirabegron,9865528,E*,0,396.5,2.1,129.0,6,4,28,C1=CC=C(C=C1)C(CNCCC2=CC=C(C=C2)NC(=O)CC3=CSC(=N3)N)O,"Liver via direct glucuronidation, amide hydrolysis, and minimal oxidative metabolism in vivo by CYP2D6 and CYP3A4. Some involvement of butylcholinesterase",
3693,Liew,Methotrimeprazine,72287,negative,0,328.5,4.7,41.0,4,0,23,CC(CN1C2=CC=CC=C2SC3=C1C=C(C=C3)OC)CN(C)C,,
428,DILIrank,alpidem,54897,vMost-DILI-Concern,1,404.3,4.8,37.6,2,0,27,CCCN(CCC)C(=O)CC1=C(N=C2N1C=C(C=C2)Cl)C3=CC=C(C=C3)Cl,"	Extensive hydroxylation, dealkylation, conjugation",
1576,LIverTox,Plicamycin,5284610,A[HD],1,1085.1,0.6,358.0,24,11,76,CC1C(C(CC(O1)OC2CC(OC(C2O)C)OC3=CC4=CC5=C(C(=O)C(C(C5)C(C(=O)C(C(C)O)O)OC)OC6CC(C(C(O6)C)O)OC7CC(C(C(O7)C)O)OC8CC(C(C(O8)C)O)(C)O)C(=C4C(=C3C)O)O)O)O,.,
2663,Xu,Furosemide,3440,Positive,1,330.74,2.0,131.0,7,3,21,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,	liver and kidney glucuronidation,
1407,LIverTox,Methsuximide,6476,E*,0,203.24,1.2,37.4,2,0,15,CC1(CC(=O)N(C1=O)C)C2=CC=CC=C2,Liver (demethylation and glucuronidation),
1862,LIverTox,Zepatier,91669168,C,1,1648.9,,388.0,21,6,119,CC(C)C(C(=O)N1CCCC1C2N=CC(=N2)C3=CC4=C(C=C3)C5=CC6=C(N5C(O4)C7=CC=CC=C7)C=CC(=C6)C8=CN=C(N8)C9CCCN9C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC.CC(C)(C)C1C(=O)N2CC(CC2C(=O)NC3(CC3C=C)C(=O)NS(=O)(=O)C4CC4)OC5=NC6=C(C=CC(=C6)OC)N=C5CCCCCC7CC7OC(=O)N1,.,
1568,LIverTox,Piperacillin-Tazobactam,9918881,B,1,817.9,,313.0,15,4,56,CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O.CC1(C(N2C(S1(=O)=O)CC2=O)C(=O)O)CN3C=CN=N3,.,
943,LIverTox,Brexanolone,92786,E,0,318.5,4.9,37.3,2,1,23,CC(=O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C,"Non-CYP450 keto-reduction via aldo-keto reductases AKR, glucuronidation via glucuronosyltransferases UGT, sulfation via sulfotransferases SULT",
2237,Greene,NaCl,5234,NE,0,58.44,,0.0,1,0,2,[Na+].[Cl-],.,
142,DILIrank,rabeprazole,5029,vLess-DILI-Concern,1,359.4,1.9,96.3,6,1,25,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCCCOC,"CYP2C19,CYP3A4",
771,DILIrank,tyramine,5610,vNo-DILI-Concern,0,137.18,1.1,46.2,2,2,10,C1=CC(=CC=C1CCN)O,"	CYP2D6, flavin-containing monooxygenase 3, monoamine oxidase A, monoamine oxidase B, phenylethanolamine N-methyltransferase, DBH, others",
429,DILIrank,bexarotene,82146,vMost-DILI-Concern,1,348.5,7.6,37.3,2,1,26,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C,CYP3A4,
2057,Greene,Dimercaprol,3080,HH,0,124.23,0.2,22.2,3,3,6,C(C(CS)S)O,,
3272,Liew,Carvedilol,2585,positive,1,406.5,4.2,75.7,5,3,30,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,,
456,DILIrank,budesonide,40000,vNo-DILI-Concern,0,430.5,2.5,93.1,6,2,31,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,CYP3A4,
147,DILIrank,benzbromarone,2333,vMost-DILI-Concern,1,424.1,5.7,50.4,3,1,22,CCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)Br)O)Br,.,
3368,Liew,Daptomycin,16129629,positive,1,1620.7,-5.1,702.0,28,22,115,CCCCCCCCCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC3C(OC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC3=O)CCCN)CC(=O)O)C)CC(=O)O)CO)C(C)CC(=O)O)CC(=O)C4=CC=CC=C4N)C,,
4045,Liew,Topiramate,5284627,positive,1,339.36,-0.8,124.0,9,1,22,CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C,Liver,
1635,LIverTox,Regorafenib,11167602,B,1,482.8,4.2,92.4,8,3,33,CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F,Hepatic UGT1A9-mediated,
964,LIverTox,Cannabidiol,644019,E*,0,314.5,6.5,40.5,2,2,23,CCCCCC1=CC(=C(C(=C1)O)C2C=C(CCC2C(=C)C)C)O,.,
724,DILIrank,ximelagatran,9574101,vMost-DILI-Concern,1,473.6,2.2,146.0,7,4,34,CCOC(=O)CNC(C1CCCCC1)C(=O)N2CCC2C(=O)NCC3=CC=C(C=C3)C(=NO)N,	to melagatran,
1372,LIverTox,Lovastatin,53232,B,1,404.5,4.3,72.8,5,1,29,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,Liver CYP3A and CYP2C8 substrate,
1828,LIverTox,Vandetanib,3081361,E*,0,475.4,4.9,59.5,7,1,30,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,"CYP3A4, FMO1, FMO3",
3234,Liew,Bethanechol,2370,negative,0,161.22,0.0,52.3,2,1,11,CC(C[N+](C)(C)C)OC(=O)N,,
3938,Liew,Rocuronium,441351,negative,0,609.7,,59.0,6,1,39,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C.[Br-],,
6,DILIrank,cyclophosphamide,2907,vLess-DILI-Concern,1,261.08,0.6,41.6,4,1,14,C1CNP(=O)(OC1)N(CCCl)CCCl,Liver,
254,DILIrank,prednisolone,5755,vLess-DILI-Concern,1,360.4,1.6,94.8,5,3,26,CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,.,
224,DILIrank,danazol,28417,vMost-DILI-Concern,1,337.5,3.8,46.3,3,1,25,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC5=C(CC34C)C=NO5,CYP3A4,
480,DILIrank,chloramphenicol,5959,vNo-DILI-Concern,1,323.13,1.1,115.0,5,3,20,C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-],Liver,
3967,Liew,Sparfloxacin,60464,positive,0,392.4,0.1,98.9,9,3,28,CC1CN(CC(N1)C)C2=C(C(=C3C(=C2F)N(C=C(C3=O)C(=O)O)C4CC4)N)F,Liver,
4012,Liew,Tertatolol,36920,negative,0,295.4,2.7,66.8,4,2,20,CC(C)(C)NCC(COC1=CC=CC2=C1SCCC2)O,,
3275,Liew,Cefadroxil,47965,positive,0,363.4,-2.1,158.0,7,4,25,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O,,
3782,Liew,Olsalazine,22419,positive,1,302.24,3.1,140.0,8,4,22,C1=CC(=C(C=C1N=NC2=CC(=C(C=C2)O)C(=O)O)C(=O)O)O,,
393,DILIrank,tamsulosin,129211,vLess-DILI-Concern,1,408.5,2.7,108.0,7,2,28,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,Liver,
3360,Liew,Cysteamine,6058,positive,1,77.15,-0.4,27.0,2,2,4,C(CS)N,,
1916,Greene,Arsenic Trioxide,261004,HH,1,197.841,,43.4,3,0,5,O=[As]O[As]=O,.,
3838,Liew,Phenindione,4760,positive,1,222.24,2.9,34.1,2,0,17,C1=CC=C(C=C1)C2C(=O)C3=CC=CC=C3C2=O,,
956,LIverTox,Butorphanol,5361092,ND,0,327.5,3.8,43.7,3,2,24,C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,hydroxylated & glucuronidated,
413,DILIrank,sildenafil,135398744,vLess-DILI-Concern,1,474.6,1.5,118.0,8,1,33,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,"Liver: CYP3A4 major route, CYP2C9 minor route",
716,DILIrank,cyanocobalamin,16212801,vNo-DILI-Concern,0,1355.4,,476.0,21,9,93,CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3],.,
3139,Liew,Acetaminophen,1983,positive,1,151.16,0.5,49.3,2,2,11,CC(=O)NC1=CC=C(C=C1)O,,
2731,Xu,Nefazodone,4449,Positive,1,470.0,4.3,51.6,5,0,33,CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl,"CYP3A4, CYP2D6",
714,DILIrank,pyridoxine,1054,vNo-DILI-Concern,0,169.18,-0.8,73.6,4,3,12,CC1=NC=C(C(=C1O)CO)CO,.,
3541,Liew,Fulvestrant,104741,negative,0,606.8,9.2,76.7,9,2,41,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F,,
186,DILIrank,mesalazine,4075,vLess-DILI-Concern,1,153.14,1.3,83.6,4,3,11,C1=CC(=C(C=C1N)C(=O)O)O,	Rapidly & extensively metabolized intestinal mucosal wall and the liver,
1755,LIverTox,Teriflunomide,54684141,D,1,270.21,3.3,73.1,6,2,19,CC(=C(C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F)O,.,
438,DILIrank,desloratadine,124087,vLess-DILI-Concern,1,310.8,4.5,24.9,2,1,22,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4,"UGT2B10, CYP2C8",
4060,Liew,Trifluridine,6256,negative,0,296.2,-0.5,99.1,8,3,20,C1C(C(OC1N2C=C(C(=O)NC2=O)C(F)(F)F)CO)O,Thymidine phosphorylase,
1076,LIverTox,Defibrotide,135565962,E,0,444.4,1.8,137.0,7,4,31,CC(C)C1=C(C=C(C(=C1)C2=NNC(=O)N2C3=CC4=C(C=C3)N(C=C4)C)O)OP(=O)(O)O,.,
2679,Xu,Imipramine HCl,3696,Positive,1,280.4,4.8,6.5,2,0,21,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31,"CYP1A2, CYP2C19, CYP2D6",
368,DILIrank,atracurium,47320,vNo-DILI-Concern,0,1243.5,,258.0,18,0,87,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-],	Hofmann elimination retro-Michael addition and ester hydrolysis by nonspecific esterases,
1921,Greene,atractyloside,442005,HH,1,726.8,1.2,267.0,16,5,48,CC(C)CC(=O)OC1C(C(C(OC1OC2CC(C3CCC45CC(CCC4C3(C2)C)C(=C)C5O)C(=O)O)CO)OS(=O)(=O)O)OS(=O)(=O)O,.,
976,LIverTox,Cariprazine,11154555,E*,0,427.4,4.3,38.8,3,1,28,CN(C)C(=O)NC1CCC(CC1)CCN2CCN(CC2)C3=C(C(=CC=C3)Cl)Cl,Liver via CYP3A4 and to a lesser extent CYP2D6,
766,DILIrank,exametazime,9552069,vNo-DILI-Concern,0,742.6,,179.0,12,8,40,CC(C(=NO)C)NCC(C)(C)CNC(C)C(=NO)C.CC(C(=NO)C)NCC(C)(C)CNC(C)C(=NO)C.[Tc].[Tc],.,
965,LIverTox,Capecitabine,60953,E*,0,359.35,0.6,121.0,7,3,25,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O,"liver, to 5'-DFCR, 5'-DFUR inactive; neoplastic tissue, 5'-DFUR to active fluorouracil",
464,DILIrank,cefaclor,51038,vLess-DILI-Concern,1,385.8,,139.0,7,4,25,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl.O,15% to 40%,
799,LIverTox,Afatinib,10184653,D,1,485.9,3.6,88.6,8,2,34,CN(C)CC=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OC4CCOC4,CYP not involved,
3406,Liew,Difluprednate,32037,negative,0,508.5,3.4,107.0,9,1,36,CCCC(=O)OC1(CCC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C(=O)COC(=O)C,,
3368,Liew,Daptomycin,16129629,positive,1,1620.7,-5.1,702.0,28,22,115,CCCCCCCCCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC3C(OC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC3=O)CCCN)CC(=O)O)C)CC(=O)O)CO)C(C)CC(=O)O)CC(=O)C4=CC=CC=C4N)C,,
464,DILIrank,cefaclor,51038,vLess-DILI-Concern,1,385.8,,139.0,7,4,25,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl.O,15% to 40%,
833,LIverTox,Amoxicillin-Clavulanate,6435924,A,1,564.6,,245.0,12,6,39,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C.C1C2N(C1=O)C(C(=CCO)O2)C(=O)O,.,
3270,Liew,Carprofen,2581,positive,1,273.71,4.0,53.1,2,2,19,CC(C1=CC2=C(C=C1)C3=C(N2)C=CC(=C3)Cl)C(=O)O,,
3628,Liew,Lenalidomide,216326,positive,1,259.26,-0.5,92.5,4,2,19,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,,
290,DILIrank,tilbroquinol,65592,vMost-DILI-Concern,1,238.08,3.1,33.1,2,1,13,CC1=CC(=C(C2=C1C=CC=N2)O)Br,.,
3659,Liew,Marimastat,119031,positive,0,331.41,0.5,128.0,5,5,23,CC(C)CC(C(C(=O)NO)O)C(=O)NC(C(=O)NC)C(C)(C)C,,
383,DILIrank,enoxaparin,772,vLess-DILI-Concern,1,1134.9,-10.8,652.0,38,15,70,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,.,
1321,LIverTox,Ivosidenib,71657455,E*,0,583.0,3.4,119.0,9,1,41,C1CC(=O)N(C1C(=O)N(C2=CC(=CN=C2)F)C(C3=CC=CC=C3Cl)C(=O)NC4CC(C4)(F)F)C5=NC=CC(=C5)C#N,.,
18,DILIrank,tetracycline,54685734,vLess-DILI-Concern,1,444.4,-2.0,182.0,9,6,32,CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O,Not metabolized,
817,LIverTox,Alprazolam,2118,D,1,308.8,2.1,43.1,3,0,22,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,"Liver, via cytochrome P450 3A4",
2659,Xu,Fluvastatin,446155,Negative,1,411.5,3.5,82.7,5,3,30,CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F,"	Liver: CYP2C9 75%, CYP3A4 20%, CYP2C8 5%",
789,LIverTox,Acarbose,444254,B,1,645.6,-8.5,321.0,19,14,44,CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO,Gastrointestinal tractglucosidasemaltogenic alpha-amylase and cyclomaltodextrinase from gut microbiome,
218,DILIrank,benoxaprofen,39941,vMost-DILI-Concern,1,301.72,4.1,63.3,4,1,21,CC(C1=CC2=C(C=C1)OC(=N2)C3=CC=C(C=C3)Cl)C(=O)O,.,
3816,Liew,Pemirolast,57697,positive,0,228.21,-0.3,87.1,5,1,17,CC1=CC=CN2C1=NC=C(C2=O)C3=NNN=N3,,
379,DILIrank,fenoldopam,3341,vNo-DILI-Concern,0,305.75,2.4,72.7,4,4,21,C1CNCC(C2=CC(=C(C(=C21)Cl)O)O)C3=CC=C(C=C3)O,	Liver CYP not involved,
1576,LIverTox,Plicamycin,5284610,A[HD],1,1085.1,0.6,358.0,24,11,76,CC1C(C(CC(O1)OC2CC(OC(C2O)C)OC3=CC4=CC5=C(C(=O)C(C(C5)C(C(=O)C(C(C)O)O)OC)OC6CC(C(C(O6)C)O)OC7CC(C(C(O7)C)O)OC8CC(C(C(O8)C)O)(C)O)C(=C4C(=C3C)O)O)O)O,.,
803,LIverTox,Alectinib,49806720,D,1,482.6,5.2,72.4,5,1,36,CCC1=CC2=C(C=C1N3CCC(CC3)N4CCOCC4)C(C5=C(C2=O)C6=C(N5)C=C(C=C6)C#N)(C)C,CYP3A4,
1710,LIverTox,Sorafenib,216239,B,1,464.8,4.1,92.4,7,3,32,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,Liver oxidation and glucuronidation CYP3A4 & UGT1A9-mediated,
3334,Liew,Clocortolone Pivalate,5282493,negative,0,495.0,4.5,80.7,6,1,34,CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1C(=O)COC(=O)C(C)(C)C)C)O)Cl)C)F,,
3323,Liew,Cimetidine,2756,positive,1,252.34,0.4,114.0,4,3,17,CC1=C(N=CN1)CSCCNC(=NC)NC#N,,
1243,LIverTox,Gilteritinib,49803313,E*,0,552.7,3.5,121.0,10,3,40,CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC(=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)OC)NC5CCOCC5,.,
425,DILIrank,frovatriptan,77992,vNo-DILI-Concern,0,243.3,1.2,70.9,2,3,18,CNC1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N,	Liver,
1957,Greene,buspirone,2477,NE,0,385.5,2.6,69.6,6,0,28,C1CCC2(C1)CC(=O)N(C(=O)C2)CCCCN3CCN(CC3)C4=NC=CC=N4,CYP3A4,
1905,Greene,amiodarone,2157,HH,1,645.3,7.6,42.7,4,0,31,CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I,Liver,
1040,LIverTox,Copanlisib,24989044,E*,0,480.5,-0.3,140.0,10,2,35,COC1=C(C=CC2=C1N=C(N3C2=NCC3)NC(=O)C4=CN=C(N=C4)N)OCCCN5CCOCC5,"CYP3A4/5 (?90%), CYP1A1 (?10%)",
3879,Liew,Probucol,4912,positive,0,516.8,11.3,91.1,4,2,35,CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)SC(C)(C)SC2=CC(=C(C(=C2)C(C)(C)C)O)C(C)(C)C,,
2270,Greene,Pargyline,4688,NE,0,159.23,2.1,3.2,1,0,12,CN(CC#C)CC1=CC=CC=C1,.,
2410,Greene,Ribavirin,37542,E*,0,244.2,-1.8,144.0,7,4,17,C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,liver and intracellularly,
193,DILIrank,corticorelin ovine triflutate,16186200,vNo-DILI-Concern,0,4757.0,-14.3,2050.0,72,67,333,CCC(C)C(C(=O)N)NC(=O)C(C(C)CC)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(=O)N)NC(=O)C(CO)NC(=O)C(CC1=CNC=N1)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)N)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)C(CCSC)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(C(C)C)NC(=O)C(CCC(=O)O)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CNC=N2)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(C(C)O)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(C(C)CC)NC(=O)C4CCCN4C(=O)C5CCCN5C(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CO)N,.,polypeptide
1294,LIverTox,Iloperidone,71360,E,0,426.5,4.1,64.8,7,0,31,CC(=O)C1=CC(=C(C=C1)OCCCN2CCC(CC2)C3=NOC4=C3C=CC(=C4)F)OC,Liver CYP2D6-mediated hydroxylation and CYP3A4-mediated O-demethylation,
3645,Liew,Lonidamine,39562,positive,0,321.2,4.3,55.1,3,1,21,C1=CC=C2C(=C1)C(=NN2CC3=C(C=C(C=C3)Cl)Cl)C(=O)O,,
3574,Liew,Halobetasol,5311167,negative,0,428.9,2.7,74.6,6,2,29,CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C)F,,
1511,LIverTox,Oxaliplatin,77994,A,1,397.29,,132.0,6,2,15,C1CCC(C(C1)N)N.C(=O)(C(=O)[O-])[O-].[Pt+2],.,
3200,Liew,Argatroban,440542,positive,0,508.6,1.3,189.0,8,5,35,CC1CCN(C(C1)C(=O)O)C(=O)C(CCCN=C(N)N)NS(=O)(=O)C2=CC=CC3=C2NCC(C3)C,,
3755,Liew,Nepafenac,151075,negative,0,254.28,1.9,86.2,3,2,19,C1=CC=C(C=C1)C(=O)C2=CC=CC(=C2N)CC(=O)N,,
186,DILIrank,mesalazine,4075,vLess-DILI-Concern,1,153.14,1.3,83.6,4,3,11,C1=CC(=C(C=C1N)C(=O)O)O,	Rapidly & extensively metabolized intestinal mucosal wall and the liver,
3820,Liew,Penfluridol,33630,negative,0,524.0,7.3,23.5,7,1,36,C1CN(CCC1(C2=CC(=C(C=C2)Cl)C(F)(F)F)O)CCCC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F,,
3337,Liew,Clofibrate,2796,positive,1,242.7,3.3,35.5,3,0,16,CCOC(=O)C(C)(C)OC1=CC=C(C=C1)Cl,,
2477,Greene,Uracil Mustard,6194,HH,1,252.09,0.5,61.4,3,2,15,C1=C(C(=O)NC(=O)N1)N(CCCl)CCCl,.,
637,DILIrank,niperotidine,3033952,vMost-DILI-Concern,1,434.5,2.9,130.0,9,2,30,CN(C)CC1=CC=C(O1)CSCCNC(=C[N+](=O)[O-])NCC2=CC3=C(C=C2)OCO3,.,
75,DILIrank,pseudoephedrine,7028,vNo-DILI-Concern,0,165.23,0.9,32.3,2,2,12,CC(C(C1=CC=CC=C1)O)NC,	10?30% liver,
3767,Liew,Nitisinone,115355,negative,0,329.23,2.3,97.0,8,0,23,C1CC(=O)C(C(=O)C1)C(=O)C2=C(C=C(C=C2)C(F)(F)F)[N+](=O)[O-],,
234,DILIrank,sunitinib,5329102,vMost-DILI-Concern,1,398.5,2.6,77.2,4,3,29,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,CYP3A4,
3416,Liew,Diphenidol,9175,negative,0,280.4,4.0,0.0,0,0,22,C1C=C2C=C3C=CC=CC3=CC2=C4C1C=C5C=CC=CC5=C4,,
1803,LIverTox,Triamterene,5546,D,1,253.26,1.0,130.0,7,3,19,C1=CC=C(C=C1)C2=NC3=C(N=C(N=C3N=C2N)N)N,hydroxylation to para-hydroxytriamterene,
1207,LIverTox,Flucytosine,3366,D,1,129.09,-0.9,67.5,3,2,9,C1=NC(=O)NC(=C1F)N,"minimal, in the GI tract",
3266,Liew,Carboprost,5281075,negative,0,368.5,2.9,98.0,5,4,26,CCCCCC(C)(C=CC1C(CC(C1CC=CCCCC(=O)O)O)O)O,,
3563,Liew,Goserelin,5311128,negative,1,1269.4,-1.5,496.0,16,17,91,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6,,
344,DILIrank,glycopyrrolate,3494,vNo-DILI-Concern,0,318.4,3.1,46.5,3,1,23,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C,.,
1623,LIverTox,Quinupristin-Dalfopristin,23724510,E*,0,1713.1,,441.0,25,6,121,CCC1C(=O)N2CCCC2C(=O)N(C(C(=O)N3CC(C(=O)CC3C(=O)NC(C(=O)OC(C(C(=O)N1)NC(=O)C4=C(C=CC=N4)O)C)C5=CC=CC=C5)CSC6CN7CCC6CC7)CC8=CC=C(C=C8)N(C)C)C.CCN(CC)CCS(=O)(=O)C1CCN2C1C(=O)OC(C(C=CC(=O)NCC=CC(=CC(CC(=O)CC3=NC(=CO3)C2=O)O)C)C)C(C)C,.,
393,DILIrank,tamsulosin,129211,vLess-DILI-Concern,1,408.5,2.7,108.0,7,2,28,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,Liver,
897,LIverTox,Azilsartan,135415867,E*,1,456.4,4.4,115.0,7,2,34,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NOC(=O)N5)C(=O)O,CYP2C9,
758,DILIrank,alaproclate,2081,vMost-DILI-Concern,1,255.74,2.8,52.3,3,1,17,CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N,.,
329,DILIrank,benzonatate,7699,vLess-DILI-Concern,1,603.7,2.4,121.0,12,1,42,CCCCNC1=CC=C(C=C1)C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC,.,
452,DILIrank,gadobenate dimeglumine,105124,vNo-DILI-Concern,0,667.7,,220.0,14,2,37,[H+].[H+].C1=CC=C(C=C1)COCC(C(=O)[O-])N(CCN(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3],.,
1661,LIverTox,Rolapitant,10311306,E,0,500.5,4.4,50.4,9,2,35,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OCC2(CCC3(CCC(=O)N3)CN2)C4=CC=CC=C4,CYP3A4,
3363,Liew,Dactinomycin,2019,positive,1,1255.4,3.8,356.0,18,5,90,CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)N)C,,
583,DILIrank,fosinopril,55891,vLess-DILI-Concern,1,563.7,6.2,110.0,7,1,39,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)O)C3CCCCC3,"liver, GIT mucosa to fosinoprilat",
6,DILIrank,cyclophosphamide,2907,vLess-DILI-Concern,1,261.08,0.6,41.6,4,1,14,C1CNP(=O)(OC1)N(CCCl)CCCl,Liver,
604,DILIrank,riboflavin,493570,vNo-DILI-Concern,0,376.4,-1.5,155.0,7,5,27,CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(CO)O)O)O,.,
3432,Liew,Doxepin,3158,positive,1,279.4,4.3,12.5,2,0,21,CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31,,
62,DILIrank,mefenamic acid,4044,vMost-DILI-Concern,1,241.28,5.1,49.3,3,2,18,CC1=C(C(=CC=C1)NC2=CC=CC=C2C(=O)O)C,CYP2C9,
1527,LIverTox,Pasireotide,9941444,E*,0,1047.2,4.7,281.0,11,9,77,C1C(CN2C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C2=O)CC3=CC=CC=C3)CC4=CC=C(C=C4)OCC5=CC=CC=C5)CCCCN)CC6=CNC7=CC=CC=C76)C8=CC=CC=C8)OC(=O)NCCN,.,
226,DILIrank,dimenhydrinate,10660,vNo-DILI-Concern,0,470.0,,81.8,5,1,33,CN1C2=C(C(=O)N(C1=O)C)NC(=N2)Cl.CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2,Liver,
3243,Liew,Bortezomib,387447,positive,1,384.2,,124.0,6,4,28,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,,
428,DILIrank,alpidem,54897,vMost-DILI-Concern,1,404.3,4.8,37.6,2,0,27,CCCN(CCC)C(=O)CC1=C(N=C2N1C=C(C=C2)Cl)C3=CC=C(C=C3)Cl,"	Extensive hydroxylation, dealkylation, conjugation",
727,DILIrank,dicloxacillin,18381,vLess-DILI-Concern,1,470.3,2.9,138.0,7,2,30,CC1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O,Liver,
2537,Xu,Biotin,171548,Negative,0,244.31,0.3,104.0,4,3,16,C1C2C(C(S1)CCCCC(=O)O)NC(=O)N2,.,
157,DILIrank,gabapentin,3446,vLess-DILI-Concern,1,171.24,-1.1,63.3,3,2,12,C1CCC(CC1)(CC(=O)O)CN,Not significantly metabolized,
344,DILIrank,glycopyrrolate,3494,vNo-DILI-Concern,0,318.4,3.1,46.5,3,1,23,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C,.,
1353,LIverTox,Levofloxacin,149096,A,1,361.4,-0.4,73.3,8,1,26,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,<5% desmethyl and N-oxide metabolites,
426,DILIrank,oxcarbazepine,34312,vLess-DILI-Concern,1,252.27,1.7,63.4,2,1,19,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N,Liver cytosolic enzymes and glucuronic acid,
3421,Liew,Disulfiram,3117,positive,1,296.5,3.9,121.0,4,0,16,CCN(CC)C(=S)SSC(=S)N(CC)CC,,
795,LIverTox,Acrivastine,5284514,E,0,348.4,1.6,53.4,4,1,26,CC1=CC=C(C=C1)C(=CCN2CCCC2)C3=CC=CC(=N3)C=CC(=O)O,.,
481,DILIrank,chlordiazepoxide,2712,vLess-DILI-Concern,1,299.75,2.4,48.2,3,1,21,CN=C1CN(C(=C2C=C(C=CC2=N1)Cl)C3=CC=CC=C3)O,Liver,
2755,Xu,Phenacetin,4754,Positive,1,179.22,1.6,38.3,2,1,13,CCOC1=CC=C(C=C1)NC(=O)C,,
4013,Liew,Testolactone,13769,negative,0,300.4,3.0,43.4,3,0,22,CC12CCC3C(C1CCC(=O)O2)CCC4=CC(=O)C=CC34C,Liver,
2741,Xu,Norgestrel,16051930,Positive,1,312.4,3.3,37.3,2,1,23,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,.,
902,LIverTox,Baloxavir,124081896,E,0,571.6,3.8,123.0,12,0,40,COC(=O)OCOC1=C2C(=O)N3CCOCC3N(N2C=CC1=O)C4C5=C(CSC6=CC=CC=C46)C(=C(C=C5)F)F,.,
3768,Liew,Nitrendipine,4507,positive,0,360.4,2.9,110.0,7,1,26,CCOC(=O)C1=C(NC(=C(C1C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OC)C)C,Liver,
1639,LIverTox,Resveratrol,445154,E,0,228.24,3.1,60.7,3,3,17,C1=CC(=CC=C1C=CC2=CC(=CC(=C2)O)O)O,.,
3782,Liew,Olsalazine,22419,positive,1,302.24,3.1,140.0,8,4,22,C1=CC(=C(C=C1N=NC2=CC(=C(C=C2)O)C(=O)O)C(=O)O)O,,
459,DILIrank,ezetimibe,150311,vLess-DILI-Concern,1,409.4,4.0,60.8,5,2,30,C1=CC(=CC=C1C2C(C(=O)N2C3=CC=C(C=C3)F)CCC(C4=CC=C(C=C4)F)O)O,"Intestinal wall, liver",
3149,Liew,Albuterol,2083,negative,0,239.31,0.3,72.7,4,4,17,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,,
3577,Liew,Histrelin,25077993,negative,0,1323.5,0.7,449.0,15,15,96,CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC2=CN(C=N2)CC3=CC=CC=C3)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8,,
1886,Greene,Acitretin,5284513,HH,1,326.4,6.1,46.5,3,1,24,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC,Liver,
1545,LIverTox,Peramivir,151164,E,0,328.41,0.0,151.0,5,5,23,CCC(CC)C(C1C(CC(C1O)C(=O)O)N=C(N)N)NC(=O)C,.,
2201,Greene,Mesoridazine Besylate,4078,HH,1,386.6,4.5,68.1,5,0,26,CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)C,	Liver/renal,
3585,Liew,Ibandronate,60852,positive,0,319.23,-4.1,139.0,8,5,19,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O,,
1717,LIverTox,Stiripentol,5311454,E,0,234.29,3.6,38.7,3,1,17,CC(C)(C)C(C=CC1=CC2=C(C=C1)OCO2)O,.,
1352,LIverTox,Levodopa,6047,E,0,197.19,-2.7,104.0,5,4,14,C1=CC(=C(C=C1CC(C(=O)O)N)O)O,Aromatic-l-amino-acid decarboxylase,
808,LIverTox,Aliskiren,5493444,C,1,551.8,3.5,146.0,7,4,39,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N,CYP3A4,
487,DILIrank,chlorothiazide,2720,vLess-DILI-Concern,1,295.7,-0.2,135.0,6,2,17,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2,	Nil,
1999,Greene,Ciclopirox,2749,NE,0,207.27,2.0,40.5,2,1,15,CC1=CC(=O)N(C(=C1)C2CCCCC2)O,.,
1482,LIverTox,Nizatidine,3033637,D,1,331.5,1.6,140.0,8,2,21,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C,Liver,
3836,Liew,Phendimetrazine,12460,negative,0,191.27,1.9,12.5,2,0,14,CC1C(OCCN1C)C2=CC=CC=C2,Liver,
4001,Liew,Temocillin,171758,negative,0,414.5,1.1,187.0,9,3,27,CC1(C(N2C(S1)C(C2=O)(NC(=O)C(C3=CSC=C3)C(=O)O)OC)C(=O)O)C,,
252,DILIrank,nystatin,14960,vNo-DILI-Concern,0,926.1,-0.2,320.0,18,12,65,CC1C=CC=CCCC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,None not extensively absorbed,
296,DILIrank,pipamazine,6761,vMost-DILI-Concern,1,402.0,4.4,74.9,4,1,27,C1CN(CCC1C(=O)N)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,.,
3006,Liew,Lomefloxacin,3948,negative,1,351.35,-0.8,72.9,8,2,25,CCN1C=C(C(=O)C2=CC(=C(C(=C21)F)N3CCNC(C3)C)F)C(=O)O,,
2009,Greene,Citicoline,11583971,NE,0,488.32,-4.0,214.0,11,4,31,C[N+](C)(C)CCOP(=O)(O)OP(=O)([O-])OCC1C(C(C(O1)N2C=CC(=NC2=O)N)O)O,.,
25,DILIrank,amphotericin b,14956,vLess-DILI-Concern,1,924.1,0.0,320.0,18,12,65,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,kidney,
3294,Liew,Celecoxib,2662,positive,1,381.4,3.4,86.4,7,1,26,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,,
1482,LIverTox,Nizatidine,3033637,D,1,331.5,1.6,140.0,8,2,21,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C,Liver,
169,DILIrank,verapamil,2520,vLess-DILI-Concern,1,454.6,3.8,64.0,6,0,33,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,liver,
4050,Liew,Tranilast,5282230,positive,1,327.3,3.2,84.9,5,2,24,COC1=C(C=C(C=C1)C=CC(=O)NC2=CC=CC=C2C(=O)O)OC,,
3681,Liew,Metergoline,28693,positive,0,403.5,3.8,46.5,3,1,30,CN1CC(CC2C1CC3=CN(C4=CC=CC2=C34)C)CNC(=O)OCC5=CC=CC=C5,,
1152,LIverTox,Enzalutamide,15951529,E,0,464.4,3.6,109.0,8,1,32,CC1(C(=O)N(C(=S)N1C2=CC(=C(C=C2)C(=O)NC)F)C3=CC(=C(C=C3)C#N)C(F)(F)F)C,"CYP2C8,CYP3A4",
3793,Liew,Oxatomide,4615,positive,0,426.6,4.1,38.8,3,1,32,C1CN(CCN1CCCN2C3=CC=CC=C3NC2=O)C(C4=CC=CC=C4)C5=CC=CC=C5,,
638,DILIrank,nitroglycerin,4510,vNo-DILI-Concern,0,227.09,1.6,165.0,9,0,15,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-],	Liver,
4056,Liew,Trichlormethiazide,5560,negative,0,380.7,0.6,135.0,7,3,20,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)NC(N2)C(Cl)Cl,,
574,DILIrank,fludarabine,657237,vNo-DILI-Concern,0,285.23,-0.6,140.0,9,4,20,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,.,
3516,Liew,Fluorescein,16850,negative,0,332.3,3.4,76.0,5,2,25,C1=CC=C2C(=C1)C(=O)OC23C4=C(C=C(C=C4)O)OC5=C3C=CC(=C5)O,,
4101,Liew,Xanomeline,60809,positive,0,281.42,3.3,66.5,5,0,19,CCCCCCOC1=NSN=C1C2=CCCN(C2)C,,
3791,Liew,Oxandrolone,5878,positive,1,306.4,3.7,46.5,3,1,22,CC12CCC3C(C1CCC2(C)O)CCC4C3(COC(=O)C4)C,Kidney,
331,DILIrank,dichlorphenamide,3038,vNo-DILI-Concern,0,305.2,0.3,137.0,6,2,16,C1=C(C=C(C(=C1S(=O)(=O)N)Cl)Cl)S(=O)(=O)N,.,
3770,Liew,Nitrofurazone,5447130,negative,0,198.14,0.2,126.0,5,2,14,C1=C(OC(=C1)[N+](=O)[O-])C=NNC(=O)N,,
1384,LIverTox,Mebendazole,4030,D,1,295.29,2.8,84.1,4,2,22,COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=CC=C3,Extensive liver,
2175,Greene,Leflunomide,3899,HH,1,270.21,2.5,55.1,6,1,19,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F,GI mucosa and liver,
1376,LIverTox,Lurasidone,213046,E,0,492.7,5.4,85.0,6,0,35,C1CCC(C(C1)CN2CCN(CC2)C3=NSC4=CC=CC=C43)CN5C(=O)C6C7CCC(C7)C6C5=O,CYP3A4,
3047,Liew,Nisoldipine,4499,negative,0,388.4,3.3,110.0,7,1,28,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,CYP3A4,
1928,Greene,Azathioprine,2265,HH,1,277.27,0.1,143.0,7,1,19,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],"	Activated non-enzymatically, deactivated mainly by xanthine oxidase",
3673,Liew,Mephobarbital,8271,positive,0,246.26,1.8,66.5,3,1,18,CCC1(C(=O)NC(=O)N(C1=O)C)C2=CC=CC=C2,,
1146,LIverTox,Encorafenib,50922675,E*,0,540.0,2.7,149.0,10,3,36,CC(C)N1C=C(C(=N1)C2=C(C(=CC(=C2)Cl)NS(=O)(=O)C)F)C3=NC(=NC=C3)NCC(C)NC(=O)OC,.,
2685,Xu,Kanamycin Sulfate,6032,Negative,0,484.5,-6.9,283.0,15,11,33,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)O)O)OC3C(C(C(C(O3)CO)O)N)O)N,	Unknown,
3500,Liew,Flavoxate,3354,negative,0,391.5,4.3,55.8,5,0,29,CC1=C(OC2=C(C1=O)C=CC=C2C(=O)OCCN3CCCCC3)C4=CC=CC=C4,,
2236,Greene,N-acetyl cysteine,12035,NE,0,163.2,0.4,67.4,4,3,10,CC(=O)NC(CS)C(=O)O,Liver,
604,DILIrank,riboflavin,493570,vNo-DILI-Concern,0,376.4,-1.5,155.0,7,5,27,CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(CO)O)O)O,.,
3483,Liew,Etretinate,5282375,positive,0,354.5,6.8,35.5,3,0,26,CCOC(=O)C=C(C)C=CC=C(C)C=CC1=C(C(=C(C=C1C)OC)C)C,,
3569,Liew,Guanethidine,3518,negative,0,198.31,0.5,67.6,2,2,14,C1CCCN(CCC1)CCN=C(N)N,,
3767,Liew,Nitisinone,115355,negative,0,329.23,2.3,97.0,8,0,23,C1CC(=O)C(C(=O)C1)C(=O)C2=C(C=C(C=C2)C(F)(F)F)[N+](=O)[O-],,
990,LIverTox,Ceritinib,57379345,D,1,558.1,6.4,114.0,8,3,38,CC1=CC(=C(C=C1C2CCNCC2)OC(C)C)NC3=NC=C(C(=N3)NC4=CC=CC=C4S(=O)(=O)C(C)C)Cl,CYP3A,
1551,LIverTox,Pexidartinib,25151352,B,1,417.8,4.5,66.5,7,2,29,C1=CC(=NC=C1CC2=CNC3=C2C=C(C=N3)Cl)NCC4=CN=C(C=C4)C(F)(F)F,.,
34,DILIrank,carboplatin,498142,vLess-DILI-Concern,1,371.25,,76.6,6,4,13,C1CC(C1)(C(=O)O)C(=O)O.[NH2-].[NH2-].[Pt],.,
1657,LIverTox,Rivaroxaban,6433119,A,1,435.9,2.5,116.0,6,1,29,C1COCC(=O)N1C2=CC=C(C=C2)N3CC(OC3=O)CNC(=O)C4=CC=C(S4)Cl,"CYP3A4, CYP2J2",
208,DILIrank,gamma hydroxybutyric acid,3037032,vNo-DILI-Concern,0,103.1,0.0,60.4,3,1,7,C(CC(=O)[O-])CO,"	95%, mainly liver, also in blood and tissues",
446,DILIrank,bendazac,2313,vMost-DILI-Concern,1,282.29,3.1,64.4,4,1,21,C1=CC=C(C=C1)CN2C3=CC=CC=C3C(=N2)OCC(=O)O,.,
3590,Liew,Iloprost,5311181,positive,0,360.5,2.8,77.8,4,3,26,CC#CCC(C)C(C=CC1C(CC2C1CC(=CCCCC(=O)O)C2)O)O,,
3918,Liew,Rapacuronium,5311398,negative,0,677.8,,55.8,6,0,44,CCC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)OC(=O)C)N5CCCCC5)C)C)[N+]6(CCCCC6)CC=C.[Br-],,
169,DILIrank,verapamil,2520,vLess-DILI-Concern,1,454.6,3.8,64.0,6,0,33,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,liver,
3784,Liew,Ondansetron,4595,positive,1,293.4,2.3,39.8,2,0,22,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,"CYP3A4, CYP1A2, CYP2D6",
3468,Liew,Eszopiclone,969472,negative,0,388.8,0.5,91.8,7,0,27,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,,
3169,Liew,Amdinocillin,36273,positive,0,325.4,2.1,98.5,5,1,22,CC1(C(N2C(S1)C(C2=O)N=CN3CCCCCC3)C(=O)O)C,,
3597,Liew,Iproniazid,3748,positive,1,179.22,0.4,54.0,3,2,13,CC(C)NNC(=O)C1=CC=NC=C1,,
3893,Liew,Propofol,4943,positive,1,178.27,3.8,20.2,1,1,13,CC(C)C1=C(C(=CC=C1)C(C)C)O,Liver,
3265,Liew,Carbimazole,31072,positive,1,186.23,0.7,64.9,3,0,12,CCOC(=O)N1C=CN(C1=S)C,,
2172,Greene,Lactose,6134,NE,0,342.3,-4.7,190.0,11,8,23,C(C1C(C(C(C(O1)OC2C(OC(C(C2O)O)O)CO)O)O)O)O,.,
3617,Liew,Ketorolac,3826,positive,1,255.27,1.9,59.3,3,1,19,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,,
1577,LIverTox,Pomalidomide,134780,D,1,273.24,0.2,110.0,5,2,20,C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)N,Liver mostly CYP1A2- and CYP3A4-mediated; some minor contributions by CYP2C19 and CYP2D6,
258,DILIrank,sulfathiazole,5340,vMost-DILI-Concern,1,255.3,0.1,122.0,6,2,16,C1=CC(=CC=C1N)S(=O)(=O)NC2=NC=CS2,.,
2436,Greene,tamoxifen,2733526,HH,1,371.5,7.1,12.5,2,0,28,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3,"CYP3A4, CYP2C9, CYP2D6",
2517,Xu,Amsacrine HCl,2179,Positive,1,393.5,4.0,88.7,6,2,28,COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=CC3=NC4=CC=CC=C42,,
3190,Liew,Anagrelide,135409400,negative,1,256.08,1.6,44.7,2,1,16,C1C2=C(C=CC(=C2Cl)Cl)N=C3N1CC(=O)N3,,
3612,Liew,Josamycin,5282165,positive,0,828.0,2.9,206.0,16,3,58,CC1CC=CC=CC(C(CC(C(C(C(CC(=O)O1)OC(=O)C)OC)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)OC(=O)CC(C)C)(C)O)N(C)C)O)CC=O)C)O,,
2073,Greene,Doxorubicin HCl,443939,HH,1,580.0,,206.0,12,7,40,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O.Cl,Liver,
3558,Liew,Gliclazide,3475,positive,1,323.4,1.5,86.9,4,2,22,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2,,
3974,Liew,Sucralfate,6398525,positive,0,1571.9,,624.0,55,28,83,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al],"Liver, GI",
1923,Greene,Aurothioglucose,6104,HH,1,392.18,,91.2,6,4,13,C(C1C(C(C(C(O1)[S-])O)O)O)O.[Au+],.,
3959,Liew,Silver sulfadiazine,441244,negative,0,357.14,,95.3,6,1,18,C1=CN=C(N=C1)[N-]S(=O)(=O)C2=CC=C(C=C2)N.[Ag+],,
2755,Xu,Phenacetin,4754,Positive,1,179.22,1.6,38.3,2,1,13,CCOC1=CC=C(C=C1)NC(=O)C,,
829,LIverTox,Amlodipine,2162,C,1,408.9,3.0,99.9,7,2,28,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,Liver,
481,DILIrank,chlordiazepoxide,2712,vLess-DILI-Concern,1,299.75,2.4,48.2,3,1,21,CN=C1CN(C(=C2C=C(C=CC2=N1)Cl)C3=CC=CC=C3)O,Liver,
4086,Liew,Vancomycin,14969,negative,1,1449.2,-2.6,531.0,26,19,101,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,,
3681,Liew,Metergoline,28693,positive,0,403.5,3.8,46.5,3,1,30,CN1CC(CC2C1CC3=CN(C4=CC=CC2=C34)C)CNC(=O)OCC5=CC=CC=C5,,
2534,Xu,Betamethasone,9782,Negative,0,392.5,1.9,94.8,6,3,28,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,CYP3A4,
1319,LIverTox,Ivabradine,132999,E,0,468.6,2.4,60.5,6,0,34,CN(CCCN1CCC2=CC(=C(C=C2CC1=O)OC)OC)CC3CC4=CC(=C(C=C34)OC)OC,"Liver first-pass >50%, CYP3A4",
3894,Liew,Propoxyphene,10100,positive,1,339.5,4.2,29.5,3,0,25,CCC(=O)OC(CC1=CC=CC=C1)(C2=CC=CC=C2)C(C)CN(C)C,CYP3A4,
3400,Liew,Dienestrol,667476,negative,0,266.3,5.4,40.5,2,2,20,CC=C(C1=CC=C(C=C1)O)C(=CC)C2=CC=C(C=C2)O,,
3555,Liew,Gemfibrozil,3463,positive,1,250.33,3.8,46.5,3,1,18,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,,
3379,Liew,Desipramine,2995,positive,1,266.4,4.9,15.3,2,1,20,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,,
3496,Liew,Fentanyl,3345,negative,0,336.5,4.0,23.6,2,0,25,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,,
254,DILIrank,prednisolone,5755,vLess-DILI-Concern,1,360.4,1.6,94.8,5,3,26,CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,.,
107,DILIrank,prednisone,5865,vLess-DILI-Concern,1,358.4,1.5,91.7,5,2,26,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,prednisolone liver,
3141,Liew,Acetophenazine,17676,positive,0,411.6,2.6,72.3,6,1,29,CC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN4CCN(CC4)CCO,,
1553,LIverTox,Phencyclidine,6468,C[HD],1,243.4,3.6,3.2,1,0,18,C1CCC(CC1)(C2=CC=CC=C2)N3CCCCC3,"Oxidative hydroxylation in liver by CYP450 enzymes, glucuronidation",
3266,Liew,Carboprost,5281075,negative,0,368.5,2.9,98.0,5,4,26,CCCCCC(C)(C=CC1C(CC(C1CC=CCCCC(=O)O)O)O)O,,
482,DILIrank,atazanavir,148192,vLess-DILI-Concern,1,704.9,5.6,171.0,9,5,51,CC(C)(C)C(C(=O)NC(CC1=CC=CC=C1)C(CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)C(C(C)(C)C)NC(=O)OC)O)NC(=O)OC,CYP3A4,
1546,LIverTox,Perampanel,9924495,E,0,349.4,3.4,57.0,3,0,27,C1=CC=C(C=C1)N2C=C(C=C(C2=O)C3=CC=CC=C3C#N)C4=CC=CC=N4,"Liver, mostly via CYP3A4 and/or CYP3A5",
2684,Xu,Isoxsuprine HCl,3783,Negative,0,301.4,2.8,61.7,4,3,22,CC(COC1=CC=CC=C1)NC(C)C(C2=CC=C(C=C2)O)O,.,
2725,Xu,Monocrotaline,9415,Positive,1,325.36,-0.7,96.3,7,2,23,CC1C(=O)OC2CCN3C2C(=CC3)COC(=O)C(C1(C)O)(C)O,.,
394,DILIrank,remifentanil,60815,vLess-DILI-Concern,1,376.4,1.9,76.2,6,0,27,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC,	cleaved by non-specific plasma and tissue esterases,
3361,Liew,Cytarabine,6253,positive,1,243.22,-2.1,129.0,5,4,17,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,,
724,DILIrank,ximelagatran,9574101,vMost-DILI-Concern,1,473.6,2.2,146.0,7,4,34,CCOC(=O)CNC(C1CCCCC1)C(=O)N2CCC2C(=O)NCC3=CC=C(C=C3)C(=NO)N,	to melagatran,
3868,Liew,Pranlukast,4887,positive,0,481.5,4.2,119.0,7,2,36,C1=CC=C(C=C1)CCCCOC2=CC=C(C=C2)C(=O)NC3=CC=CC4=C3OC(=CC4=O)C5=NNN=N5,CYP3A4,
3558,Liew,Gliclazide,3475,positive,1,323.4,1.5,86.9,4,2,22,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2,,
738,DILIrank,l-arginine,6322,vNo-DILI-Concern,0,174.2,-4.2,128.0,4,4,12,C(CC(C(=O)O)N)CN=C(N)N,.,
3704,Liew,Methyltestosterone,6010,positive,1,302.5,3.4,37.3,2,1,22,CC12CCC(=O)C=C1CCC3C2CCC4(C3CCC4(C)O)C,,
3222,Liew,Bendroflumethiazide,2315,positive,1,421.4,1.2,135.0,10,3,27,C1=CC=C(C=C1)CC2NC3=C(C=C(C(=C3)C(F)(F)F)S(=O)(=O)N)S(=O)(=O)N2,,
1446,LIverTox,Nabilone,5284592,E,0,372.5,6.4,46.5,3,1,27,CCCCCCC(C)(C)C1=CC(=C2C3CC(=O)CCC3C(OC2=C1)(C)C)O,.,
1743,LIverTox,Tedizolid,11234049,E*,0,370.3,1.4,106.0,8,1,27,CN1N=C(N=N1)C2=NC=C(C=C2)C3=C(C=C(C=C3)N4CC(OC4=O)CO)F,.,
2473,Greene,Troleandomycin,5284630,HH,1,814.0,4.3,184.0,16,0,57,CC1CC(C(C(O1)OC2C(CC3(CO3)C(=O)C(C(C(C(OC(=O)C(C(C2C)OC4CC(C(C(O4)C)OC(=O)C)OC)C)C)C)OC(=O)C)C)C)OC(=O)C)N(C)C,.,
2530,Xu,Benazepril,5362124,Negative,1,424.5,1.3,95.9,6,2,31,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O,Liver glucuronidation,
358,DILIrank,nitroprusside,11953895,vNo-DILI-Concern,0,297.95,,139.0,14,2,17,[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[N-]=O.O.O.[Na+].[Na+].[Fe+4],,complex
3180,Liew,Amitriptyline ,2160,positive,1,277.4,5.0,3.2,1,0,21,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,,
4047,Liew,Toremifene,3005573,positive,1,406.0,7.2,12.5,2,0,29,CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3,CYP3A4,
1700,LIverTox,Simvastatin,54454,A,1,418.6,4.7,72.8,5,1,30,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,.,
2685,Xu,Kanamycin Sulfate,6032,Negative,0,484.5,-6.9,283.0,15,11,33,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)O)O)OC3C(C(C(C(O3)CO)O)N)O)N,	Unknown,
944,LIverTox,Brexpiprazole,11978813,E,0,433.6,4.7,73.0,5,1,31,C1CN(CCN1CCCCOC2=CC3=C(C=C2)C=CC(=O)N3)C4=C5C=CSC5=CC=C4,Liver mainly mediated by CYP3A4 and CYP2D6,
1912,Greene,Amrinone,3698,HH,1,187.2,-0.2,68.0,3,2,14,C1=CN=CC=C1C2=CNC(=O)C(=C2)N,Liver,
62,DILIrank,mefenamic acid,4044,vMost-DILI-Concern,1,241.28,5.1,49.3,3,2,18,CC1=C(C(=CC=C1)NC2=CC=CC=C2C(=O)O)C,CYP2C9,
1580,LIverTox,Pralatrexate,148121,E*,0,477.5,-0.9,207.0,11,5,35,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,.,
3600,Liew,Isepamicin,3037209,positive,0,569.6,-6.9,298.0,16,12,39,CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(C(C(C(O3)CN)O)O)O)N)NC(=O)C(CN)O)O,,
1527,LIverTox,Pasireotide,9941444,E*,0,1047.2,4.7,281.0,11,9,77,C1C(CN2C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C2=O)CC3=CC=CC=C3)CC4=CC=C(C=C4)OCC5=CC=CC=C5)CCCCN)CC6=CNC7=CC=CC=C76)C8=CC=CC=C8)OC(=O)NCCN,.,
296,DILIrank,pipamazine,6761,vMost-DILI-Concern,1,402.0,4.4,74.9,4,1,27,C1CN(CCC1C(=O)N)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,.,
1475,LIverTox,Niraparib,24958200,E*,0,320.4,2.2,72.9,3,2,24,C1CC(CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N,Carboxylesterases,
1782,LIverTox,Tizanidine,5487,C,1,253.71,1.1,90.4,4,2,16,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl,"Liver CYP1A2, 95%",
3796,Liew,Oxiconazole,5361463,negative,0,429.1,6.1,39.4,3,0,26,C1=CC(=C(C=C1Cl)Cl)CON=C(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,,
1786,LIverTox,Tolcapone,4659569,C,1,273.24,3.3,103.0,5,2,20,CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-],Liver mainly glucuronidation,
2638,Xu,Eserine,5983,Negative,0,275.35,0.7,44.8,4,1,20,CC12CCN(C1N(C3=C2C=C(C=C3)OC(=O)NC)C)C,	Major metabolite: Eseroline,
1176,LIverTox,Etodolac,3308,C,1,287.35,2.8,62.3,3,2,21,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,liver,
3150,Liew,Alclometasone,5311000,negative,0,408.9,2.2,94.8,5,3,28,CC1CC2C3C(CC4=CC(=O)C=CC4(C3C(CC2(C1(C(=O)CO)O)C)O)C)Cl,,
3885,Liew,Progabide,5361323,positive,0,334.8,3.1,72.2,4,2,23,C1=CC(=CC=C1C(=C2C=C(C=CC2=O)F)NCCCC(=O)N)Cl,Liver,
1050,LIverTox,Cyproheptadine,2913,C,1,287.4,4.7,3.2,1,0,22,CN1CCC(=C2C3=CC=CC=C3C=CC4=CC=CC=C42)CC1,CYP3A4,
3199,Liew,Arbutamine,60789,negative,0,317.4,0.9,93.0,5,5,23,C1=CC(=CC=C1CCCCNCC(C2=CC(=C(C=C2)O)O)O)O,,
3539,Liew,Fotemustine,104799,positive,0,315.69,0.9,97.3,6,1,19,CCOP(=O)(C(C)NC(=O)N(CCCl)N=O)OCC,,
640,DILIrank,norfloxacin,4539,vLess-DILI-Concern,1,319.33,-1.0,72.9,7,2,23,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,Liver,
394,DILIrank,remifentanil,60815,vLess-DILI-Concern,1,376.4,1.9,76.2,6,0,27,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC,	cleaved by non-specific plasma and tissue esterases,
3175,Liew,Aminohippuric acid,2148,negative,0,194.19,-0.9,92.4,4,3,14,C1=CC(=CC=C1C(=O)NCC(=O)O)N,,
453,DILIrank,atomoxetine,54841,vMost-DILI-Concern,1,255.35,3.7,21.3,2,1,19,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2,CYP2D6,
750,DILIrank,mepazine,6075,vMost-DILI-Concern,1,310.5,5.6,31.8,3,0,22,CN1CCCC(C1)CN2C3=CC=CC=C3SC4=CC=CC=C42,.,
3815,Liew,Pefloxacin,51081,positive,0,333.36,0.3,64.1,7,1,24,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCN(CC3)C)F)C(=O)O,Liver,
1435,LIverTox,Molindone,23897,D,1,276.37,1.7,45.3,3,1,20,CCC1=C(NC2=C1C(=O)C(CC2)CN3CCOCC3)C,Liver,
3660,Liew,Mazindol,4020,negative,0,284.74,2.2,35.8,2,1,20,C1CN2C(=N1)C3=CC=CC=C3C2(C4=CC=C(C=C4)Cl)O,,
3562,Liew,Gonadorelin,638793,negative,0,1182.3,-2.4,475.0,15,16,85,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)CNC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6,,
3575,Liew,Halofantrine,37393,positive,0,500.4,8.6,23.5,5,1,33,CCCCN(CCCC)CCC(C1=C2C=CC(=CC2=C3C=C(C=C(C3=C1)Cl)Cl)C(F)(F)F)O,,
345,DILIrank,metyrapone,4174,vNo-DILI-Concern,0,226.27,2.0,42.8,3,0,17,CC(C)(C1=CN=CC=C1)C(=O)C2=CN=CC=C2,.,
63,DILIrank,meloxicam,54677470,vLess-DILI-Concern,1,351.4,3.0,136.0,7,2,23,CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O,"CYP2C9,3A4",
259,DILIrank,terbinafine,1549008,vMost-DILI-Concern,1,291.4,5.6,3.2,1,0,22,CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21,liver,
3181,Liew,Amlexanox,2161,negative,0,298.29,3.1,103.0,6,2,22,CC(C)C1=CC2=C(C=C1)OC3=NC(=C(C=C3C2=O)C(=O)O)N,,
3545,Liew,Gabexate,3447,positive,0,321.37,1.4,117.0,5,2,23,CCOC(=O)C1=CC=C(C=C1)OC(=O)CCCCCN=C(N)N,,
3904,Liew,Quazepam,4999,negative,0,386.8,4.0,47.7,6,0,25,C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F,Liver,
1413,LIverTox,Metronidazole,4173,C,1,171.15,0.0,83.9,4,1,12,CC1=NC=C(N1CCO)[N+](=O)[O-],Liver,
1428,LIverTox,Mirtazapine,4205,C,1,265.35,3.3,19.4,3,0,20,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,"CYP1A2, CYP2D6, CYP3A4",
1152,LIverTox,Enzalutamide,15951529,E,0,464.4,3.6,109.0,8,1,32,CC1(C(=O)N(C(=S)N1C2=CC(=C(C=C2)C(=O)NC)F)C3=CC(=C(C=C3)C#N)C(F)(F)F)C,"CYP2C8,CYP3A4",
746,DILIrank,glafenine,3474,vMost-DILI-Concern,1,372.8,3.5,91.7,6,3,26,C1=CC=C(C(=C1)C(=O)OCC(CO)O)NC2=C3C=CC(=CC3=NC=C2)Cl,.,
3022,Liew,Metolazone,4170,positive,1,365.8,4.1,101.0,5,2,24,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,,
2111,Greene,Flufenamic Acid (Flufenamate),3371,WE,1,281.23,5.2,49.3,6,2,20,C1=CC=C(C(=C1)C(=O)O)NC2=CC=CC(=C2)C(F)(F)F,"	Hydroxylation, glucuronidation",
415,DILIrank,acebutolol,1978,vLess-DILI-Concern,1,336.4,1.7,87.7,5,3,24,CCCC(=O)NC1=CC(=C(C=C1)OCC(CNC(C)C)O)C(=O)C,LIver,
3945,Liew,Roxatidine,91276,positive,0,306.4,1.5,61.8,4,2,22,C1CCN(CC1)CC2=CC(=CC=C2)OCCCNC(=O)CO,Liver,
435,DILIrank,levothyroxine,5819,vLess-DILI-Concern,1,776.87,2.4,92.8,5,3,24,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,"	Mainly in liver, kidneys, brain and muscles",
1569,LIverTox,Pirfenidone,40632,D,1,185.22,1.9,20.3,1,0,14,CC1=CN(C(=O)C=C1)C2=CC=CC=C2,"Liver 70?80% CYP1A2-mediated; minor contributions from CYP2C9, CYP2C19, CYP2D6 and CYP2E1",
1787,LIverTox,Tolmetin,5509,D,1,257.28,2.8,59.3,3,1,19,CC1=CC=C(C=C1)C(=O)C2=CC=C(N2C)CC(=O)O,.,
2172,Greene,Lactose,6134,NE,0,342.3,-4.7,190.0,11,8,23,C(C1C(C(C(C(O1)OC2C(OC(C(C2O)O)O)CO)O)O)O)O,.,
75,DILIrank,pseudoephedrine,7028,vNo-DILI-Concern,0,165.23,0.9,32.3,2,2,12,CC(C(C1=CC=CC=C1)O)NC,	10?30% liver,
1641,LIverTox,Revefenacin,11753673,E,0,597.7,4.1,108.0,6,2,44,CN(CCN1CCC(CC1)OC(=O)NC2=CC=CC=C2C3=CC=CC=C3)C(=O)C4=CC=C(C=C4)CN5CCC(CC5)C(=O)N,.,
2500,Xu,Acetylcholine Chloride,187,Negative,0,146.21,0.2,26.3,2,0,10,CC(=O)OCC[N+](C)(C)C,ACH,
3500,Liew,Flavoxate,3354,negative,0,391.5,4.3,55.8,5,0,29,CC1=C(OC2=C(C1=O)C=CC=C2C(=O)OCCN3CCCCC3)C4=CC=CC=C4,,
1243,LIverTox,Gilteritinib,49803313,E*,0,552.7,3.5,121.0,10,3,40,CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC(=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)OC)NC5CCOCC5,.,
945,LIverTox,Brigatinib,68165256,E*,0,584.1,4.6,85.9,9,2,40,CN1CCN(CC1)C2CCN(CC2)C3=CC(=C(C=C3)NC4=NC=C(C(=N4)NC5=CC=CC=C5P(=O)(C)C)Cl)OC,.,
897,LIverTox,Azilsartan,135415867,E*,1,456.4,4.4,115.0,7,2,34,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NOC(=O)N5)C(=O)O,CYP2C9,
195,DILIrank,sirolimus,5284616,vLess-DILI-Concern,1,914.2,6.0,195.0,13,3,65,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC,Liver,
3546,Liew,Gadodiamide,153921,negative,0,573.7,,188.0,11,2,30,CNC(=O)CN(CCN(CCN(CC(=O)NC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3],,
132,DILIrank,glipizide,3478,vLess-DILI-Concern,1,445.5,1.9,139.0,6,3,31,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,Liver hydroxylation,
3562,Liew,Gonadorelin,638793,negative,0,1182.3,-2.4,475.0,15,16,85,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)CNC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6,,
208,DILIrank,gamma hydroxybutyric acid,3037032,vNo-DILI-Concern,0,103.1,0.0,60.4,3,1,7,C(CC(=O)[O-])CO,"	95%, mainly liver, also in blood and tissues",
3812,Liew,Paromomycin,441375,negative,1,713.7,,430.0,23,15,47,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N.OS(=O)(=O)O,,
3721,Liew,Miglustat,51634,negative,0,219.28,-0.6,84.2,5,4,15,CCCCN1CC(C(C(C1CO)O)O)O,,
276,DILIrank,eltrombopag olamine,9846180,vMost-DILI-Concern,1,442.5,4.5,111.0,7,3,33,CC1=C(C=C(C=C1)N2C(=O)C(=C(N2)C)NN=C3C=CC=C(C3=O)C4=CC(=CC=C4)C(=O)O)C,	extensive liver through CYP1A2 and CYP2C8,
707,DILIrank,rosuvastatin,446157,vLess-DILI-Concern,1,481.5,1.6,149.0,10,3,33,CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,Liver: CYP2C9 major and CYP2C19-mediated; ~10% metabolized,
3221,Liew,Bendamustine,65628,negative,0,358.3,2.9,58.4,4,1,23,CN1C2=C(C=C(C=C2)N(CCCl)CCCl)N=C1CCCC(=O)O,,
1032,LIverTox,Cobimetinib,16222096,D,1,531.3,3.9,64.6,7,3,30,C1CCNC(C1)C2(CN(C2)C(=O)C3=C(C(=C(C=C3)F)F)NC4=C(C=C(C=C4)I)F)O,Intestinal and low Liver clearance mostly CYP3A4 oxidation and UGT2B7 glucuronidation,
4063,Liew,Trimeprazine,5574,positive,0,298.4,4.7,31.8,3,0,21,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)CN(C)C,Liver,
2648,Xu,Fenoprofen Sodium,3342,Positive,1,242.27,3.3,46.5,3,1,18,CC(C1=CC(=CC=C1)OC2=CC=CC=C2)C(=O)O,,
250,DILIrank,neomycin,8378,vNo-DILI-Concern,0,614.6,-9.0,353.0,19,13,42,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N,,
4061,Liew,Trihexyphenidyl,5572,negative,0,301.5,4.5,23.5,2,1,22,C1CCC(CC1)C(CCN2CCCCC2)(C3=CC=CC=C3)O,,
3280,Liew,Cefmenoxime,9570757,positive,0,511.6,0.0,270.0,14,3,33,CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O,,
1983,Greene,Ceftazidime,5481173,WE,1,546.6,0.4,245.0,12,3,37,CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],	negligible,
1189,LIverTox,Felbamate,3331,B,1,238.24,0.6,105.0,4,2,17,C1=CC=C(C=C1)C(COC(=O)N)COC(=O)N,Liver,
3204,Liew,Atenolol,2249,negative,1,266.34,0.2,84.6,4,3,19,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,,
3756,Liew,Netilmicin,41859,positive,0,475.6,-4.2,200.0,12,8,33,CCNC1CC(C(C(C1OC2C(C(C(CO2)(C)O)NC)O)O)OC3C(CC=C(O3)CN)N)N,,
3325,Liew,Cinoxacin,2762,positive,0,262.22,2.1,88.4,7,1,19,CCN1C2=CC3=C(C=C2C(=O)C(=N1)C(=O)O)OCO3,,
3917,Liew,Ranolazine,56959,negative,1,427.5,2.7,74.3,6,2,31,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O,"CYP3A, CYP2D6",
137,DILIrank,atorvastatin,60823,vMost-DILI-Concern,1,558.6,5.0,112.0,6,4,41,CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,CYP3A4,
383,DILIrank,enoxaparin,772,vLess-DILI-Concern,1,1134.9,-10.8,652.0,38,15,70,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,.,
2731,Xu,Nefazodone,4449,Positive,1,470.0,4.3,51.6,5,0,33,CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl,"CYP3A4, CYP2D6",
77,DILIrank,rifabutin,6323490,vLess-DILI-Concern,1,847.0,6.3,206.0,14,5,61,CC1C=CC=C(C(=O)NC2=C3C(=NC4(N3)CCN(CC4)CC(C)C)C5=C(C2=O)C(=C(C6=C5C(=O)C(O6)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)C,liver,
3875,Liew,Prilocaine,4906,negative,0,220.31,2.1,41.1,2,2,16,CCCNC(C)C(=O)NC1=CC=CC=C1C,"Liver, Kidney",
1944,Greene,Bezafibrate,39042,NE,0,361.8,3.8,75.6,4,2,25,CC(C)(C(=O)O)OC1=CC=C(C=C1)CCNC(=O)C2=CC=C(C=C2)Cl,.,
426,DILIrank,oxcarbazepine,34312,vLess-DILI-Concern,1,252.27,1.7,63.4,2,1,19,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N,Liver cytosolic enzymes and glucuronic acid,
3243,Liew,Bortezomib,387447,positive,1,384.2,,124.0,6,4,28,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,,
3715,Liew,Mibefradil,60662,negative,0,568.5,,67.4,6,3,38,CC(C)C1C2=C(CCC1(CCN(C)CCCC3=NC4=CC=CC=C4N3)OC(=O)COC)C=C(C=C2)F.Cl.Cl,,
2762,Xu,phenytoin,1775,Positive,1,252.27,2.5,58.2,2,2,19,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,Liver,
1969,Greene,carbamazepine,2554,HH,1,236.27,2.5,46.3,1,1,18,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,CYP3A4,
145,DILIrank,quetiapine,5002,vLess-DILI-Concern,1,383.5,2.1,73.6,5,1,27,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,Liver via CYP3A4-catalysed sulfoxidation to its active metabolite norquetiapine N-desalkylquetiapine,
3609,Liew,Itraconazole,55283,positive,1,705.6,5.7,101.0,9,0,49,CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,,
3838,Liew,Phenindione,4760,positive,1,222.24,2.9,34.1,2,0,17,C1=CC=C(C=C1)C2C(=O)C3=CC=CC=C3C2=O,,
1078,LIverTox,Delafloxacin,487101,E*,0,440.8,2.7,120.0,11,3,30,C1C(CN1C2=C(C=C3C(=C2Cl)N(C=C(C3=O)C(=O)O)C4=C(C=C(C(=N4)N)F)F)F)O,.,
1973,Greene,carbon tetrachloride (2),5943,HH,1,153.8,2.8,0.0,0,0,5,C(Cl)(Cl)(Cl)Cl,.,
1450,LIverTox,Naldemedine,54732242,E,0,570.6,3.2,141.0,9,4,42,CC(C)(C1=NC(=NO1)C2=CC=CC=C2)NC(=O)C3=C(C4C56CCN(C(C5(C3)O)CC7=C6C(=C(C=C7)O)O4)CC8CC8)O,primarily CYP3A4,
3511,Liew,Flumethasone,16490,negative,0,410.5,1.9,94.8,7,3,29,CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C)F,,
2014,Greene,Clindamycin HCl,446598,HH,1,425.0,2.2,128.0,7,4,27,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl,Liver,
633,DILIrank,nalbuphine,5311304,vNo-DILI-Concern,0,357.4,0.2,73.2,5,3,26,C1CC(C1)CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O,	Liver glucuronidation,
833,LIverTox,Amoxicillin-Clavulanate,6435924,A,1,564.6,,245.0,12,6,39,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C.C1C2N(C1=O)C(C(=CCO)O2)C(=O)O,.,
3181,Liew,Amlexanox,2161,negative,0,298.29,3.1,103.0,6,2,22,CC(C)C1=CC2=C(C=C1)OC3=NC(=C(C=C3C2=O)C(=O)O)N,,
3374,Liew,Delapril,5362116,positive,0,452.5,1.7,95.9,6,2,33,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N(CC(=O)O)C2CC3=CC=CC=C3C2,,
681,DILIrank,sulcotidil,5354,vMost-DILI-Concern,1,337.6,5.8,57.6,3,2,23,CCCCCCCCNC(C)C(C1=CC=C(C=C1)SC(C)C)O,.,
3707,Liew,Metoclopramide,4168,negative,1,299.79,2.6,67.6,4,2,20,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,,
6,DILIrank,cyclophosphamide,2907,vLess-DILI-Concern,1,261.08,0.6,41.6,4,1,14,C1CNP(=O)(OC1)N(CCCl)CCCl,Liver,
500,DILIrank,cloxacillin,6098,vLess-DILI-Concern,1,435.9,2.4,138.0,7,2,29,CC1=C(C(=NO1)C2=CC=CC=C2Cl)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O,.,
1652,LIverTox,Rimantadine,5071,E,0,179.3,2.6,26.0,1,1,13,CC(C12CC3CC(C1)CC(C3)C2)N,Liver hydroxylation and glucuronidation,
3006,Liew,Lomefloxacin,3948,negative,1,351.35,-0.8,72.9,8,2,25,CCN1C=C(C(=O)C2=CC(=C(C(=C21)F)N3CCNC(C3)C)F)C(=O)O,,
2009,Greene,Citicoline,11583971,NE,0,488.32,-4.0,214.0,11,4,31,C[N+](C)(C)CCOP(=O)(O)OP(=O)([O-])OCC1C(C(C(O1)N2C=CC(=NC2=O)N)O)O,.,
1573,LIverTox,Plazomicin,42613186,E,0,592.7,-6.2,269.0,15,11,41,CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CC=C(O3)CNCCO)N)N)NC(=O)C(CCN)O)O,.,
941,LIverTox,Bosutinib,5328940,D,1,530.4,5.4,82.9,8,1,36,CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC,"By CYP3A4, to inactive metabolites",
2545,Xu,Calcium Pantothenate,988,Negative,0,219.23,-1.1,107.0,5,4,15,CC(C)(CO)C(C(=O)NCCC(=O)O)O,.,
3429,Liew,Doxacurium,60169,negative,0,1035.2,7.4,163.0,16,0,74,C[N+]1(CCC2=CC(=C(C(=C2C1CC3=CC(=C(C(=C3)OC)OC)OC)OC)OC)OC)CCCOC(=O)CCC(=O)OCCC[N+]4(CCC5=CC(=C(C(=C5C4CC6=CC(=C(C(=C6)OC)OC)OC)OC)OC)OC)C,,
3875,Liew,Prilocaine,4906,negative,0,220.31,2.1,41.1,2,2,16,CCCNC(C)C(=O)NC1=CC=CC=C1C,"Liver, Kidney",
3243,Liew,Bortezomib,387447,positive,1,384.2,,124.0,6,4,28,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,,
1034,LIverTox,Codeine,5284371,E,0,299.4,1.1,41.9,4,1,22,CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O,"Liver: CYP2D6 to morphine, CYP3A4 to norcodeine, UGT2B7 to 3- and 6-glucuronides of codeine, norcodeine, and morphine",
142,DILIrank,rabeprazole,5029,vLess-DILI-Concern,1,359.4,1.9,96.3,6,1,25,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCCCOC,"CYP2C19,CYP3A4",
1146,LIverTox,Encorafenib,50922675,E*,0,540.0,2.7,149.0,10,3,36,CC(C)N1C=C(C(=N1)C2=C(C(=CC(=C2)Cl)NS(=O)(=O)C)F)C3=NC(=NC=C3)NCC(C)NC(=O)OC,.,
3453,Liew,Epalrestat,1549120,positive,1,319.4,3.8,115.0,5,1,21,CC(=CC1=CC=CC=C1)C=C2C(=O)N(C(=S)S2)CC(=O)O,,
1375,LIverTox,Lubiprostone,157920,E,0,390.5,4.0,83.8,7,2,27,CCCCC(C1(CCC2C(O1)CC(=O)C2CCCCCCC(=O)O)O)(F)F,"Extensive, CYP not involved",
1374,LIverTox,Loxapine,3964,D,1,327.8,3.1,28.1,3,0,23,CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl,"Extensive Liver; active metabolites include amoxapine and 8-hydroxyloxapine. Inhibits P-gp and is a substrate of CYP1A2, CYP3A4 and CYP2D6",
3396,Liew,Dibucaine,3025,negative,0,343.5,4.4,54.5,4,1,25,CCCCOC1=NC2=CC=CC=C2C(=C1)C(=O)NCCN(CC)CC,,
3533,Liew,Fosaprepitant,219090,positive,0,614.4,1.0,124.0,14,3,41,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)N(N3)P(=O)(O)O)C4=CC=C(C=C4)F,,
3472,Liew,Ethchlorvynol,5281077,positive,0,144.6,1.5,20.2,1,1,9,CCC(C=CCl)(C#C)O,,
3306,Liew,Chlormezanone,2717,positive,1,273.74,1.1,62.8,3,0,17,CN1C(S(=O)(=O)CCC1=O)C2=CC=C(C=C2)Cl,,
4064,Liew,Trimethaphan,23576,negative,0,365.5,3.6,24.6,1,0,26,C1CC2C3C(C[S+]2C1)N(C(=O)N3CC4=CC=CC=C4)CC5=CC=CC=C5,,
3563,Liew,Goserelin,5311128,negative,1,1269.4,-1.5,496.0,16,17,91,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6,,
2365,Greene,phenothiazine,7108,HH,1,199.27,4.2,37.3,2,1,14,C1=CC=C2C(=C1)NC3=CC=CC=C3S2,.,
2498,Xu,Acetazolamide,1986,Positive,1,222.3,-0.3,152.0,7,2,13,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,	None,
1225,LIverTox,Fostamatinib,11671467,E*,0,580.5,1.6,187.0,15,4,40,CC1(C(=O)N(C2=C(O1)C=CC(=N2)NC3=NC(=NC=C3F)NC4=CC(=C(C(=C4)OC)OC)OC)COP(=O)(O)O)C,"Gut ALP to tamatinib Liver tamatinib metabolite by CYP3A4, UGT1A9",
407,DILIrank,candesartan,2541,vLess-DILI-Concern,1,440.5,4.1,119.0,7,2,33,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,Candesartan cilexetil: intestinal wall; candesartan: Hepatic CYP2C9,
250,DILIrank,neomycin,8378,vNo-DILI-Concern,0,614.6,-9.0,353.0,19,13,42,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N,,
1009,LIverTox,Cholic Acid,221493,D[HD],1,408.6,3.6,98.0,5,4,29,CC(CCC(=O)O)C1CCC2C1(C(CC3C2C(CC4C3(CCC(C4)O)C)O)O)C,.,
3201,Liew,Aripiprazole,60795,negative,1,448.4,4.6,44.8,4,1,30,C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl,Liver mostly via CYP3A4 and 2D6,
3101,Liew,Teriparatide,16132393,negative,0,4118.0,-18.7,1800.0,62,60,289,CCC(C)C(C(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(CCSC)C(=O)NC(CC1=CN=CN1)C(=O)NC(CC(=O)N)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CC2=CN=CN2)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)N)C(=O)NC(CO)C(=O)NC(CCSC)C(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(C(C)C)C(=O)NC(CC5=CN=CN5)C(=O)NC(CC(=O)N)C(=O)NC(CC6=CC=CC=C6)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CO)N,,
3262,Liew,Captopril,44093,positive,1,217.29,0.3,58.6,4,2,14,CC(CS)C(=O)N1CCCC1C(=O)O,,
3411,Liew,Diltiazem,39186,positive,1,414.5,3.1,84.4,6,0,29,CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC,,
1033,LIverTox,Cocaine,446220,A[HD],1,303.35,2.3,55.8,5,0,22,CN1C2CCC1C(C(C2)OC(=O)C3=CC=CC=C3)C(=O)OC,CYP3A4,
3803,Liew,Oxyphencyclimine,4642,negative,0,344.4,2.9,62.1,4,1,25,CN1CCCN=C1COC(=O)C(C2CCCCC2)(C3=CC=CC=C3)O,,
415,DILIrank,acebutolol,1978,vLess-DILI-Concern,1,336.4,1.7,87.7,5,3,24,CCCC(=O)NC1=CC(=C(C=C1)OCC(CNC(C)C)O)C(=O)C,LIver,
409,DILIrank,rizatriptan,5078,vNo-DILI-Concern,0,269.34,1.7,49.7,3,1,20,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3,	By monoamine oxidase,
464,DILIrank,cefaclor,51038,vLess-DILI-Concern,1,385.8,,139.0,7,4,25,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl.O,15% to 40%,
1198,LIverTox,Fidaxomicin,10034073,E,0,1058.0,6.4,267.0,18,7,72,CCC1C=C(C(CC=CC=C(C(=O)OC(CC=C(C=C(C1OC2C(C(C(C(O2)(C)C)OC(=O)C(C)C)O)O)C)C)C(C)O)COC3C(C(C(C(O3)C)OC(=O)C4=C(C(=C(C(=C4O)Cl)O)Cl)CC)O)OC)O)C,.,
3892,Liew,Propiomazine,4940,negative,0,340.5,4.8,48.8,4,0,24,CCC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CC(C)N(C)C,,
3535,Liew,Fosfomycin,446987,positive,1,138.06,-1.4,70.1,4,2,8,CC1C(O1)P(=O)(O)O,,
1602,LIverTox,Propylthiouracil,657298,A,1,170.23,0.8,73.2,2,2,11,CCCC1=CC(=O)NC(=S)N1,.,
1399,LIverTox,Meropenem,441130,D,1,383.5,-2.4,136.0,7,3,26,CC1C2C(C(=O)N2C(=C1SC3CC(NC3)C(=O)N(C)C)C(=O)O)C(C)O,.,
3601,Liew,Isocarboxazid,3759,positive,0,231.25,1.5,67.2,4,2,17,CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2,,
3936,Liew,Rivastigmine,77991,negative,1,250.34,2.3,32.8,3,0,18,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C,Liver,
60,DILIrank,labetalol,3869,vMost-DILI-Concern,1,328.4,3.1,95.6,4,4,24,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O,"Liver pass metabolism,",
2833,Xu,Warfarin,54678486,Negative,1,308.3,2.7,63.6,4,1,23,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O,"Liver: CYP2C9, 2C19, 2C8, 2C18, 1A2,3A4",
2416,Greene,Rosiglitazone,77999,WE,1,357.4,3.1,96.8,6,1,25,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,CYP2C8,
3938,Liew,Rocuronium,441351,negative,0,609.7,,59.0,6,1,39,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C.[Br-],,
157,DILIrank,gabapentin,3446,vLess-DILI-Concern,1,171.24,-1.1,63.3,3,2,12,C1CCC(CC1)(CC(=O)O)CN,Not significantly metabolized,
3870,Liew,Prazepam,4890,negative,0,324.8,3.6,32.7,2,0,23,C1CC1CN2C(=O)CN=C(C3=C2C=CC(=C3)Cl)C4=CC=CC=C4,Liver,
3145,Liew,Adapalene,60164,negative,0,412.5,7.7,46.5,3,1,31,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5,,
1347,LIverTox,Letermovir,45138674,E,0,572.5,4.6,77.8,10,1,41,COC1=C(C=C(C=C1)C(F)(F)F)N2C(C3=C(C(=CC=C3)F)N=C2N4CCN(CC4)C5=CC(=CC=C5)OC)CC(=O)O,glucuronidation UGT1A1/1A3 to a minor extent,
1083,LIverTox,Desflurane,42113,C,1,168.04,2.6,9.2,7,0,10,C(C(F)(F)F)(OC(F)F)F,Not metabolized,
630,DILIrank,moxisylyte,4260,vMost-DILI-Concern,1,279.37,3.2,38.8,4,0,20,CC1=CC(=C(C=C1OC(=O)C)C(C)C)OCCN(C)C,.,
492,DILIrank,ramelteon,208902,vNo-DILI-Concern,0,259.34,2.7,38.3,2,1,19,CCC(=O)NCCC1CCC2=C1C3=C(C=C2)OCC3,"Liver CYP1A2 major, CYP2C,CYP3A4 minor",
1786,LIverTox,Tolcapone,4659569,C,1,273.24,3.3,103.0,5,2,20,CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-],Liver mainly glucuronidation,
794,LIverTox,Aclidinium,11519741,E,0,564.6,,112.0,7,1,34,C1C[N+]2(CCC1C(C2)OC(=O)C(C3=CC=CS3)(C4=CC=CS4)O)CCCOC5=CC=CC=C5.[Br-],Ester hydrolysis,
3513,Liew,Flunisolide,82153,negative,0,434.5,2.5,93.1,7,2,31,CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C,,
3784,Liew,Ondansetron,4595,positive,1,293.4,2.3,39.8,2,0,22,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,"CYP3A4, CYP1A2, CYP2D6",
630,DILIrank,moxisylyte,4260,vMost-DILI-Concern,1,279.37,3.2,38.8,4,0,20,CC1=CC(=C(C=C1OC(=O)C)C(C)C)OCCN(C)C,.,
2816,Xu,Ticlopidine,5472,Positive,1,263.8,3.6,31.5,2,0,17,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl,Liver,
3841,Liew,Phenoxybenzamine,4768,negative,0,303.8,4.4,12.5,2,0,21,CC(COC1=CC=CC=C1)N(CCCl)CC2=CC=CC=C2,,
4094,Liew,Vigabatrin,5665,positive,1,129.16,-2.2,63.3,3,2,9,C=CC(CCC(=O)O)N,,
956,LIverTox,Butorphanol,5361092,ND,0,327.5,3.8,43.7,3,2,24,C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,hydroxylated & glucuronidated,
1803,LIverTox,Triamterene,5546,D,1,253.26,1.0,130.0,7,3,19,C1=CC=C(C=C1)C2=NC3=C(N=C(N=C3N=C2N)N)N,hydroxylation to para-hydroxytriamterene,
46,DILIrank,diflunisal,3059,vMost-DILI-Concern,1,250.2,4.4,57.5,5,2,18,C1=CC(=C(C=C1C2=C(C=C(C=C2)F)F)C(=O)O)O,Liver,
2760,Xu,Phenylbutazone,4781,Positive,1,308.4,3.2,40.6,2,0,23,CCCCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3,,
692,DILIrank,ebrotidine,65869,vMost-DILI-Concern,1,477.4,1.5,198.0,7,3,26,C1=CC(=CC=C1S(=O)(=O)NC=NCCSCC2=CSC(=N2)N=C(N)N)Br,.,
1451,LIverTox,Nalmefene,5284594,E,0,339.4,2.7,52.9,4,2,25,C=C1CCC2(C3CC4=C5C2(C1OC5=C(C=C4)O)CCN3CC6CC6)O,Liver,
3450,Liew,Enoxacin,3229,positive,0,320.32,-0.2,85.8,8,2,23,CCN1C=C(C(=O)C2=CC(=C(N=C21)N3CCNCC3)F)C(=O)O,,
1641,LIverTox,Revefenacin,11753673,E,0,597.7,4.1,108.0,6,2,44,CN(CCN1CCC(CC1)OC(=O)NC2=CC=CC=C2C3=CC=CC=C3)C(=O)C4=CC=C(C=C4)CN5CCC(CC5)C(=O)N,.,
3335,Liew,Clofarabine,119182,positive,1,303.68,0.9,119.0,8,3,20,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N,,
2740,Xu,Norethindrone,6230,Positive,1,298.4,3.0,37.3,2,1,22,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,"	Mainly CYP3A4 liver; also 5??-/5??-reductase, 3??-Tooltip 3??-hydroxysteroid dehydrogenase/3??-HSDTooltip 3??-hydroxysteroid dehydrogenase, and aromatase",
3262,Liew,Captopril,44093,positive,1,217.29,0.3,58.6,4,2,14,CC(CS)C(=O)N1CCCC1C(=O)O,,
353,DILIrank,pentagastrin,9853654,vNo-DILI-Concern,0,767.9,1.5,276.0,10,8,54,CC(C)(C)OC(=O)NCCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CCSC)C(=O)NC(CC(=O)O)C(=O)NC(CC3=CC=CC=C3)C(=O)N,.,
133,DILIrank,pemoline,4723,vMost-DILI-Concern,1,176.17,0.9,64.7,2,1,13,C1=CC=C(C=C1)C2C(=O)N=C(O2)N,	Liver,
1416,LIverTox,Midostaurin,9829523,E*,0,570.6,4.8,77.7,4,1,43,CC12C(C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)N(C)C(=O)C9=CC=CC=C9)OC,.,
102,DILIrank,venlafaxine,5656,vLess-DILI-Concern,1,277.4,2.9,32.7,3,1,20,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,"	Extensively metabolised by the liver, primarily via CYP2D6",
3476,Liew,Etidocaine,37497,negative,0,276.4,3.7,32.3,2,1,20,CCCN(CC)C(CC)C(=O)NC1=C(C=CC=C1C)C,,
3625,Liew,Latanoprost,5311221,negative,0,432.6,4.3,87.0,5,3,31,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O,,
3401,Liew,Diethylcarbamazine,3052,negative,1,199.29,0.3,26.8,2,0,14,CCN(CC)C(=O)N1CCN(CC1)C,,
1959,Greene,Butoconazole Nitrate,47472,NE,0,411.8,6.4,43.1,2,0,25,C1=CC(=C(C(=C1)Cl)SC(CCC2=CC=C(C=C2)Cl)CN3C=CN=C3)Cl,,
1826,LIverTox,Valsartan,60846,D,1,435.5,4.4,112.0,6,2,32,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O,.,
2117,Greene,Fluspirilene,3396,HH,1,475.6,5.6,35.6,5,1,35,C1CN(CCC12C(=O)NCN2C3=CC=CC=C3)CCCC(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F,,
567,DILIrank,fipexide,3351,vMost-DILI-Concern,1,388.8,3.2,51.2,5,0,27,C1CN(CCN1CC2=CC3=C(C=C2)OCO3)C(=O)COC4=CC=C(C=C4)Cl,.,
3555,Liew,Gemfibrozil,3463,positive,1,250.33,3.8,46.5,3,1,18,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,,
1797,LIverTox,Trametinib,11707110,E*,0,615.4,3.4,102.0,6,2,37,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5,.,
4087,Liew,Vardenafil,110634,positive,0,488.6,2.5,118.0,7,1,34,CCCC1=NC(=C2N1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC)C,CYP3A4,
3401,Liew,Diethylcarbamazine,3052,negative,1,199.29,0.3,26.8,2,0,14,CCN(CC)C(=O)N1CCN(CC1)C,,
3583,Liew,Hydroxyurea,3657,positive,1,76.055,-1.8,75.4,2,3,5,C(=O)(N)NO,,
3335,Liew,Clofarabine,119182,positive,1,303.68,0.9,119.0,8,3,20,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N,,
3281,Liew,Cefmetazole,42008,positive,0,471.5,-0.6,239.0,12,2,30,CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)(NC(=O)CSCC#N)OC)SC2)C(=O)O,,
806,LIverTox,Alfuzosin,2092,C,1,389.4,1.7,112.0,8,2,28,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,CYP3A4,
356,DILIrank,calcitonin salmon,16133812,vNo-DILI-Concern,0,3431.9,-16.6,1560.0,55,52,239,CC(C)CC1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)N1)CC(=O)N)CO)N)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC2=CNC=N2)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(C(C)O)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)N4CCCC4C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CO)C(=O)NCC(=O)NC(C(C)O)C(=O)N5CCCC5C(=O)N)C(C)O)CO,.,
588,DILIrank,gemcitabine,60750,vMost-DILI-Concern,1,263.2,-1.5,108.0,6,3,18,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,.,
1372,LIverTox,Lovastatin,53232,B,1,404.5,4.3,72.8,5,1,29,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,Liver CYP3A and CYP2C8 substrate,
3858,Liew,Piretanide,4849,positive,0,362.4,2.2,118.0,7,2,25,C1CCN(C1)C2=C(C(=CC(=C2)C(=O)O)S(=O)(=O)N)OC3=CC=CC=C3,,
258,DILIrank,sulfathiazole,5340,vMost-DILI-Concern,1,255.3,0.1,122.0,6,2,16,C1=CC(=CC=C1N)S(=O)(=O)NC2=NC=CS2,.,
4017,Liew,Tetrahydrozoline,5419,negative,0,200.28,1.8,24.4,1,1,15,C1CC(C2=CC=CC=C2C1)C3=NCCN3,,
3224,Liew,Benoxinate,4633,negative,0,308.4,3.1,64.8,5,1,22,CCCCOC1=C(C=CC(=C1)C(=O)OCCN(CC)CC)N,,
746,DILIrank,glafenine,3474,vMost-DILI-Concern,1,372.8,3.5,91.7,6,3,26,C1=CC=C(C(=C1)C(=O)OCC(CO)O)NC2=C3C=CC(=CC3=NC=C2)Cl,.,
1983,Greene,Ceftazidime,5481173,WE,1,546.6,0.4,245.0,12,3,37,CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],	negligible,
3037,Liew,Mycophenolic acid,446541,positive,1,320.3,3.2,93.1,6,2,23,CC1=C2COC(=O)C2=C(C(=C1OC)CC=C(C)CCC(=O)O)O,,
3828,Liew,Perazine,4744,positive,0,339.5,4.1,35.0,4,0,24,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=CC=CC=C42,,
3280,Liew,Cefmenoxime,9570757,positive,0,511.6,0.0,270.0,14,3,33,CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O,,
3734,Liew,Moxalactam,47499,positive,0,520.5,-0.6,232.0,13,4,36,CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)(NC(=O)C(C4=CC=C(C=C4)O)C(=O)O)OC)OC2)C(=O)O,,
3990,Liew,Talinolol,68770,positive,0,363.5,2.6,82.6,4,4,26,CC(C)(C)NCC(COC1=CC=C(C=C1)NC(=O)NC2CCCCC2)O,,
2665,Xu,Gallamine Triethiodide,6172,Negative,0,891.5,,27.7,6,0,39,CC[N+](CC)(CC)CCOC1=C(C(=CC=C1)OCC[N+](CC)(CC)CC)OCC[N+](CC)(CC)CC.[I-].[I-].[I-],.,
3880,Liew,Procainamide,4913,positive,1,235.33,0.9,58.4,3,2,17,CCN(CC)CCNC(=O)C1=CC=C(C=C1)N,CYP2D6,
118,DILIrank,isoproterenol,3779,vNo-DILI-Concern,0,211.26,-0.6,72.7,4,4,15,CC(C)NCC(C1=CC(=C(C=C1)O)O)O,.,
1518,LIverTox,Oxycodone,5284603,E,0,315.4,1.2,59.0,5,1,23,CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O,"Liver: mainly CYP3A, and, to a much lesser extent, CYP2D6 ~5%; 95% metabolized i.e., 5% excreted unchanged",
4019,Liew,Theophylline,2153,negative,0,180.16,0.0,69.3,3,1,13,CN1C2=C(C(=O)N(C1=O)C)NC=N2,hepatic,
2679,Xu,Imipramine HCl,3696,Positive,1,280.4,4.8,6.5,2,0,21,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31,"CYP1A2, CYP2C19, CYP2D6",
2153,Greene,indacrinone,42266,HH,1,365.2,4.5,63.6,4,1,24,CC1(CC2=CC(=C(C(=C2C1=O)Cl)Cl)OCC(=O)O)C3=CC=CC=C3,.,
3283,Liew,Cefonicid,43594,positive,0,542.6,-1.9,264.0,13,4,35,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)O)C(=O)O)CSC4=NN=NN4CS(=O)(=O)O,,
1342,LIverTox,Lavender,702,E,0,46.07,-0.1,20.2,1,1,3,CCO,.,
3323,Liew,Cimetidine,2756,positive,1,252.34,0.4,114.0,4,3,17,CC1=C(N=CN1)CSCCNC(=NC)NC#N,,
500,DILIrank,cloxacillin,6098,vLess-DILI-Concern,1,435.9,2.4,138.0,7,2,29,CC1=C(C(=NO1)C2=CC=CC=C2Cl)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O,.,
3274,Liew,Cefaclor,51039,positive,1,367.8,-1.8,138.0,6,3,24,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,,
1416,LIverTox,Midostaurin,9829523,E*,0,570.6,4.8,77.7,4,1,43,CC12C(C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)N(C)C(=O)C9=CC=CC=C9)OC,.,
252,DILIrank,nystatin,14960,vNo-DILI-Concern,0,926.1,-0.2,320.0,18,12,65,CC1C=CC=CCCC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,None not extensively absorbed,
3278,Liew,Cefdinir,6915944,positive,1,395.4,0.0,212.0,10,4,26,C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O,,
2088,Greene,Estrone,5870,HH,1,270.4,3.1,37.3,2,1,20,CC12CCC3C(C1CCC2=O)CCC4=C3C=CC(=C4)O,.,
3521,Liew,Fluphenazine,3372,positive,1,437.5,4.4,55.2,8,1,30,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO,,
1138,LIverTox,Eluxadoline,11250029,C,1,569.6,0.9,165.0,7,4,42,CC1=CC(=CC(=C1CC(C(=O)N(CC2=CC(=C(C=C2)OC)C(=O)O)C(C)C3=NC=C(N3)C4=CC=CC=C4)N)C)C(=O)N,.,
1547,LIverTox,Pergolide,47811,E*,0,314.5,4.2,44.3,2,1,22,CCCN1CC(CC2C1CC3=CNC4=CC=CC2=C34)CSC,Extensively Liver,
1852,LIverTox,Vortioxetine,9966051,E*,0,298.4,4.2,40.6,3,1,21,CC1=CC(=C(C=C1)SC2=CC=CC=C2N3CCNCC3)C,"Liver, primarily CYP2D6-mediated oxidation",
3144,Liew,Acyclovir,2022,positive,1,225.2,-1.6,115.0,4,3,16,C1=NC2=C(N1COCCO)NC(=NC2=O)N,,
3529,Liew,Folic acid,6037,negative,0,441.4,-1.1,209.0,9,6,32,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N,,
3511,Liew,Flumethasone,16490,negative,0,410.5,1.9,94.8,7,3,29,CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C)F,,
3413,Liew,Dinoprost,5280363,negative,0,354.5,2.7,98.0,5,4,25,CCCCCC(C=CC1C(CC(C1CC=CCCCC(=O)O)O)O)O,,
2701,Xu,maleic acid,444266,Positive,1,116.07,-0.3,74.6,4,2,8,C(=CC(=O)O)C(=O)O,.,
1588,LIverTox,Pretomanid,456199,D,1,359.26,2.8,91.3,9,0,25,C1C(COC2=NC(=CN21)[N+](=O)[O-])OCC3=CC=C(C=C3)OC(F)(F)F,.,
1787,LIverTox,Tolmetin,5509,D,1,257.28,2.8,59.3,3,1,19,CC1=CC=C(C=C1)C(=O)C2=CC=C(N2C)CC(=O)O,.,
3480,Liew,Etonogestrel,21729469,positive,0,324.5,3.3,37.3,2,1,24,CCC12CC(=C)C3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,,
3325,Liew,Cinoxacin,2762,positive,0,262.22,2.1,88.4,7,1,19,CCN1C2=CC3=C(C=C2C(=O)C(=N1)C(=O)O)OCO3,,
1375,LIverTox,Lubiprostone,157920,E,0,390.5,4.0,83.8,7,2,27,CCCCC(C1(CCC2C(O1)CC(=O)C2CCCCCCC(=O)O)O)(F)F,"Extensive, CYP not involved",
1782,LIverTox,Tizanidine,5487,C,1,253.71,1.1,90.4,4,2,16,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl,"Liver CYP1A2, 95%",
3835,Liew,Phenacemide,4753,positive,0,178.19,0.9,72.2,2,2,13,C1=CC=C(C=C1)CC(=O)NC(=O)N,,
2500,Xu,Acetylcholine Chloride,187,Negative,0,146.21,0.2,26.3,2,0,10,CC(=O)OCC[N+](C)(C)C,ACH,
3893,Liew,Propofol,4943,positive,1,178.27,3.8,20.2,1,1,13,CC(C)C1=C(C(=CC=C1)C(C)C)O,Liver,
1352,LIverTox,Levodopa,6047,E,0,197.19,-2.7,104.0,5,4,14,C1=CC(=C(C=C1CC(C(=O)O)N)O)O,Aromatic-l-amino-acid decarboxylase,
1210,LIverTox,Fluorouracil,3385,A,1,130.08,-0.9,58.2,3,2,9,C1=C(C(=O)NC(=O)N1)F,Intracellular and liver CYP-mediated,
126,DILIrank,testosterone,6013,vMost-DILI-Concern,1,288.4,3.3,37.3,2,1,21,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C,	Liver mainly reduction and conjugation,
2675,Xu,Hydrocortisone,5754,Negative,0,362.5,1.6,94.8,5,3,26,CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,"	11??-HSDsTooltip 11??-Hydroxysteroid dehydrogenases, others",
764,DILIrank,tenofovir,5481350,vLess-DILI-Concern,1,519.4,1.6,185.0,14,1,35,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C,Ester hydrolysis,
2452,Greene,tianeptine,68870,HH,1,437.0,1.2,95.1,6,2,29,CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O,Liver by ??-oxidation,
598,DILIrank,hydroxyzine,3658,vNo-DILI-Concern,0,374.9,3.7,35.9,4,1,26,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Liver,
3152,Liew,Alendronate,2088,positive,1,249.1,-6.5,161.0,8,6,14,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,,
3333,Liew,Clobetasol,5311051,negative,0,410.9,2.5,74.6,5,2,28,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C,,
1736,LIverTox,Tafenoquine,115358,E,0,463.5,5.4,78.6,9,2,33,CC1=CC(=NC2=C1C(=C(C=C2NC(C)CCCN)OC)OC3=CC=CC(=C3)C(F)(F)F)OC,.,
3416,Liew,Diphenidol,9175,negative,0,280.4,4.0,0.0,0,0,22,C1C=C2C=C3C=CC=CC3=CC2=C4C1C=C5C=CC=CC5=C4,,
1559,LIverTox,Phenyltoloxamine,7077,E,0,255.35,3.9,12.5,2,0,19,CN(C)CCOC1=CC=CC=C1CC2=CC=CC=C2,.,
3406,Liew,Difluprednate,32037,negative,0,508.5,3.4,107.0,9,1,36,CCCC(=O)OC1(CCC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C(=O)COC(=O)C,,
2549,Xu,Carbidopa,34359,Negative,0,226.23,-2.2,116.0,6,5,16,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)NN,"	7 metabolites known, not metabolized extensively",
4047,Liew,Toremifene,3005573,positive,1,406.0,7.2,12.5,2,0,29,CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3,CYP3A4,
1248,LIverTox,Glatiramer Acetate,3081884,B,1,623.7,,374.0,18,12,43,CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N,.,
83,DILIrank,streptomycin,19649,vNo-DILI-Concern,0,581.6,-8.0,336.0,15,12,40,CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O,.,
265,DILIrank,clevidipine,153994,vNo-DILI-Concern,0,456.3,4.3,90.9,7,1,30,CCCC(=O)OCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,Blood and tissue esterases,
3955,Liew,Sertraline,68617,positive,1,306.2,4.8,12.0,1,1,20,CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,"CYP2B6(major), CYP2C19",
1405,LIverTox,Methocarbamol,4107,E,0,241.24,0.6,91.0,5,2,17,COC1=CC=CC=C1OCC(COC(=O)N)O,Liver,
285,DILIrank,ecallantide,118984459,vNo-DILI-Concern,0,7054.0,-27.9,3120.0,110,100,492,CCC(C)C1C(=O)NC(C(=O)NCC(=O)NCC(=O)NC2CSSCC3C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N4CCCC4C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)N5CCCC5C(=O)N3)CC(=O)O)CC(=O)O)C)CCCCN)CC6=CC=CC=C6)C)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CO)NC(=O)C(CC8=CN=CN8)NC(=O)C(CCSC)NC(=O)C(C)NC(=O)C(CCC(=O)O)N)C(=O)NC(C(C)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(=O)O)C(=O)O)CCSC)CCCCN)CCCCN)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC2=O)CCC(=O)O)CC(=O)N)CCC(=O)N)CC(=O)N)CCCNC(=N)N)CC9=CC=CC=C9)CCC(=O)O)CO)CC(C)C)CCC(=O)O)CCC(=O)O)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CC1=CC=CC=C1)CCC(=O)O)CCC(=O)O)CCC(=O)N)CCCNC(=N)N)C(C)O)CC1=CC=CC=C1)C(C)CC)CC(=O)N)CC1=CC=CC=C1)CC1=CC=CC=C1)CC1=CNC2=CC=CC=C21)CCCNC(=N)N)CC1=CN=CN1)C)C)CCCNC(=N)N)CC1=CC=C(C=C1)O,.,protein
1745,LIverTox,Telbivudine,159269,E,0,242.23,-1.2,99.1,5,3,17,CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)O,Nil,
3922,Liew,Repaglinide,65981,negative,1,452.6,5.2,78.9,5,2,33,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,CYP3A4,
2206,Greene,Methapyrilene,4098,HH,1,261.39,2.6,47.6,4,0,18,CN(C)CCN(CC1=CC=CS1)C2=CC=CC=N2,,
3628,Liew,Lenalidomide,216326,positive,1,259.26,-0.5,92.5,4,2,19,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,,
3870,Liew,Prazepam,4890,negative,0,324.8,3.6,32.7,2,0,23,C1CC1CN2C(=O)CN=C(C3=C2C=CC(=C3)Cl)C4=CC=CC=C4,Liver,
2441,Greene,Temafloxacin,60021,HH,1,417.4,0.6,72.9,9,2,30,CC1CN(CCN1)C2=C(C=C3C(=C2)N(C=C(C3=O)C(=O)O)C4=C(C=C(C=C4)F)F)F,.,
3949,Liew,Salsalate,5161,positive,1,258.23,3.0,83.8,5,2,19,C1=CC=C(C(=C1)C(=O)OC2=CC=CC=C2C(=O)O)O,,
3810,Liew,Papaverine,4680,positive,1,339.4,3.9,49.8,5,0,25,COC1=C(C=C(C=C1)CC2=NC=CC3=CC(=C(C=C32)OC)OC)OC,Liver,
373,DILIrank,rubidium chloride rb-82,71357,vNo-DILI-Concern,0,117.37,,0.0,1,0,2,[Cl-].[Rb+],.,
3403,Liew,Diethylstilbestrol,448537,positive,0,268.3,5.1,40.5,2,2,20,CCC(=C(CC)C1=CC=C(C=C1)O)C2=CC=C(C=C2)O,,
1929,Greene,Azithromycin,55185,WE,1,749.0,4.0,180.0,14,5,52,CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O,LIver,
3273,Liew,Caspofungin,468682,positive,1,1093.3,0.3,412.0,18,16,77,CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2C(CCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)O)NCCN)O,,
3753,Liew,Nelfinavir,64143,positive,1,567.8,5.7,127.0,6,4,40,CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O,,
2416,Greene,Rosiglitazone,77999,WE,1,357.4,3.1,96.8,6,1,25,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,CYP2C8,
3981,Liew,Sulfapyridine,5336,positive,0,249.29,0.0,93.5,5,2,17,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N,,
2816,Xu,Ticlopidine,5472,Positive,1,263.8,3.6,31.5,2,0,17,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl,Liver,
2726,Xu,montelukast,5281040,Negative,1,586.2,7.7,95.7,5,2,41,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O,"CYP2C8, CYP3A4, CYP2C9",
3521,Liew,Fluphenazine,3372,positive,1,437.5,4.4,55.2,8,1,30,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO,,
2177,Greene,Leucovorin Calcium,6006,NE,0,473.4,-1.2,216.0,9,7,34,C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,.,
4101,Liew,Xanomeline,60809,positive,0,281.42,3.3,66.5,5,0,19,CCCCCCOC1=NSN=C1C2=CCCN(C2)C,,
778,DILIrank,levomefolate calcium,444412,vNo-DILI-Concern,0,459.5,-0.5,199.0,9,7,33,CN1C(CNC2=C1C(=O)N=C(N2)N)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,.,
3307,Liew,Chloroprocaine,8612,negative,0,270.75,2.9,55.6,4,1,18,CCN(CC)CCOC(=O)C1=C(C=C(C=C1)N)Cl,,
3418,Liew,Dipyridamole,3108,negative,0,504.6,0.7,145.0,12,4,36,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,,
1138,LIverTox,Eluxadoline,11250029,C,1,569.6,0.9,165.0,7,4,42,CC1=CC(=CC(=C1CC(C(=O)N(CC2=CC(=C(C=C2)OC)C(=O)O)C(C)C3=NC=C(N3)C4=CC=CC=C4)N)C)C(=O)N,.,
3664,Liew,Medrysone,247839,negative,0,344.5,2.7,54.4,3,1,25,CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)CC4)C)O)C)C(=O)C,,
290,DILIrank,tilbroquinol,65592,vMost-DILI-Concern,1,238.08,3.1,33.1,2,1,13,CC1=CC(=C(C2=C1C=CC=N2)O)Br,.,
4013,Liew,Testolactone,13769,negative,0,300.4,3.0,43.4,3,0,22,CC12CCC3C(C1CCC(=O)O2)CCC4=CC(=O)C=CC34C,Liver,
2701,Xu,maleic acid,444266,Positive,1,116.07,-0.3,74.6,4,2,8,C(=CC(=O)O)C(=O)O,.,
3978,Liew,Sulfacytine,5322,positive,0,294.33,0.1,113.0,4,2,20,CCN1C=CC(=NC1=O)NS(=O)(=O)C2=CC=C(C=C2)N,,
1719,LIverTox,Streptozocin,29327,D,1,265.22,-1.4,152.0,8,5,18,CN(C(=O)NC1C(C(C(OC1O)CO)O)O)N=O,"Liver, Kidney",
133,DILIrank,pemoline,4723,vMost-DILI-Concern,1,176.17,0.9,64.7,2,1,13,C1=CC=C(C=C1)C2C(=O)N=C(O2)N,	Liver,
2678,Xu,Idoxuridine,5905,Positive,1,354.1,-1.0,99.1,5,3,17,C1C(C(OC1N2C=C(C(=O)NC2=O)I)CO)O,.,
1641,LIverTox,Revefenacin,11753673,E,0,597.7,4.1,108.0,6,2,44,CN(CCN1CCC(CC1)OC(=O)NC2=CC=CC=C2C3=CC=CC=C3)C(=O)C4=CC=C(C=C4)CN5CCC(CC5)C(=O)N,.,
1755,LIverTox,Teriflunomide,54684141,D,1,270.21,3.3,73.1,6,2,19,CC(=C(C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F)O,.,
1557,LIverTox,Phentermine-Topiramate,56842108,E*,0,488.6,,150.0,10,2,33,CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C.CC(C)(CC1=CC=CC=C1)N,.,
1225,LIverTox,Fostamatinib,11671467,E*,0,580.5,1.6,187.0,15,4,40,CC1(C(=O)N(C2=C(O1)C=CC(=N2)NC3=NC(=NC=C3F)NC4=CC(=C(C(=C4)OC)OC)OC)COP(=O)(O)O)C,"Gut ALP to tamatinib Liver tamatinib metabolite by CYP3A4, UGT1A9",
3337,Liew,Clofibrate,2796,positive,1,242.7,3.3,35.5,3,0,16,CCOC(=O)C(C)(C)OC1=CC=C(C=C1)Cl,,
739,DILIrank,pyridostigmine,4991,vNo-DILI-Concern,0,181.21,0.7,33.4,2,0,13,C[N+]1=CC=CC(=C1)OC(=O)N(C)C,.,
3709,Liew,Metoprolol,4171,positive,1,267.36,1.9,50.7,4,2,19,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,,
3893,Liew,Propofol,4943,positive,1,178.27,3.8,20.2,1,1,13,CC(C)C1=C(C(=CC=C1)C(C)C)O,Liver,
1160,LIverTox,Eribulin,11354606,E*,0,729.9,1.1,146.0,12,2,52,CC1CC2CCC3C(=C)CC(O3)CCC45CC6C(O4)C7C(O6)C(O5)C8C(O7)CCC(O8)CC(=O)CC9C(CC(C1=C)O2)OC(C9OC)CC(CN)O,.,
4027,Liew,Tibolone,444008,negative,1,312.4,2.4,37.3,2,1,23,CC1CC2=C(CCC(=O)C2)C3C1C4CCC(C4(CC3)C)(C#C)O,"Liver, Intestine",
3835,Liew,Phenacemide,4753,positive,0,178.19,0.9,72.2,2,2,13,C1=CC=C(C=C1)CC(=O)NC(=O)N,,
3514,Liew,Fluocinolone,91488,negative,0,412.4,1.1,115.0,8,4,29,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CC(C4=CC(=O)C=CC43C)F)F)O,,
3571,Liew,Gusperimus,55362,negative,0,387.5,-2.0,181.0,6,7,27,C(CCCN=C(N)N)CCC(=O)NC(C(=O)NCCCCNCCCN)O,,
1568,LIverTox,Piperacillin-Tazobactam,9918881,B,1,817.9,,313.0,15,4,56,CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O.CC1(C(N2C(S1(=O)=O)CC2=O)C(=O)O)CN3C=CN=N3,.,
941,LIverTox,Bosutinib,5328940,D,1,530.4,5.4,82.9,8,1,36,CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC,"By CYP3A4, to inactive metabolites",
943,LIverTox,Brexanolone,92786,E,0,318.5,4.9,37.3,2,1,23,CC(=O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C,"Non-CYP450 keto-reduction via aldo-keto reductases AKR, glucuronidation via glucuronosyltransferases UGT, sulfation via sulfotransferases SULT",
3590,Liew,Iloprost,5311181,positive,0,360.5,2.8,77.8,4,3,26,CC#CCC(C)C(C=CC1C(CC2C1CC(=CCCCC(=O)O)C2)O)O,,
1832,LIverTox,Vemurafenib,42611257,E*,0,489.9,5.0,100.0,7,2,33,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)C4=CC=C(C=C4)Cl)F,.,
779,DILIrank,sitaxsentan,216235,vMost-DILI-Concern,1,454.9,3.7,144.0,9,1,29,CC1=CC2=C(C=C1CC(=O)C3=C(C=CS3)S(=O)(=O)NC4=C(C(=NO4)C)Cl)OCO2,"CYP2C9,CYP3A4",
2642,Xu,Ethynodiol Diacetate,9270,Positive,1,384.5,3.9,52.6,4,0,28,CC(=O)OC1CCC2C3CCC4(C(C3CCC2=C1)CCC4(C#C)OC(=O)C)C,.,
831,LIverTox,Amoxapine,2170,E,0,313.8,2.6,36.9,3,1,22,C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl,Liver cytochrome P450 system,
428,DILIrank,alpidem,54897,vMost-DILI-Concern,1,404.3,4.8,37.6,2,0,27,CCCN(CCC)C(=O)CC1=C(N=C2N1C=C(C=C2)Cl)C3=CC=C(C=C3)Cl,"	Extensive hydroxylation, dealkylation, conjugation",
157,DILIrank,gabapentin,3446,vLess-DILI-Concern,1,171.24,-1.1,63.3,3,2,12,C1CCC(CC1)(CC(=O)O)CN,Not significantly metabolized,
1243,LIverTox,Gilteritinib,49803313,E*,0,552.7,3.5,121.0,10,3,40,CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC(=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)OC)NC5CCOCC5,.,
672,DILIrank,riluzole,5070,vMost-DILI-Concern,1,234.2,3.6,76.4,7,1,15,C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N,CYP1A2,
50,DILIrank,famotidine,3325,vLess-DILI-Concern,1,337.5,-0.6,238.0,8,4,20,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,.,
1666,LIverTox,Rotigotine,57537,E,0,315.5,4.9,51.7,3,1,22,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O,CYP450,
3176,Liew,Aminolevulinic acid,137,positive,1,131.13,-3.8,80.4,4,2,9,C(CC(=O)O)C(=O)CN,,
990,LIverTox,Ceritinib,57379345,D,1,558.1,6.4,114.0,8,3,38,CC1=CC(=C(C=C1C2CCNCC2)OC(C)C)NC3=NC=C(C(=N3)NC4=CC=CC=C4S(=O)(=O)C(C)C)Cl,CYP3A,
3760,Liew,Niclosamide,4477,negative,0,327.12,4.0,95.2,4,2,21,C1=CC(=C(C=C1[N+](=O)[O-])Cl)NC(=O)C2=C(C=CC(=C2)Cl)O,,
1581,LIverTox,Pramipexole,119570,E,0,211.33,1.9,79.2,4,2,14,CCCNC1CCC2=C(C1)SC(=N2)N,.,
523,DILIrank,polymyxin b sulfate,5702105,vNo-DILI-Concern,0,1301.6,,574.0,22,20,90,CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O,.,
2365,Greene,phenothiazine,7108,HH,1,199.27,4.2,37.3,2,1,14,C1=CC=C2C(=C1)NC3=CC=CC=C3S2,.,
2801,Xu,Sulfasalazine,5339,Positive,1,398.4,-0.7,150.0,9,3,28,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N=NC3=CC(=C(C=C3)O)C(=O)O,.,
764,DILIrank,tenofovir,5481350,vLess-DILI-Concern,1,519.4,1.6,185.0,14,1,35,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C,Ester hydrolysis,
2076,Greene,Edrophonium Chloride,8307,NE,0,201.69,,20.2,2,1,13,CC[N+](C)(C)C1=CC(=CC=C1)O.[Cl-],.,
3165,Liew,Amantadine,2130,positive,0,151.25,2.4,26.0,1,1,11,C1C2CC3CC1CC(C2)(C3)N,,
3250,Liew,Buclizine,6729,negative,0,433.0,7.1,6.5,2,0,31,CC(C)(C)C1=CC=C(C=C1)CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=C(C=C4)Cl,,
133,DILIrank,pemoline,4723,vMost-DILI-Concern,1,176.17,0.9,64.7,2,1,13,C1=CC=C(C=C1)C2C(=O)N=C(O2)N,	Liver,
2500,Xu,Acetylcholine Chloride,187,Negative,0,146.21,0.2,26.3,2,0,10,CC(=O)OCC[N+](C)(C)C,ACH,
3891,Liew,Proparacaine,4935,negative,0,294.39,2.7,64.8,5,1,21,CCCOC1=C(C=C(C=C1)C(=O)OCCN(CC)CC)N,,
1923,Greene,Aurothioglucose,6104,HH,1,392.18,,91.2,6,4,13,C(C1C(C(C(C(O1)[S-])O)O)O)O.[Au+],.,
3476,Liew,Etidocaine,37497,negative,0,276.4,3.7,32.3,2,1,20,CCCN(CC)C(CC)C(=O)NC1=C(C=CC=C1C)C,,
327,DILIrank,meclizine,4034,vNo-DILI-Concern,0,390.9,5.8,6.5,2,0,28,CC1=CC(=CC=C1)CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=C(C=C4)Cl,Liver,
1402,LIverTox,Metformin,4091,B,1,129.16,-1.3,91.5,1,3,9,CN(C)C(=N)N=C(N)N,Not by liver,
157,DILIrank,gabapentin,3446,vLess-DILI-Concern,1,171.24,-1.1,63.3,3,2,12,C1CCC(CC1)(CC(=O)O)CN,Not significantly metabolized,
1755,LIverTox,Teriflunomide,54684141,D,1,270.21,3.3,73.1,6,2,19,CC(=C(C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F)O,.,
3870,Liew,Prazepam,4890,negative,0,324.8,3.6,32.7,2,0,23,C1CC1CN2C(=O)CN=C(C3=C2C=CC(=C3)Cl)C4=CC=CC=C4,Liver,
3396,Liew,Dibucaine,3025,negative,0,343.5,4.4,54.5,4,1,25,CCCCOC1=NC2=CC=CC=C2C(=C1)C(=O)NCCN(CC)CC,,
1077,LIverTox,Degarelix,16136245,E,0,1632.3,3.5,513.0,18,17,117,CC(C)CC(C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)NC(=O)N)NC(=O)C(CC3=CC=C(C=C3)NC(=O)C4CC(=O)NC(=O)N4)NC(=O)C(CO)NC(=O)C(CC5=CN=CC=C5)NC(=O)C(CC6=CC=C(C=C6)Cl)NC(=O)C(CC7=CC8=CC=CC=C8C=C7)NC(=O)C,Subject to common peptidic degradation during passage through the hepato-biliary system; not a substrate for the human CYP450 system,
1366,LIverTox,Lopinavir,92727,D,1,628.8,5.9,120.0,5,4,46,CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O,Liver,
3756,Liew,Netilmicin,41859,positive,0,475.6,-4.2,200.0,12,8,33,CCNC1CC(C(C(C1OC2C(C(C(CO2)(C)O)NC)O)O)OC3C(CC=C(O3)CN)N)N,,
36,DILIrank,chlorcyclizine,2710,vLess-DILI-Concern,1,300.8,4.5,6.5,2,0,21,CN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,.,
2175,Greene,Leflunomide,3899,HH,1,270.21,2.5,55.1,6,1,19,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F,GI mucosa and liver,
2630,Xu,Donepezil,3152,Negative,1,379.5,4.3,38.8,4,0,28,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,"	CYP2D6, CYP3A4, and glucuronidation.Four major metabolites, two of which are active.",
3852,Liew,Pipecuronium,65332,negative,0,762.7,,59.1,8,0,45,CC(=O)OC1CC2CCC3C(C2(CC1N4CC[N+](CC4)(C)C)C)CCC5(C3CC(C5OC(=O)C)N6CC[N+](CC6)(C)C)C.[Br-].[Br-],,
601,DILIrank,l-methionine,6137,vNo-DILI-Concern,0,149.21,-1.9,88.6,4,2,9,CSCCC(C(=O)O)N,.,
487,DILIrank,chlorothiazide,2720,vLess-DILI-Concern,1,295.7,-0.2,135.0,6,2,17,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2,	Nil,
2684,Xu,Isoxsuprine HCl,3783,Negative,0,301.4,2.8,61.7,4,3,22,CC(COC1=CC=CC=C1)NC(C)C(C2=CC=C(C=C2)O)O,.,
3239,Liew,Bimatoprost,5311027,positive,0,415.6,2.8,89.8,4,4,30,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O,,
296,DILIrank,pipamazine,6761,vMost-DILI-Concern,1,402.0,4.4,74.9,4,1,27,C1CN(CCC1C(=O)N)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,.,
3785,Liew,Opipramol,9417,positive,1,363.5,3.6,30.0,4,1,27,C1CN(CCN1CCCN2C3=CC=CC=C3C=CC4=CC=CC=C42)CCO,CYP2D6,
3637,Liew,Levorphanol,5359272,negative,0,257.37,3.1,23.5,2,1,19,CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)O,,
3990,Liew,Talinolol,68770,positive,0,363.5,2.6,82.6,4,4,26,CC(C)(C)NCC(COC1=CC=C(C=C1)NC(=O)NC2CCCCC2)O,,
646,DILIrank,oxacillin,6196,vLess-DILI-Concern,1,401.4,2.4,138.0,7,2,28,CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O,.,
1555,LIverTox,Phenobarbital,4763,B,1,232.23,1.5,75.3,3,2,17,CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2,CYP2C19,
1489,LIverTox,Obeticholic Acid,447715,B,1,420.6,5.7,77.8,4,3,30,CCC1C2CC(CCC2(C3CCC4(C(C3C1O)CCC4C(C)CCC(=O)O)C)C)O,.,
3234,Liew,Bethanechol,2370,negative,0,161.22,0.0,52.3,2,1,11,CC(C[N+](C)(C)C)OC(=O)N,,
3384,Liew,Desvenlafaxine,125017,negative,1,263.37,2.6,43.7,3,2,19,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O,,
1009,LIverTox,Cholic Acid,221493,D[HD],1,408.6,3.6,98.0,5,4,29,CC(CCC(=O)O)C1CCC2C1(C(CC3C2C(CC4C3(CCC(C4)O)C)O)O)C,.,
1733,LIverTox,Tacrine,1935,A,1,198.26,2.7,38.9,2,1,15,C1CCC2=NC3=CC=CC=C3C(=C2C1)N,CYP1A2,
3941,Liew,Ropivacaine,175805,negative,0,274.4,2.9,32.3,2,1,20,CCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,CYP1A2,
505,DILIrank,darunavir,213039,vMost-DILI-Concern,1,547.7,2.9,149.0,9,3,38,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N,CYP3A4,
1719,LIverTox,Streptozocin,29327,D,1,265.22,-1.4,152.0,8,5,18,CN(C(=O)NC1C(C(C(OC1O)CO)O)O)N=O,"Liver, Kidney",
2222,Greene,mianserin,4184,HH,1,264.4,3.4,6.5,2,0,20,CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42,"	Liver CYP2D6; via aromatic hydroxylation, N-oxidation, N-demethylation",
3191,Liew,Anastrozole,2187,positive,1,293.4,2.1,78.3,4,0,22,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,,
237,DILIrank,methylnaltrexone bromide,5361918,vNo-DILI-Concern,0,356.4,1.6,66.8,4,2,26,C[N+]1(CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O)CC6CC6,	Liver,
1662,LIverTox,Romidepsin,5352062,C,1,540.7,2.2,193.0,8,4,36,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,CYP3A4,
2186,Greene,Loperamide HCl,3955,NE,0,477.0,5.0,43.8,3,1,34,CN(C)C(=O)C(CCN1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,	Liver extensive,
1028,LIverTox,Clopidogrel,60606,B,1,321.8,3.8,57.8,4,0,21,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,Liver,
1973,Greene,carbon tetrachloride (2),5943,HH,1,153.8,2.8,0.0,0,0,5,C(Cl)(Cl)(Cl)Cl,.,
3177,Liew,4-Aminosalicylic acid,4649,positive,1,153.14,1.3,83.6,4,3,11,C1=CC(=C(C=C1N)O)C(=O)O,,
1018,LIverTox,Clemastine,26987,E,0,343.9,5.0,12.5,2,0,24,CC(C1=CC=CC=C1)(C2=CC=C(C=C2)Cl)OCCC3CCCN3C,Liver,
3151,Liew,Aldrin,2087,positive,0,364.9,4.5,0.0,0,0,18,C1C2C=CC1C3C2C4(C(=C(C3(C4(Cl)Cl)Cl)Cl)Cl)Cl,,
779,DILIrank,sitaxsentan,216235,vMost-DILI-Concern,1,454.9,3.7,144.0,9,1,29,CC1=CC2=C(C=C1CC(=O)C3=C(C=CS3)S(=O)(=O)NC4=C(C(=NO4)C)Cl)OCO2,"CYP2C9,CYP3A4",
3940,Liew,Ropinirole,5095,negative,1,260.37,2.7,32.3,2,1,19,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,CYP1A2,
2739,Xu,nomifensine,4528,Positive,1,238.33,2.6,29.3,2,1,18,CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3,.,
830,LIverTox,Amodiaquine,2165,A,1,355.9,2.6,48.4,4,2,25,CCN(CC)CC1=C(C=CC(=C1)NC2=C3C=CC(=CC3=NC=C2)Cl)O,.,
1581,LIverTox,Pramipexole,119570,E,0,211.33,1.9,79.2,4,2,14,CCCNC1CCC2=C(C1)SC(=N2)N,.,
3832,Liew,Perindopril,107807,negative,0,368.5,0.9,95.9,6,2,26,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O,Kidney,
3656,Liew,Malathion,4004,negative,0,330.4,2.4,128.0,8,0,19,CCOC(=O)CC(C(=O)OCC)SP(=S)(OC)OC,,
2663,Xu,Furosemide,3440,Positive,1,330.74,2.0,131.0,7,3,21,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,	liver and kidney glucuronidation,
3531,Liew,Formestane,11273,negative,0,302.4,2.6,54.4,3,1,22,CC12CCC(=O)C(=C1CCC3C2CCC4(C3CCC4=O)C)O,,
3505,Liew,Floxuridine,5790,positive,1,246.19,-1.2,99.1,6,3,17,C1C(C(OC1N2C=C(C(=O)NC2=O)F)CO)O,,
1458,LIverTox,Nebivolol,71301,E,0,405.4,3.0,71.0,7,3,29,C1CC2=C(C=CC(=C2)F)OC1C(CNCC(C3CCC4=C(O3)C=CC(=C4)F)O)O,CYP2D6,
1973,Greene,carbon tetrachloride (2),5943,HH,1,153.8,2.8,0.0,0,0,5,C(Cl)(Cl)(Cl)Cl,.,
4065,Liew,Trimethobenzamide,5577,positive,1,388.5,2.3,69.3,6,1,28,CN(C)CCOC1=CC=C(C=C1)CNC(=O)C2=CC(=C(C(=C2)OC)OC)OC,,
936,LIverTox,Bleomycin,5460769,D,1,1415.6,-7.5,685.0,31,20,96,CC1=C(N=C(N=C1N)C(CC(=O)N)NCC(C(=O)N)N)C(=O)NC(C(C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)NC(C)C(C(C)C(=O)NC(C(C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O,.,
3366,Liew,Dapiprazole,3033538,negative,0,325.5,2.4,37.2,4,0,24,CC1=CC=CC=C1N2CCN(CC2)CCC3=NN=C4N3CCCC4,,
3450,Liew,Enoxacin,3229,positive,0,320.32,-0.2,85.8,8,2,23,CCN1C=C(C(=O)C2=CC(=C(N=C21)N3CCNCC3)F)C(=O)O,,
3774,Liew,Norepinephrine,439260,negative,0,169.18,-1.2,86.7,4,4,12,C1=CC(=C(C=C1C(CN)O)O)O,,
2760,Xu,Phenylbutazone,4781,Positive,1,308.4,3.2,40.6,2,0,23,CCCCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3,,
1428,LIverTox,Mirtazapine,4205,C,1,265.35,3.3,19.4,3,0,20,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,"CYP1A2, CYP2D6, CYP3A4",
3171,Liew,Amikacin,37768,positive,0,585.6,-7.9,332.0,17,13,40,C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N,,
3552,Liew,Gatifloxacin,5379,positive,0,375.4,-0.7,82.1,8,2,27,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F,,
1342,LIverTox,Lavender,702,E,0,46.07,-0.1,20.2,1,1,3,CCO,.,
1863,LIverTox,Zidovudine,35370,B,1,267.24,0.0,93.2,6,2,19,CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-],Liver,
1546,LIverTox,Perampanel,9924495,E,0,349.4,3.4,57.0,3,0,27,C1=CC=C(C=C1)N2C=C(C=C(C2=O)C3=CC=CC=C3C#N)C4=CC=CC=N4,"Liver, mostly via CYP3A4 and/or CYP3A5",
3740,Liew,Nafarelin,25077649,negative,0,1322.5,0.8,475.0,15,16,96,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)C(CC2=CC3=CC=CC=C3C=C2)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8,,
1101,LIverTox,Diphenoxylate,13505,ND,0,452.6,5.7,53.3,4,0,34,CCOC(=O)C1(CCN(CC1)CCC(C#N)(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC=CC=C4,.,
3633,Liew,Levobunolol,39468,negative,0,291.4,2.4,58.6,4,2,21,CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O,,
186,DILIrank,mesalazine,4075,vLess-DILI-Concern,1,153.14,1.3,83.6,4,3,11,C1=CC(=C(C=C1N)C(=O)O)O,	Rapidly & extensively metabolized intestinal mucosal wall and the liver,
3257,Liew,Butenafine,2484,negative,0,317.5,6.3,3.2,1,0,24,CC(C)(C)C1=CC=C(C=C1)CN(C)CC2=CC=CC3=CC=CC=C32,,
634,DILIrank,esomeprazole Sodium,9579578,vLess-DILI-Concern,1,345.4,2.2,96.3,6,1,24,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,"	Liver CYP2C19, CYP3A4",
1650,LIverTox,Rilpivirine,6451164,D,1,366.4,4.5,97.4,6,2,28,CC1=CC(=CC(=C1NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C)C=CC#N,CYP3A4,
1555,LIverTox,Phenobarbital,4763,B,1,232.23,1.5,75.3,3,2,17,CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2,CYP2C19,
674,DILIrank,ritonavir,392622,vMost-DILI-Concern,1,720.9,6.0,202.0,9,4,50,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,Liver,
4087,Liew,Vardenafil,110634,positive,0,488.6,2.5,118.0,7,1,34,CCCC1=NC(=C2N1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC)C,CYP3A4,
3098,Liew,Sumatriptan,5358,negative,0,295.4,0.9,73.6,4,2,20,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,MAO,
25,DILIrank,amphotericin b,14956,vLess-DILI-Concern,1,924.1,0.0,320.0,18,12,65,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,kidney,
439,DILIrank,zoledronate,68740,vLess-DILI-Concern,1,272.09,-4.3,153.0,8,5,16,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O,	Nil,
357,DILIrank,pentetic acid,3053,vNo-DILI-Concern,0,393.35,-8.5,196.0,13,5,27,C(CN(CC(=O)O)CC(=O)O)N(CCN(CC(=O)O)CC(=O)O)CC(=O)O,.,
3257,Liew,Butenafine,2484,negative,0,317.5,6.3,3.2,1,0,24,CC(C)(C)C1=CC=C(C=C1)CN(C)CC2=CC=CC3=CC=CC=C32,,
1342,LIverTox,Lavender,702,E,0,46.07,-0.1,20.2,1,1,3,CCO,.,
2901,Liew,Ciprofibrate,2763,positive,1,289.15,3.4,46.5,3,1,18,CC(C)(C(=O)O)OC1=CC=C(C=C1)C2CC2(Cl)Cl,,
4097,Liew,Voglibose,444020,positive,0,267.28,-4.1,154.0,8,8,18,C1C(C(C(C(C1(CO)O)O)O)O)NC(CO)CO,,
=======
ID,Source,Compound,CID,Class,Label,MW,XLOGP,TPSA,H-Bond ACC,H-Bond Donor,Heavy_Atom_Count,Canonical SMILES,Metabolism,Note
3765,Liew,Nimesulide,4495,positive,1,308.31,2.6,110.0,6,1,21,CS(=O)(=O)NC1=C(C=C(C=C1)[N+](=O)[O-])OC2=CC=CC=C2,Liver,
1661,LIverTox,Rolapitant,10311306,E,0,500.5,4.4,50.4,9,2,35,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OCC2(CCC3(CCC(=O)N3)CN2)C4=CC=CC=C4,CYP3A4,
3835,Liew,Phenacemide,4753,positive,0,178.19,0.9,72.2,2,2,13,C1=CC=C(C=C1)CC(=O)NC(=O)N,,
1637,LIverTox,Reserpine,5770,E,0,608.7,4.0,118.0,10,1,44,COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC,"Liver, Gut",
966,LIverTox,Capreomycin,3000502,E,0,1321.4,,737.0,23,27,93,CC1C(=O)NC(C(=O)NC(=CNC(=O)N)C(=O)NC(C(=O)NCC(C(=O)N1)N)C2CCN=C(N2)N)CNC(=O)CC(CCCN)N.C1CN=C(NC1C2C(=O)NCC(C(=O)NC(C(=O)NC(C(=O)NC(=CNC(=O)N)C(=O)N2)CNC(=O)CC(CCCN)N)CO)N)N,.,
259,DILIrank,terbinafine,1549008,vMost-DILI-Concern,1,291.4,5.6,3.2,1,0,22,CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21,liver,
2659,Xu,Fluvastatin,446155,Negative,1,411.5,3.5,82.7,5,3,30,CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F,"	Liver: CYP2C9 75%, CYP3A4 20%, CYP2C8 5%",
1015,LIverTox,Citalopram,2771,C,1,324.4,3.2,36.3,4,0,24,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,"CYP3A4,CYP2C19",
3510,Liew,Flumequine,3374,positive,1,261.25,2.9,57.6,5,1,19,CC1CCC2=C3N1C=C(C(=O)C3=CC(=C2)F)C(=O)O,,
1650,LIverTox,Rilpivirine,6451164,D,1,366.4,4.5,97.4,6,2,28,CC1=CC(=CC(=C1NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C)C=CC#N,CYP3A4,
3036,Liew,Morphine,5288826,positive,0,285.34,0.8,52.9,4,2,21,CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,,
70,DILIrank,pentamidine,4735,vLess-DILI-Concern,1,340.4,2.6,118.0,4,4,25,C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N,.,
2883,Liew,Carbinoxamine,2564,negative,0,290.79,2.9,25.4,3,0,20,CN(C)CCOC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2,,
1028,LIverTox,Clopidogrel,60606,B,1,321.8,3.8,57.8,4,0,21,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,Liver,
1450,LIverTox,Naldemedine,54732242,E,0,570.6,3.2,141.0,9,4,42,CC(C)(C1=NC(=NO1)C2=CC=CC=C2)NC(=O)C3=C(C4C56CCN(C(C5(C3)O)CC7=C6C(=C(C=C7)O)O4)CC8CC8)O,primarily CYP3A4,
4047,Liew,Toremifene,3005573,positive,1,406.0,7.2,12.5,2,0,29,CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3,CYP3A4,
687,DILIrank,trazodone,5533,vLess-DILI-Concern,1,371.9,2.8,42.4,4,0,26,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl,"CYP3A4, CYP2D6, CYP1A2",
4076,Liew,Tropisetron,72165,positive,0,284.35,3.8,45.3,3,1,21,CN1C2CCC1CC(C2)OC(=O)C3=CNC4=CC=CC=C43,"CYP3A4, CYP1A2, CYP2D6",
2561,Xu,Ciprofloxacin HCl,2764,Positive,1,331.34,-1.1,72.9,7,2,24,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,	Liver incl. CYP1A2,
1402,LIverTox,Metformin,4091,B,1,129.16,-1.3,91.5,1,3,9,CN(C)C(=N)N=C(N)N,Not by liver,
1816,LIverTox,Trospium,107979,E,0,428.0,,46.5,4,1,30,C1CC[N+]2(C1)C3CCC2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O.[Cl-],.,
1870,Greene,"1,3 dinitrobenzene",7452,HH,1,168.11,1.5,91.6,4,0,12,C1=CC(=CC(=C1)[N+](=O)[O-])[N+](=O)[O-],.,
1735,LIverTox,Tadalafil,110635,D,1,389.4,2.3,74.9,4,1,29,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36,Liver predominantly CYP3A4,
4047,Liew,Toremifene,3005573,positive,1,406.0,7.2,12.5,2,0,29,CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3,CYP3A4,
4004,Liew,Tenidap,60712,positive,1,320.8,3.8,114.0,4,2,21,C1=CSC(=C1)C(=O)C2=C(N(C3=C2C=C(C=C3)Cl)C(=O)N)O,,
3231,Liew,Benzthiazide,2343,negative,0,431.9,1.7,161.0,7,2,26,C1=CC=C(C=C1)CSCC2=NS(=O)(=O)C3=CC(=C(C=C3N2)Cl)S(=O)(=O)N,,
3173,Liew,Aminocaproic acid,564,positive,0,131.17,-3.0,63.3,3,2,9,C(CCC(=O)O)CCN,,
3988,Liew,Suprofen,5359,positive,0,260.31,3.3,82.6,4,1,18,CC(C1=CC=C(C=C1)C(=O)C2=CC=CS2)C(=O)O,,
3746,Liew,Naphazoline,4436,negative,0,210.27,2.1,24.4,1,1,16,C1CN=C(N1)CC2=CC=CC3=CC=CC=C32,,
2764,Xu,Pinacidil,4826,Negative,0,245.32,2.7,73.1,3,2,18,CC(C(C)(C)C)N=C(NC#N)NC1=CC=NC=C1,.,
614,DILIrank,mefloquine,40692,vLess-DILI-Concern,1,378.31,3.6,45.2,9,2,26,C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O,Extensive liver; main metabolite is inactive,
438,DILIrank,desloratadine,124087,vLess-DILI-Concern,1,310.8,4.5,24.9,2,1,22,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4,"UGT2B10, CYP2C8",
938,LIverTox,Boceprevir,10324367,B,1,519.7,3.1,151.0,5,4,37,CC1(C2C1C(N(C2)C(=O)C(C(C)(C)C)NC(=O)NC(C)(C)C)C(=O)NC(CC3CCC3)C(=O)C(=O)N)C,.,
1803,LIverTox,Triamterene,5546,D,1,253.26,1.0,130.0,7,3,19,C1=CC=C(C=C1)C2=NC3=C(N=C(N=C3N=C2N)N)N,hydroxylation to para-hydroxytriamterene,
2088,Greene,Estrone,5870,HH,1,270.4,3.1,37.3,2,1,20,CC12CCC3C(C1CCC2=O)CCC4=C3C=CC(=C4)O,.,
2452,Greene,tianeptine,68870,HH,1,437.0,1.2,95.1,6,2,29,CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O,Liver by ??-oxidation,
3856,Liew,Pirarubicin,3033521,positive,0,627.6,2.7,204.0,13,5,45,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)OC6CCCCO6,,
833,LIverTox,Amoxicillin-Clavulanate,6435924,A,1,564.6,,245.0,12,6,39,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C.C1C2N(C1=O)C(C(=CCO)O2)C(=O)O,.,
3620,Liew,Lacidipine,5311217,positive,0,455.5,4.5,90.9,7,1,33,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2C=CC(=O)OC(C)(C)C)C(=O)OCC)C)C,,
1145,LIverTox,Enasidenib,89683805,E*,0,473.4,3.5,109.0,14,3,33,CC(C)(CNC1=NC(=NC(=N1)C2=NC(=CC=C2)C(F)(F)F)NC3=CC(=NC=C3)C(F)(F)F)O,.,
3199,Liew,Arbutamine,60789,negative,0,317.4,0.9,93.0,5,5,23,C1=CC(=CC=C1CCCCNCC(C2=CC(=C(C=C2)O)O)O)O,,
3335,Liew,Clofarabine,119182,positive,1,303.68,0.9,119.0,8,3,20,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N,,
1263,LIverTox,Guanfacine,3519,E,0,246.09,2.0,81.5,1,2,15,C1=CC(=C(C(=C1)Cl)CC(=O)N=C(N)N)Cl,CYP3A4,
518,DILIrank,colistimethate,5311054,vNo-DILI-Concern,0,1155.4,-3.3,491.0,18,18,81,CCC(C)CCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC(C)C)CC(C)C)CCN)CCN)C(C)O,.,
2186,Greene,Loperamide HCl,3955,NE,0,477.0,5.0,43.8,3,1,34,CN(C)C(=O)C(CCN1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,	Liver extensive,
4063,Liew,Trimeprazine,5574,positive,0,298.4,4.7,31.8,3,0,21,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)CN(C)C,Liver,
3057,Liew,Pamidronate,4674,negative,0,235.07,-6.9,161.0,8,6,13,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O,,
3503,Liew,Flomoxef,65864,positive,0,496.5,-1.3,220.0,14,3,32,COC1(C2N(C1=O)C(=C(CO2)CSC3=NN=NN3CCO)C(=O)O)NC(=O)CSC(F)F,,
1018,LIverTox,Clemastine,26987,E,0,343.9,5.0,12.5,2,0,24,CC(C1=CC=CC=C1)(C2=CC=C(C=C2)Cl)OCCC3CCCN3C,Liver,
4087,Liew,Vardenafil,110634,positive,0,488.6,2.5,118.0,7,1,34,CCCC1=NC(=C2N1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC)C,CYP3A4,
3396,Liew,Dibucaine,3025,negative,0,343.5,4.4,54.5,4,1,25,CCCCOC1=NC2=CC=CC=C2C(=C1)C(=O)NCCN(CC)CC,,
3374,Liew,Delapril,5362116,positive,0,452.5,1.7,95.9,6,2,33,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N(CC(=O)O)C2CC3=CC=CC=C3C2,,
1669,LIverTox,Ruxolitinib,25126798,C,1,306.4,2.1,83.2,4,1,23,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,CYP3A4,
2153,Greene,indacrinone,42266,HH,1,365.2,4.5,63.6,4,1,24,CC1(CC2=CC(=C(C(=C2C1=O)Cl)Cl)OCC(=O)O)C3=CC=CC=C3,.,
2494,Greene,Zomepirac,5733,NE,0,291.73,2.8,59.3,3,1,20,CC1=C(N(C(=C1)CC(=O)O)C)C(=O)C2=CC=C(C=C2)Cl,.,
2452,Greene,tianeptine,68870,HH,1,437.0,1.2,95.1,6,2,29,CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O,Liver by ??-oxidation,
331,DILIrank,dichlorphenamide,3038,vNo-DILI-Concern,0,305.2,0.3,137.0,6,2,16,C1=C(C=C(C(=C1S(=O)(=O)N)Cl)Cl)S(=O)(=O)N,.,
3242,Liew,Bitolterol,35330,negative,0,461.5,5.2,84.9,6,2,34,CC1=CC=C(C=C1)C(=O)OC2=C(C=C(C=C2)C(CNC(C)(C)C)O)OC(=O)C3=CC=C(C=C3)C,,
3703,Liew,Methylprednisolone,6741,positive,1,374.5,1.9,94.8,5,3,27,CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,,
638,DILIrank,nitroglycerin,4510,vNo-DILI-Concern,0,227.09,1.6,165.0,9,0,15,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-],	Liver,
492,DILIrank,ramelteon,208902,vNo-DILI-Concern,0,259.34,2.7,38.3,2,1,19,CCC(=O)NCCC1CCC2=C1C3=C(C=C2)OCC3,"Liver CYP1A2 major, CYP2C,CYP3A4 minor",
2050,Greene,Didanosine,135398739,HH,1,236.23,-1.2,88.7,5,2,17,C1CC(OC1CO)N2C=NC3=C2N=CNC3=O,.,
4070,Liew,Tripelennamine,5587,negative,0,255.36,3.3,19.4,3,0,19,CN(C)CCN(CC1=CC=CC=C1)C2=CC=CC=N2,Liver,
2537,Xu,Biotin,171548,Negative,0,244.31,0.3,104.0,4,3,16,C1C2C(C(S1)CCCCC(=O)O)NC(=O)N2,.,
3315,Liew,Chlorprothixene,667467,positive,1,315.9,5.2,28.5,2,0,21,CN(C)CCC=C1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,,
449,DILIrank,benztropine,1201549,vNo-DILI-Concern,0,307.4,4.5,12.5,2,0,23,CN1C2CCC1CC(C2)OC(C3=CC=CC=C3)C4=CC=CC=C4,Liver,
473,DILIrank,ceftriaxone,5479530,vLess-DILI-Concern,1,554.6,-1.3,288.0,13,4,36,CN1C(=NC(=O)C(=O)N1)SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O,Negligible,
437,DILIrank,gemifloxacin,9571107,vLess-DILI-Concern,1,389.4,-0.7,121.0,10,2,28,CON=C1CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F,Limited metabolism by the liver to minor metabolites,
242,DILIrank,methimazole,1349907,vMost-DILI-Concern,1,114.17,-0.3,47.4,1,1,7,CN1C=CNC1=S,Liver,
3912,Liew,Raloxifene,5035,positive,0,473.6,6.1,98.2,6,2,34,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,Liver,
3764,Liew,Nilvadipine,4494,positive,0,385.4,2.9,134.0,8,1,28,CC1=C(C(C(=C(N1)C#N)C(=O)OC)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OC(C)C,,
226,DILIrank,dimenhydrinate,10660,vNo-DILI-Concern,0,470.0,,81.8,5,1,33,CN1C2=C(C(=O)N(C1=O)C)NC(=N2)Cl.CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2,Liver,
302,DILIrank,phenoxypropazine,71467,vMost-DILI-Concern,1,166.22,1.1,47.3,3,2,12,CC(COC1=CC=CC=C1)NN,.,
234,DILIrank,sunitinib,5329102,vMost-DILI-Concern,1,398.5,2.6,77.2,4,3,29,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,CYP3A4,
2764,Xu,Pinacidil,4826,Negative,0,245.32,2.7,73.1,3,2,18,CC(C(C)(C)C)N=C(NC#N)NC1=CC=NC=C1,.,
3334,Liew,Clocortolone Pivalate,5282493,negative,0,495.0,4.5,80.7,6,1,34,CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1C(=O)COC(=O)C(C)(C)C)C)O)Cl)C)F,,
509,DILIrank,cyclofenil,2898,vMost-DILI-Concern,1,364.4,5.5,52.6,4,0,27,CC(=O)OC1=CC=C(C=C1)C(=C2CCCCC2)C3=CC=C(C=C3)OC(=O)C,.,
443,DILIrank,dutasteride,6918296,vNo-DILI-Concern,0,528.5,5.4,58.2,8,2,37,CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C,CYP3A4,
84,DILIrank,sulfadiazine,5215,vLess-DILI-Concern,1,250.28,-0.1,106.0,6,2,17,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N,Liver acetylation,
692,DILIrank,ebrotidine,65869,vMost-DILI-Concern,1,477.4,1.5,198.0,7,3,26,C1=CC(=CC=C1S(=O)(=O)NC=NCCSCC2=CSC(=N2)N=C(N)N)Br,.,
1132,LIverTox,Edoxaban,10280735,D,1,548.1,1.4,165.0,8,3,37,CN1CCC2=C(C1)SC(=N2)C(=O)NC3CC(CCC3NC(=O)C(=O)NC4=NC=C(C=C4)Cl)C(=O)N(C)C,"minimal CES1, CYP3A4/5, hydrolysis, glucuronidation",
3559,Liew,Glutethimide,3487,negative,0,217.26,1.9,46.2,2,1,16,CCC1(CCC(=O)NC1=O)C2=CC=CC=C2,,
3838,Liew,Phenindione,4760,positive,1,222.24,2.9,34.1,2,0,17,C1=CC=C(C=C1)C2C(=O)C3=CC=CC=C3C2=O,,
634,DILIrank,esomeprazole Sodium,9579578,vLess-DILI-Concern,1,345.4,2.2,96.3,6,1,24,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,"	Liver CYP2C19, CYP3A4",
3401,Liew,Diethylcarbamazine,3052,negative,1,199.29,0.3,26.8,2,0,14,CCN(CC)C(=O)N1CCN(CC1)C,,
1917,Greene,Ascorbate,54670067,NE,0,176.12,-1.6,107.0,6,4,12,C(C(C1C(=C(C(=O)O1)O)O)O)O,.,
3797,Liew,Oxprenolol,4631,negative,0,265.35,2.1,50.7,4,2,19,CC(C)NCC(COC1=CC=CC=C1OCC=C)O,Liver,
1121,LIverTox,Droxidopa,92974,E,0,213.19,-3.2,124.0,6,5,15,C1=CC(=C(C=C1C(C(C(=O)O)N)O)O)O,Liver,
194,DILIrank,sodium thiosulfate,24477,vNo-DILI-Concern,0,158.11,,104.0,4,0,7,[O-]S(=O)(=S)[O-].[Na+].[Na+],.,
1405,LIverTox,Methocarbamol,4107,E,0,241.24,0.6,91.0,5,2,17,COC1=CC=CC=C1OCC(COC(=O)N)O,Liver,
3950,Liew,Sapropterin,135398654,negative,0,241.25,-1.9,132.0,6,6,17,CC(C(C1CNC2=C(N1)C(=O)NC(=N2)N)O)O,,
4084,Liew,Valrubicin,454216,negative,0,723.6,4.0,215.0,16,5,51,CCCCC(=O)OCC(=O)C1(CC(C2=C(C1)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4OC)O)OC5CC(C(C(O5)C)O)NC(=O)C(F)(F)F)O,,
3670,Liew,Mepenzolate,4057,negative,0,340.4,3.2,46.5,3,1,25,C[N+]1(CCCC(C1)OC(=O)C(C2=CC=CC=C2)(C3=CC=CC=C3)O)C,,
1063,LIverTox,Dalfampridine,1727,E*,0,94.11,0.3,38.9,2,1,7,C1=CN=CC=C1N,.,
1015,LIverTox,Citalopram,2771,C,1,324.4,3.2,36.3,4,0,24,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,"CYP3A4,CYP2C19",
1474,LIverTox,Nintedanib,9809715,E*,0,539.6,3.3,94.2,7,2,40,CN1CCN(CC1)CC(=O)N(C)C2=CC=C(C=C2)NC(=C3C4=C(C=C(C=C4)C(=O)OC)NC3=O)C5=CC=CC=C5,"Esterases, glucuronidation",
4001,Liew,Temocillin,171758,negative,0,414.5,1.1,187.0,9,3,27,CC1(C(N2C(S1)C(C2=O)(NC(=O)C(C3=CSC=C3)C(=O)O)OC)C(=O)O)C,,
3990,Liew,Talinolol,68770,positive,0,363.5,2.6,82.6,4,4,26,CC(C)(C)NCC(COC1=CC=C(C=C1)NC(=O)NC2CCCCC2)O,,
2278,Greene,perhexiline,4746,HH,1,277.5,6.8,12.0,1,1,20,C1CCC(CC1)C(CC2CCCCN2)C3CCCCC3,	Saturable Liver,
3204,Liew,Atenolol,2249,negative,1,266.34,0.2,84.6,4,3,19,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,,
2186,Greene,Loperamide HCl,3955,NE,0,477.0,5.0,43.8,3,1,34,CN(C)C(=O)C(CCN1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,	Liver extensive,
3575,Liew,Halofantrine,37393,positive,0,500.4,8.6,23.5,5,1,33,CCCCN(CCCC)CCC(C1=C2C=CC(=CC2=C3C=C(C=C(C3=C1)Cl)Cl)C(F)(F)F)O,,
3285,Liew,Ceforanide,43507,positive,0,519.6,-3.2,244.0,12,4,35,C1C(=C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3CN)C(=O)O)CSC4=NN=NN4CC(=O)O,,
672,DILIrank,riluzole,5070,vMost-DILI-Concern,1,234.2,3.6,76.4,7,1,15,C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N,CYP1A2,
760,DILIrank,apomorphine,6005,vNo-DILI-Concern,0,267.32,2.3,43.7,3,2,20,CN1CCC2=C3C1CC4=C(C3=CC=C2)C(=C(C=C4)O)O,"Liver, phase II",
149,DILIrank,busulfan,2478,vMost-DILI-Concern,1,246.3,-0.5,104.0,6,0,14,CS(=O)(=O)OCCCCOS(=O)(=O)C,Liver,
818,LIverTox,Altretamine,2123,E*,0,210.28,2.7,48.4,6,0,15,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,Extensive liver,
2180,Greene,Lidocaine,3676,NE,0,234.34,2.3,32.3,2,1,17,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,"	Liver, 90% CYP3A4",
3708,Liew,Metocurine,21233,negative,0,652.8,6.7,55.4,6,0,48,C[N+]1(CCC2=CC(=C3C=C2C1CC4=CC=C(C=C4)OC5=C6C(CC7=CC(=C(C=C7)OC)O3)[N+](CCC6=CC(=C5OC)OC)(C)C)OC)C,,
1755,LIverTox,Teriflunomide,54684141,D,1,270.21,3.3,73.1,6,2,19,CC(=C(C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F)O,.,
3513,Liew,Flunisolide,82153,negative,0,434.5,2.5,93.1,7,2,31,CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C,,
619,DILIrank,methazolamide,4100,vLess-DILI-Concern,1,236.3,0.1,139.0,6,1,14,CC(=O)N=C1N(N=C(S1)S(=O)(=O)N)C,.,
3321,Liew,Cilnidipine,5282138,positive,0,492.5,4.4,120.0,8,1,36,CC1=C(C(C(=C(N1)C)C(=O)OCC=CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OCCOC,,
79,DILIrank,indocyanine green,5282412,vNo-DILI-Concern,0,775.0,,137.0,7,0,54,CC1(C(=[N+](C2=C1C3=CC=CC=C3C=C2)CCCCS(=O)(=O)[O-])C=CC=CC=CC=C4C(C5=C(N4CCCCS(=O)(=O)[O-])C=CC6=CC=CC=C65)(C)C)C.[Na+],.,
349,DILIrank,cosyntropin,16132265,vNo-DILI-Concern,0,4541.0,-19.7,1860.0,68,63,322,CC(C)CC(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)O)NC(=O)C2CCCN2C(=O)C(CC3=CC=CC=C3)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)CNC(=O)C(CC(=O)N)NC(=O)C4CCCN4C(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(C(C)C)NC(=O)C(CCCCN)NC(=O)C(C(C)C)NC(=O)C6CCCN6C(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(C(C)C)NC(=O)C7CCCN7C(=O)C(CCCCN)NC(=O)CNC(=O)C(CC8=CNC9=CC=CC=C98)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC1=CN=CN1)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CO)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(CO)N,.,peptide
31,DILIrank,bupropion,444,vLess-DILI-Concern,1,239.74,3.2,29.1,2,1,16,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,"Liver, intestines",
2507,Xu,Amantadine HCl,64150,Negative,0,187.71,,26.0,1,2,12,C1C2CC3CC1CC(C2)(C3)N.Cl,	Minimal mostly to acetyl metabolites,
1857,LIverTox,Yohimbine,8969,E,0,354.4,2.9,65.6,4,2,26,COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O,.,
2718,Xu,Methysergide Maleate,9681,Negative,0,353.5,2.3,57.5,3,2,26,CCC(CO)NC(=O)C1CN(C2CC3=CN(C4=CC=CC(=C34)C2=C1)C)C,.,
3437,Liew,Droperidol,3168,negative,0,379.4,3.5,52.6,4,1,28,C1CN(CC=C1N2C3=CC=CC=C3NC2=O)CCCC(=O)C4=CC=C(C=C4)F,,
1667,LIverTox,Rucaparib,9931954,E*,0,323.4,2.5,56.9,3,3,24,CNCC1=CC=C(C=C1)C2=C3CCNC(=O)C4=C3C(=CC(=C4)F)N2,Liver primarily CYP2D6; 1A2 and 3A4 to a lesser extent,
3505,Liew,Floxuridine,5790,positive,1,246.19,-1.2,99.1,6,3,17,C1C(C(OC1N2C=C(C(=O)NC2=O)F)CO)O,,
2144,Greene,Hydrochlorothiazide,3639,HH,1,297.7,-0.1,135.0,7,3,17,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,	Not significant,
2410,Greene,Ribavirin,37542,E*,0,244.2,-1.8,144.0,7,4,17,C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,liver and intracellularly,
4007,Liew,Tenoxicam,5282194,positive,0,337.4,2.2,136.0,8,2,22,CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=C(S1(=O)=O)C=CS3,,
3915,Liew,Ramipril,5362129,positive,1,416.5,1.4,95.9,6,2,30,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,Liver,
2261,Greene,Orphenadrine Citrate,4601,NE,0,269.4,3.8,12.5,2,0,20,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,	Liver demethylation,
3294,Liew,Celecoxib,2662,positive,1,381.4,3.4,86.4,7,1,26,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,,
1057,LIverTox,Dabrafenib,44462760,E*,0,519.6,4.8,148.0,11,2,35,CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F,.,
482,DILIrank,atazanavir,148192,vLess-DILI-Concern,1,704.9,5.6,171.0,9,5,51,CC(C)(C)C(C(=O)NC(CC1=CC=CC=C1)C(CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)C(C(C)(C)C)NC(=O)OC)O)NC(=O)OC,CYP3A4,
3145,Liew,Adapalene,60164,negative,0,412.5,7.7,46.5,3,1,31,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5,,
3967,Liew,Sparfloxacin,60464,positive,0,392.4,0.1,98.9,9,3,28,CC1CN(CC(N1)C)C2=C(C(=C3C(=C2F)N(C=C(C3=O)C(=O)O)C4CC4)N)F,Liver,
2431,Greene,Sulfanilamide,5333,HH,1,172.21,-0.6,94.6,4,2,11,C1=CC(=CC=C1N)S(=O)(=O)N,.,
435,DILIrank,levothyroxine,5819,vLess-DILI-Concern,1,776.87,2.4,92.8,5,3,24,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,"	Mainly in liver, kidneys, brain and muscles",
3925,Liew,Retapamulin,6918462,negative,0,517.8,6.1,92.1,6,1,36,CC1CCC23CCC(=O)C2C1(C(CC(C(C3C)O)(C)C=C)OC(=O)CSC4CC5CCC(C4)N5C)C,CYP3A4,
1556,LIverTox,Phentermine,4771,E,0,149.23,1.9,26.0,1,1,11,CC(C)(CC1=CC=CC=C1)N,Liver,
3848,Liew,Pimecrolimus,16051947,negative,0,810.4,3.8,158.0,11,2,56,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C,CYP3A5,
3901,Liew,Pyrazinamide,1046,positive,1,123.11,-0.6,68.9,3,1,9,C1=CN=C(C=N1)C(=O)N,Liver,
133,DILIrank,pemoline,4723,vMost-DILI-Concern,1,176.17,0.9,64.7,2,1,13,C1=CC=C(C=C1)C2C(=O)N=C(O2)N,	Liver,
3650,Liew,Loteprednol,444025,negative,0,466.9,3.9,99.1,7,1,32,CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl,,
711,DILIrank,valdecoxib,119607,vLess-DILI-Concern,1,314.4,2.6,94.6,5,1,22,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N,"CYP3A4,2C9",
1639,LIverTox,Resveratrol,445154,E,0,228.24,3.1,60.7,3,3,17,C1=CC(=CC=C1C=CC2=CC(=CC(=C2)O)O)O,.,
2663,Xu,Furosemide,3440,Positive,1,330.74,2.0,131.0,7,3,21,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,	liver and kidney glucuronidation,
1551,LIverTox,Pexidartinib,25151352,B,1,417.8,4.5,66.5,7,2,29,C1=CC(=NC=C1CC2=CNC3=C2C=C(C=N3)Cl)NCC4=CN=C(C=C4)C(F)(F)F,.,
4013,Liew,Testolactone,13769,negative,0,300.4,3.0,43.4,3,0,22,CC12CCC3C(C1CCC(=O)O2)CCC4=CC(=O)C=CC34C,Liver,
2718,Xu,Methysergide Maleate,9681,Negative,0,353.5,2.3,57.5,3,2,26,CCC(CO)NC(=O)C1CN(C2CC3=CN(C4=CC=CC(=C34)C2=C1)C)C,.,
693,DILIrank,aceclofenac,71771,vLess-DILI-Concern,1,354.2,4.3,75.6,5,2,23,C1=CC=C(C(=C1)CC(=O)OCC(=O)O)NC2=C(C=CC=C2Cl)Cl,.,
492,DILIrank,ramelteon,208902,vNo-DILI-Concern,0,259.34,2.7,38.3,2,1,19,CCC(=O)NCCC1CCC2=C1C3=C(C=C2)OCC3,"Liver CYP1A2 major, CYP2C,CYP3A4 minor",
1334,LIverTox,Lacosamide,219078,D,1,250.29,0.3,67.4,3,2,18,CC(=O)NC(COC)C(=O)NCC1=CC=CC=C1,.,
753,DILIrank,simethicone,6433516,vNo-DILI-Concern,0,238.46,,52.6,4,0,13,CO[Si](C)(C)O[Si](C)(C)C.O=[Si]=O,	Not metabolized,
1922,Greene,Auranofin,6333901,HH,1,679.5,,115.0,10,0,32,CC[PH+](CC)CC.CC(=O)OCC1C(C(C(C(O1)[S-])OC(=O)C)OC(=O)C)OC(=O)C.[Au+],	Plasma membrane of the cell removes the acetyl groups of the glucose moiety.,
1895,Greene,Allyl alcohol,7858,HH,1,58.08,0.2,20.2,1,1,4,C=CCO,,
2760,Xu,Phenylbutazone,4781,Positive,1,308.4,3.2,40.6,2,0,23,CCCCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3,,
3200,Liew,Argatroban,440542,positive,0,508.6,1.3,189.0,8,5,35,CC1CCN(C(C1)C(=O)O)C(=O)C(CCCN=C(N)N)NS(=O)(=O)C2=CC=CC3=C2NCC(C3)C,,
3567,Liew,Guanabenz,5702063,positive,0,231.08,1.7,76.8,2,2,14,C1=CC(=C(C(=C1)Cl)C=NN=C(N)N)Cl,,
4101,Liew,Xanomeline,60809,positive,0,281.42,3.3,66.5,5,0,19,CCCCCCOC1=NSN=C1C2=CCCN(C2)C,,
388,DILIrank,porfimer,57166,vNo-DILI-Concern,0,1179.4,5.2,314.0,15,10,87,CC1=C(C2=CC3=NC(=CC4=NC(=CC5=C(C(=C(N5)C=C1N2)C(C)OC(C)C6=C(C7=CC8=C(C(=C(N8)C=C9C(=C(C(=N9)C=C1C(=C(C(=N1)C=C6N7)C)CCC(=O)O)CCC(=O)O)C)C)C(C)O)C)C)C(=C4CCC(=O)O)C)C(=C3C)CCC(=O)O)C(C)O,.,no small molecule
714,DILIrank,pyridoxine,1054,vNo-DILI-Concern,0,169.18,-0.8,73.6,4,3,12,CC1=NC=C(C(=C1O)CO)CO,.,
738,DILIrank,l-arginine,6322,vNo-DILI-Concern,0,174.2,-4.2,128.0,4,4,12,C(CC(C(=O)O)N)CN=C(N)N,.,
3125,Liew,Valganciclovir,135413535,negative,1,354.36,-1.5,167.0,8,4,25,CC(C)C(C(=O)OCC(CO)OCN1C=NC2=C1N=C(NC2=O)N)N,,
3263,Liew,Carbachol,5831,negative,0,182.65,,52.3,3,1,11,C[N+](C)(C)CCOC(=O)N.[Cl-],,
126,DILIrank,testosterone,6013,vMost-DILI-Concern,1,288.4,3.3,37.3,2,1,21,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C,	Liver mainly reduction and conjugation,
480,DILIrank,chloramphenicol,5959,vNo-DILI-Concern,1,323.13,1.1,115.0,5,3,20,C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-],Liver,
709,DILIrank,telithromycin,5462516,vMost-DILI-Concern,1,812.0,4.2,172.0,13,1,58,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C,Liver 50% CYP3A4,
2498,Xu,Acetazolamide,1986,Positive,1,222.3,-0.3,152.0,7,2,13,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,	None,
3183,Liew,Amonafide,50515,positive,0,283.32,1.5,66.6,4,1,21,CN(C)CCN1C(=O)C2=CC=CC3=CC(=CC(=C32)C1=O)N,,
3688,Liew,Methenolone,3037705,positive,1,302.5,3.9,37.3,2,1,22,CC1=CC(=O)CC2C1(C3CCC4(C(C3CC2)CCC4O)C)C,,
4062,Liew,Trilostane,656583,negative,0,329.4,2.9,76.8,4,2,24,CC12CCC3C(C1CCC2O)CCC45C3(CC(=C(C4O5)O)C#N)C,Liver,
1547,LIverTox,Pergolide,47811,E*,0,314.5,4.2,44.3,2,1,22,CCCN1CC(CC2C1CC3=CNC4=CC=CC2=C34)CSC,Extensively Liver,
1657,LIverTox,Rivaroxaban,6433119,A,1,435.9,2.5,116.0,6,1,29,C1COCC(=O)N1C2=CC=C(C=C2)N3CC(OC3=O)CNC(=O)C4=CC=C(S4)Cl,"CYP3A4, CYP2J2",
4024,Liew,Thiopental,3000714,positive,0,264.32,,96.6,3,1,17,CCCC(C)C1(C(=O)NC(=S)N=C1[O-])CC.[Na+],Liver,
1969,Greene,carbamazepine,2554,HH,1,236.27,2.5,46.3,1,1,18,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,CYP3A4,
1891,Greene,aflatoxin B1,14403,HH,1,312.27,1.6,71.1,6,0,23,COC1=C2C3=C(C(=O)CC3)C(=O)OC2=C4C5C=COC5OC4=C1,.,
1917,Greene,Ascorbate,54670067,NE,0,176.12,-1.6,107.0,6,4,12,C(C(C1C(=C(C(=O)O1)O)O)O)O,.,
3311,Liew,Chlorphenesin,2724,negative,0,245.66,1.2,81.8,4,2,16,C1=CC(=CC=C1OCC(COC(=O)N)O)Cl,,
2883,Liew,Carbinoxamine,2564,negative,0,290.79,2.9,25.4,3,0,20,CN(C)CCOC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2,,
3745,Liew,Nandrolone,9904,positive,0,274.4,2.6,37.3,2,1,20,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34,,
3183,Liew,Amonafide,50515,positive,0,283.32,1.5,66.6,4,1,21,CN(C)CCN1C(=O)C2=CC=CC3=CC(=CC(=C32)C1=O)N,,
1071,LIverTox,Daunorubicin,30323,E*,0,527.5,1.8,186.0,11,5,38,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O,Liver,
692,DILIrank,ebrotidine,65869,vMost-DILI-Concern,1,477.4,1.5,198.0,7,3,26,C1=CC(=CC=C1S(=O)(=O)NC=NCCSCC2=CSC(=N2)N=C(N)N)Br,.,
3425,Liew,Dolasetron,60654,positive,0,324.4,3.4,62.4,4,1,24,C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,,
1309,LIverTox,Irbesartan,3749,C,1,428.5,4.1,87.1,5,1,32,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,CYP2C9,
3474,Liew,Ethionamide,2761171,positive,1,166.25,1.1,71.0,2,1,11,CCC1=NC=CC(=C1)C(=S)N,,
3980,Liew,Sulfamethizole,5328,positive,1,270.3,0.5,135.0,7,2,17,CC1=NN=C(S1)NS(=O)(=O)C2=CC=C(C=C2)N,,
1708,LIverTox,Solifenacin,154059,D,1,362.5,4.0,32.8,3,0,27,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5,CYP3A4,
732,DILIrank,telmisartan,65999,vLess-DILI-Concern,1,514.6,6.9,72.9,4,1,39,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,Minimal liver glucuronidation,
1210,LIverTox,Fluorouracil,3385,A,1,130.08,-0.9,58.2,3,2,9,C1=C(C(=O)NC(=O)N1)F,Intracellular and liver CYP-mediated,
291,DILIrank,alclofenac,30951,vMost-DILI-Concern,1,226.65,2.5,46.5,3,1,15,C=CCOC1=C(C=C(C=C1)CC(=O)O)Cl,.,
602,DILIrank,isradipine,3784,vLess-DILI-Concern,1,371.4,4.3,104.0,8,1,27,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC,100% Liver,
1072,LIverTox,Decitabine,451668,E*,0,228.21,-1.2,121.0,4,3,16,C1C(C(OC1N2C=NC(=NC2=O)N)CO)O,.,
1957,Greene,buspirone,2477,NE,0,385.5,2.6,69.6,6,0,28,C1CCC2(C1)CC(=O)N(C(=O)C2)CCCCN3CCN(CC3)C4=NC=CC=N4,CYP3A4,
3612,Liew,Josamycin,5282165,positive,0,828.0,2.9,206.0,16,3,58,CC1CC=CC=CC(C(CC(C(C(C(CC(=O)O1)OC(=O)C)OC)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)OC(=O)CC(C)C)(C)O)N(C)C)O)CC=O)C)O,,
1923,Greene,Aurothioglucose,6104,HH,1,392.18,,91.2,6,4,13,C(C1C(C(C(C(O1)[S-])O)O)O)O.[Au+],.,
3938,Liew,Rocuronium,441351,negative,0,609.7,,59.0,6,1,39,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C.[Br-],,
172,DILIrank,sincalide,32800,vNo-DILI-Concern,0,1143.3,-2.6,486.0,19,13,78,CSCCC(C(=O)NCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CCSC)C(=O)NC(CC(=O)O)C(=O)NC(CC3=CC=CC=C3)C(=O)N)NC(=O)C(CC4=CC=C(C=C4)OS(=O)(=O)O)NC(=O)C(CC(=O)O)N,.,
2466,Greene,Trientine HCl,5565,HH,0,146.23,-2.5,76.1,4,4,10,C(CNCCNCCN)N,,
1338,LIverTox,Lanreotide,71349,E*,0,1096.3,2.5,406.0,14,13,77,CC(C)C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)N)C(=O)NC(C(C)O)C(=O)N,In GI tract,
635,DILIrank,nialamide,4472,vMost-DILI-Concern,1,298.34,0.9,83.1,4,3,22,C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2,.,
36,DILIrank,chlorcyclizine,2710,vLess-DILI-Concern,1,300.8,4.5,6.5,2,0,21,CN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,.,
1650,LIverTox,Rilpivirine,6451164,D,1,366.4,4.5,97.4,6,2,28,CC1=CC(=CC(=C1NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C)C=CC#N,CYP3A4,
139,DILIrank,nevirapine,4463,vMost-DILI-Concern,1,266.3,2.0,58.1,4,1,20,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,Liver,
4101,Liew,Xanomeline,60809,positive,0,281.42,3.3,66.5,5,0,19,CCCCCCOC1=NSN=C1C2=CCCN(C2)C,,
1280,LIverTox,Hydralazine,3637,A,1,160.18,0.7,63.8,4,2,12,C1=CC=C2C(=C1)C=NN=C2NN,Liver,
789,LIverTox,Acarbose,444254,B,1,645.6,-8.5,321.0,19,14,44,CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO,Gastrointestinal tractglucosidasemaltogenic alpha-amylase and cyclomaltodextrinase from gut microbiome,
3765,Liew,Nimesulide,4495,positive,1,308.31,2.6,110.0,6,1,21,CS(=O)(=O)NC1=C(C=C(C=C1)[N+](=O)[O-])OC2=CC=CC=C2,Liver,
3407,Liew,Digitoxin,441207,negative,0,764.9,2.3,183.0,13,5,54,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CCC7(C6(CCC7C8=CC(=O)OC8)O)C)C)C)C)O)O,,
653,DILIrank,pentostatin,439693,vMost-DILI-Concern,1,268.27,-2.1,112.0,6,4,19,C1C(C(OC1N2C=NC3=C2NC=NCC3O)CO)O,"Liver, minor",
505,DILIrank,darunavir,213039,vMost-DILI-Concern,1,547.7,2.9,149.0,9,3,38,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N,CYP3A4,
3173,Liew,Aminocaproic acid,564,positive,0,131.17,-3.0,63.3,3,2,9,C(CCC(=O)O)CCN,,
3664,Liew,Medrysone,247839,negative,0,344.5,2.7,54.4,3,1,25,CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)CC4)C)O)C)C(=O)C,,
327,DILIrank,meclizine,4034,vNo-DILI-Concern,0,390.9,5.8,6.5,2,0,28,CC1=CC(=CC=C1)CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=C(C=C4)Cl,Liver,
4076,Liew,Tropisetron,72165,positive,0,284.35,3.8,45.3,3,1,21,CN1C2CCC1CC(C2)OC(=O)C3=CNC4=CC=CC=C43,"CYP3A4, CYP1A2, CYP2D6",
523,DILIrank,polymyxin b sulfate,5702105,vNo-DILI-Concern,0,1301.6,,574.0,22,20,90,CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O,.,
1395,LIverTox,Meperidine,4058,ND,0,247.33,2.5,29.5,3,0,18,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,Liver,
201,DILIrank,triptorelin pamoate,25074470,vLess-DILI-Concern,0,1311.4,-0.3,490.0,15,17,95,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8,.,oligopeptide
636,DILIrank,nilutamide,4493,vMost-DILI-Concern,1,317.22,2.0,95.2,7,1,22,CC1(C(=O)N(C(=O)N1)C2=CC(=C(C=C2)[N+](=O)[O-])C(F)(F)F)C,"Liver CYP2C19, FMOTooltip flavin-containing monooxygenase",
4013,Liew,Testolactone,13769,negative,0,300.4,3.0,43.4,3,0,22,CC12CCC3C(C1CCC(=O)O2)CCC4=CC(=O)C=CC34C,Liver,
646,DILIrank,oxacillin,6196,vLess-DILI-Concern,1,401.4,2.4,138.0,7,2,28,CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O,.,
394,DILIrank,remifentanil,60815,vLess-DILI-Concern,1,376.4,1.9,76.2,6,0,27,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC,	cleaved by non-specific plasma and tissue esterases,
2457,Greene,Tolazamide,5503,HH,1,311.4,1.5,86.9,4,2,21,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CCCCCC2,	metabolized in the liver to active metabolites,
1123,LIverTox,Duloxetine,60835,B,1,297.4,4.3,49.5,3,1,21,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,"Liver, two P450 isozymes, CYP2D6 and CYP1A2",
3518,Liew,Fluorometholone,9878,negative,0,376.5,2.0,74.6,5,2,27,CC1CC2C3CCC(C3(CC(C2(C4(C1=CC(=O)C=C4)C)F)O)C)(C(=O)C)O,,
3222,Liew,Bendroflumethiazide,2315,positive,1,421.4,1.2,135.0,10,3,27,C1=CC=C(C=C1)CC2NC3=C(C=C(C(=C3)C(F)(F)F)S(=O)(=O)N)S(=O)(=O)N2,,
2387,Greene,Procarbazine HCl,4915,HH,1,221.3,0.1,53.2,3,3,16,CC(C)NC(=O)C1=CC=C(C=C1)CNNC,"Liver, Kidney",
288,DILIrank,tasosartan,60919,vMost-DILI-Concern,1,411.5,3.0,101.0,6,1,31,CC1=C2CCC(=O)N(C2=NC(=N1)C)CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,.,
3407,Liew,Digitoxin,441207,negative,0,764.9,2.3,183.0,13,5,54,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CCC7(C6(CCC7C8=CC(=O)OC8)O)C)C)C)C)O)O,,
2741,Xu,Norgestrel,16051930,Positive,1,312.4,3.3,37.3,2,1,23,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,.,
1321,LIverTox,Ivosidenib,71657455,E*,0,583.0,3.4,119.0,9,1,41,C1CC(=O)N(C1C(=O)N(C2=CC(=CN=C2)F)C(C3=CC=CC=C3Cl)C(=O)NC4CC(C4)(F)F)C5=NC=CC(=C5)C#N,.,
966,LIverTox,Capreomycin,3000502,E,0,1321.4,,737.0,23,27,93,CC1C(=O)NC(C(=O)NC(=CNC(=O)N)C(=O)NC(C(=O)NCC(C(=O)N1)N)C2CCN=C(N2)N)CNC(=O)CC(CCCN)N.C1CN=C(NC1C2C(=O)NCC(C(=O)NC(C(=O)NC(C(=O)NC(=CNC(=O)N)C(=O)N2)CNC(=O)CC(CCCN)N)CO)N)N,.,
3828,Liew,Perazine,4744,positive,0,339.5,4.1,35.0,4,0,24,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=CC=CC=C42,,
3804,Liew,Oxyphenisatin,31315,positive,1,317.3,3.2,69.6,3,3,24,C1=CC=C2C(=C1)C(C(=O)N2)(C3=CC=C(C=C3)O)C4=CC=C(C=C4)O,,
116,DILIrank,ergocalciferol,5280793,vNo-DILI-Concern,0,396.6,7.4,20.2,1,1,29,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,.,
1618,LIverTox,Quercetin,5280343,E,0,302.23,1.5,127.0,7,5,22,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O,.,
195,DILIrank,sirolimus,5284616,vLess-DILI-Concern,1,914.2,6.0,195.0,13,3,65,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC,Liver,
2561,Xu,Ciprofloxacin HCl,2764,Positive,1,331.34,-1.1,72.9,7,2,24,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,	Liver incl. CYP1A2,
4069,Liew,Trioxsalen,5585,negative,0,228.24,3.0,39.4,3,0,17,CC1=CC(=O)OC2=C1C=C3C=C(OC3=C2C)C,,
642,DILIrank,octreotide,448601,vLess-DILI-Concern,1,1019.2,1.0,383.0,14,13,71,CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O,Liver,
3194,Liew,Anisotropine,6647,negative,0,362.3,,26.3,3,0,21,CCCC(CCC)C(=O)OC1CC2CCC(C1)[N+]2(C)C.[Br-],,
753,DILIrank,simethicone,6433516,vNo-DILI-Concern,0,238.46,,52.6,4,0,13,CO[Si](C)(C)O[Si](C)(C)C.O=[Si]=O,	Not metabolized,
3402,Liew,Diethylpropion,7029,negative,0,205.3,2.8,20.3,2,0,15,CCN(CC)C(C)C(=O)C1=CC=CC=C1,,
922,LIverTox,Betrixaban,10275777,E*,0,451.9,3.6,107.0,5,3,32,CN(C)C(=N)C1=CC=C(C=C1)C(=O)NC2=C(C=C(C=C2)OC)C(=O)NC3=NC=C(C=C3)Cl,.,
3609,Liew,Itraconazole,55283,positive,1,705.6,5.7,101.0,9,0,49,CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,,
292,DILIrank,aplaviroc,3001322,vMost-DILI-Concern,1,577.7,3.1,119.0,7,3,42,CCCCN1C(=O)C(NC(=O)C12CCN(CC2)CC3=CC=C(C=C3)OC4=CC=C(C=C4)C(=O)O)C(C5CCCCC5)O,.,
4087,Liew,Vardenafil,110634,positive,0,488.6,2.5,118.0,7,1,34,CCCC1=NC(=C2N1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC)C,CYP3A4,
2238,Greene,Nadolol,39147,NE,0,309.4,0.7,82.0,5,4,22,CC(C)(C)NCC(COC1=CC=CC2=C1CC(C(C2)O)O)O,Not metabolised,
588,DILIrank,gemcitabine,60750,vMost-DILI-Concern,1,263.2,-1.5,108.0,6,3,18,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,.,
3563,Liew,Goserelin,5311128,negative,1,1269.4,-1.5,496.0,16,17,91,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6,,
2685,Xu,Kanamycin Sulfate,6032,Negative,0,484.5,-6.9,283.0,15,11,33,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)O)O)OC3C(C(C(C(O3)CO)O)N)O)N,	Unknown,
1895,Greene,Allyl alcohol,7858,HH,1,58.08,0.2,20.2,1,1,4,C=CCO,,
3836,Liew,Phendimetrazine,12460,negative,0,191.27,1.9,12.5,2,0,14,CC1C(OCCN1C)C2=CC=CC=C2,Liver,
3791,Liew,Oxandrolone,5878,positive,1,306.4,3.7,46.5,3,1,22,CC12CCC3C(C1CCC2(C)O)CCC4C3(COC(=O)C4)C,Kidney,
3558,Liew,Gliclazide,3475,positive,1,323.4,1.5,86.9,4,2,22,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2,,
712,DILIrank,dexpanthenol,4678,vNo-DILI-Concern,0,205.25,-0.9,89.8,4,4,14,CC(C)(CO)C(C(=O)NCCCO)O,.,
1635,LIverTox,Regorafenib,11167602,B,1,482.8,4.2,92.4,8,3,33,CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F,Hepatic UGT1A9-mediated,
817,LIverTox,Alprazolam,2118,D,1,308.8,2.1,43.1,3,0,22,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,"Liver, via cytochrome P450 3A4",
3680,Liew,Metaraminol,5906,negative,0,167.2,-0.4,66.5,3,3,12,CC(C(C1=CC(=CC=C1)O)O)N,,
3643,Liew,Lofepramine,3947,positive,1,419.0,6.8,23.6,3,0,30,CN(CCCN1C2=CC=CC=C2CCC3=CC=CC=C31)CC(=O)C4=CC=C(C=C4)Cl,,
3485,Liew,Exisulind,5472495,positive,0,372.4,3.5,79.8,5,1,26,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)(=O)C)C=CC(=C2)F)CC(=O)O,,
2441,Greene,Temafloxacin,60021,HH,1,417.4,0.6,72.9,9,2,30,CC1CN(CCN1)C2=C(C=C3C(=C2)N(C=C(C3=O)C(=O)O)C4=C(C=C(C=C4)F)F)F,.,
3101,Liew,Teriparatide,16132393,negative,0,4118.0,-18.7,1800.0,62,60,289,CCC(C)C(C(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(CCSC)C(=O)NC(CC1=CN=CN1)C(=O)NC(CC(=O)N)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CC2=CN=CN2)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)N)C(=O)NC(CO)C(=O)NC(CCSC)C(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(C(C)C)C(=O)NC(CC5=CN=CN5)C(=O)NC(CC(=O)N)C(=O)NC(CC6=CC=CC=C6)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CO)N,,
1323,LIverTox,Ixazomib,25183872,E*,0,361.0,,98.7,4,4,23,B(C(CC(C)C)NC(=O)CNC(=O)C1=C(C=CC(=C1)Cl)Cl)(O)O,"Liver CYP: 3A4 42%, 1A2 26%, 2B6 16% and others",
471,DILIrank,cefprozil,9887643,vLess-DILI-Concern,1,407.4,,159.0,8,5,28,CC=CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O.O,.,
70,DILIrank,pentamidine,4735,vLess-DILI-Concern,1,340.4,2.6,118.0,4,4,25,C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N,.,
2742,Xu,Nortriptyline HCl,4543,Positive,1,263.4,4.5,12.0,1,1,20,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,Liver,
2679,Xu,Imipramine HCl,3696,Positive,1,280.4,4.8,6.5,2,0,21,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31,"CYP1A2, CYP2C19, CYP2D6",
2113,Greene,flunoxaprofen,68869,WE,1,285.27,3.6,63.3,5,1,21,CC(C1=CC2=C(C=C1)OC(=N2)C3=CC=C(C=C3)F)C(=O)O,.,
3276,Liew,Cefamandole,456255,positive,0,462.5,-0.9,201.0,10,3,31,CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)NC(=O)C(C4=CC=CC=C4)O)SC2)C(=O)O,,
2387,Greene,Procarbazine HCl,4915,HH,1,221.3,0.1,53.2,3,3,16,CC(C)NC(=O)C1=CC=C(C=C1)CNNC,"Liver, Kidney",
265,DILIrank,clevidipine,153994,vNo-DILI-Concern,0,456.3,4.3,90.9,7,1,30,CCCC(=O)OCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,Blood and tissue esterases,
83,DILIrank,streptomycin,19649,vNo-DILI-Concern,0,581.6,-8.0,336.0,15,12,40,CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O,.,
3317,Liew,Chlorzoxazone,2733,positive,1,169.56,1.8,38.3,2,1,11,C1=CC2=C(C=C1Cl)NC(=O)O2,,
3334,Liew,Clocortolone Pivalate,5282493,negative,0,495.0,4.5,80.7,6,1,34,CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1C(=O)COC(=O)C(C)(C)C)C)O)Cl)C)F,,
1166,LIverTox,Eslicarbazepine,179344,D,1,296.32,2.0,72.6,3,1,22,CC(=O)OC1CC2=CC=CC=C2N(C3=CC=CC=C13)C(=O)N,UGT ,
3881,Liew,Procaine,4914,negative,0,236.31,1.9,55.6,4,1,17,CCN(CC)CCOC(=O)C1=CC=C(C=C1)N,,
765,DILIrank,norethindrone acetate,5832,vNo-DILI-Concern,0,340.5,3.5,43.4,3,0,25,CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C,.,
3582,Liew,Hydroxychloroquine,3652,negative,1,335.9,3.6,48.4,4,2,23,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,,
2801,Xu,Sulfasalazine,5339,Positive,1,398.4,-0.7,150.0,9,3,28,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N=NC3=CC(=C(C=C3)O)C(=O)O,.,
1127,LIverTox,Duvelisib,50905713,E*,0,416.9,4.1,86.8,5,2,30,CC(C1=CC2=C(C(=CC=C2)Cl)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5,mainly metabolized by CYP3A4,
3162,Liew,Alprostadil,5280723,positive,0,354.5,3.2,94.8,5,3,25,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,,
1243,LIverTox,Gilteritinib,49803313,E*,0,552.7,3.5,121.0,10,3,40,CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC(=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)OC)NC5CCOCC5,.,
2801,Xu,Sulfasalazine,5339,Positive,1,398.4,-0.7,150.0,9,3,28,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N=NC3=CC(=C(C=C3)O)C(=O)O,.,
3152,Liew,Alendronate,2088,positive,1,249.1,-6.5,161.0,8,6,14,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,,
3416,Liew,Diphenidol,9175,negative,0,280.4,4.0,0.0,0,0,22,C1C=C2C=C3C=CC=CC3=CC2=C4C1C=C5C=CC=CC5=C4,,
1863,LIverTox,Zidovudine,35370,B,1,267.24,0.0,93.2,6,2,19,CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-],Liver,
3893,Liew,Propofol,4943,positive,1,178.27,3.8,20.2,1,1,13,CC(C)C1=C(C(=CC=C1)C(C)C)O,Liver,
1745,LIverTox,Telbivudine,159269,E,0,242.23,-1.2,99.1,5,3,17,CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)O,Nil,
2111,Greene,Flufenamic Acid (Flufenamate),3371,WE,1,281.23,5.2,49.3,6,2,20,C1=CC=C(C(=C1)C(=O)O)NC2=CC=CC(=C2)C(F)(F)F,"	Hydroxylation, glucuronidation",
4101,Liew,Xanomeline,60809,positive,0,281.42,3.3,66.5,5,0,19,CCCCCCOC1=NSN=C1C2=CCCN(C2)C,,
1851,LIverTox,Vorinostat,5311,E,0,264.32,1.9,78.4,3,3,19,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,"Liver glucuronidation and ??-oxidation
CYP system not involved",
1921,Greene,atractyloside,442005,HH,1,726.8,1.2,267.0,16,5,48,CC(C)CC(=O)OC1C(C(C(OC1OC2CC(C3CCC45CC(CCC4C3(C2)C)C(=C)C5O)C(=O)O)CO)OS(=O)(=O)O)OS(=O)(=O)O,.,
1942,Greene,Betaine HCl,247,NE,0,117.15,0.5,40.1,2,0,8,C[N+](C)(C)CC(=O)[O-],,
2428,Greene,Sulconazole Nitrate,5318,NE,0,397.7,6.1,43.1,2,0,24,C1=CC(=CC=C1CSC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl,,
3746,Liew,Naphazoline,4436,negative,0,210.27,2.1,24.4,1,1,16,C1CN=C(N1)CC2=CC=CC3=CC=CC=C32,,
904,LIverTox,Baricitinib,44205240,E*,0,371.4,-0.5,129.0,7,1,26,CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,CYP3A4 <10%,
1127,LIverTox,Duvelisib,50905713,E*,0,416.9,4.1,86.8,5,2,30,CC(C1=CC2=C(C(=CC=C2)Cl)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5,mainly metabolized by CYP3A4,
1135,LIverTox,Elagolix,11250647,E,0,631.6,2.6,99.2,11,2,45,CC1=C(C(=O)N(C(=O)N1CC2=C(C=CC=C2F)C(F)(F)F)CC(C3=CC=CC=C3)NCCCC(=O)O)C4=C(C(=CC=C4)OC)F,CYP3A,
1546,LIverTox,Perampanel,9924495,E,0,349.4,3.4,57.0,3,0,27,C1=CC=C(C=C1)N2C=C(C=C(C2=O)C3=CC=CC=C3C#N)C4=CC=CC=N4,"Liver, mostly via CYP3A4 and/or CYP3A5",
482,DILIrank,atazanavir,148192,vLess-DILI-Concern,1,704.9,5.6,171.0,9,5,51,CC(C)(C)C(C(=O)NC(CC1=CC=CC=C1)C(CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)C(C(C)(C)C)NC(=O)OC)O)NC(=O)OC,CYP3A4,
3200,Liew,Argatroban,440542,positive,0,508.6,1.3,189.0,8,5,35,CC1CCN(C(C1)C(=O)O)C(=O)C(CCCN=C(N)N)NS(=O)(=O)C2=CC=CC3=C2NCC(C3)C,,
115,DILIrank,progesterone,5994,vLess-DILI-Concern,1,314.5,3.9,34.1,2,0,23,CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C,"	Liver CYP2C19, CYP3A4, CYP2C9, 5??-reductase, 3??-HSDTooltip 3??-hydroxysteroid dehydrogenase, 17??-hydroxylase, 21-hydroxylase, 20??-HSDTooltip 20??-hydroxysteroid dehydrogenase",
3770,Liew,Nitrofurazone,5447130,negative,0,198.14,0.2,126.0,5,2,14,C1=C(OC(=C1)[N+](=O)[O-])C=NNC(=O)N,,
3518,Liew,Fluorometholone,9878,negative,0,376.5,2.0,74.6,5,2,27,CC1CC2C3CCC(C3(CC(C2(C4(C1=CC(=O)C=C4)C)F)O)C)(C(=O)C)O,,
3988,Liew,Suprofen,5359,positive,0,260.31,3.3,82.6,4,1,18,CC(C1=CC=C(C=C1)C(=O)C2=CC=CS2)C(=O)O,,
4075,Liew,Tropicamide,5593,negative,0,284.35,1.5,53.4,3,1,21,CCN(CC1=CC=NC=C1)C(=O)C(CO)C2=CC=CC=C2,,
1407,LIverTox,Methsuximide,6476,E*,0,203.24,1.2,37.4,2,0,15,CC1(CC(=O)N(C1=O)C)C2=CC=CC=C2,Liver (demethylation and glucuronidation),
1015,LIverTox,Citalopram,2771,C,1,324.4,3.2,36.3,4,0,24,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,"CYP3A4,CYP2C19",
2725,Xu,Monocrotaline,9415,Positive,1,325.36,-0.7,96.3,7,2,23,CC1C(=O)OC2CCN3C2C(=CC3)COC(=O)C(C1(C)O)(C)O,.,
3383,Liew,Desoximetasone,5311067,negative,0,376.5,2.3,74.6,5,2,27,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1C(=O)CO)C)O)F)C,,
686,DILIrank,tranylcypromine,19493,vLess-DILI-Concern,1,133.19,1.5,26.0,1,1,10,C1C(C1N)C2=CC=CC=C2,Liver,
140,DILIrank,primidone,4909,vNo-DILI-Concern,0,218.25,0.9,58.2,2,2,16,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2,Liver,
3750,Liew,Nedocromil,50294,negative,0,371.3,2.2,121.0,8,2,27,CCCC1=C2C(=CC3=C1OC(=CC3=O)C(=O)O)C(=O)C=C(N2CC)C(=O)O,,
3815,Liew,Pefloxacin,51081,positive,0,333.36,0.3,64.1,7,1,24,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCN(CC3)C)F)C(=O)O,Liver,
3583,Liew,Hydroxyurea,3657,positive,1,76.055,-1.8,75.4,2,3,5,C(=O)(N)NO,,
1146,LIverTox,Encorafenib,50922675,E*,0,540.0,2.7,149.0,10,3,36,CC(C)N1C=C(C(=N1)C2=C(C(=CC(=C2)Cl)NS(=O)(=O)C)F)C3=NC(=NC=C3)NCC(C)NC(=O)OC,.,
3604,Liew,Isopropamide,3775,negative,0,353.5,4.3,43.1,1,1,26,CC(C)[N+](C)(CCC(C1=CC=CC=C1)(C2=CC=CC=C2)C(=O)N)C(C)C,,
2111,Greene,Flufenamic Acid (Flufenamate),3371,WE,1,281.23,5.2,49.3,6,2,20,C1=CC=C(C(=C1)C(=O)O)NC2=CC=CC(=C2)C(F)(F)F,"	Hydroxylation, glucuronidation",
1200,LIverTox,Fingolimod,107970,C,1,307.5,4.2,66.5,3,3,22,CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N,.,
3192,Liew,Aniracetam,2196,negative,0,219.24,1.6,46.6,3,0,16,COC1=CC=C(C=C1)C(=O)N2CCCC2=O,,
1072,LIverTox,Decitabine,451668,E*,0,228.21,-1.2,121.0,4,3,16,C1C(C(OC1N2C=NC(=NC2=O)N)CO)O,.,
1334,LIverTox,Lacosamide,219078,D,1,250.29,0.3,67.4,3,2,18,CC(=O)NC(COC)C(=O)NCC1=CC=CC=C1,.,
3563,Liew,Goserelin,5311128,negative,1,1269.4,-1.5,496.0,16,17,91,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6,,
785,LIverTox,Abemaciclib,46220502,E*,0,506.6,3.8,75.0,9,1,37,CCN1CCN(CC1)CC2=CN=C(C=C2)NC3=NC=C(C(=N3)C4=CC5=C(C(=C4)F)N=C(N5C(C)C)C)F,.,
1427,LIverTox,Mirabegron,9865528,E*,0,396.5,2.1,129.0,6,4,28,C1=CC=C(C=C1)C(CNCCC2=CC=C(C=C2)NC(=O)CC3=CSC(=N3)N)O,"Liver via direct glucuronidation, amide hydrolysis, and minimal oxidative metabolism in vivo by CYP2D6 and CYP3A4. Some involvement of butylcholinesterase",
3693,Liew,Methotrimeprazine,72287,negative,0,328.5,4.7,41.0,4,0,23,CC(CN1C2=CC=CC=C2SC3=C1C=C(C=C3)OC)CN(C)C,,
428,DILIrank,alpidem,54897,vMost-DILI-Concern,1,404.3,4.8,37.6,2,0,27,CCCN(CCC)C(=O)CC1=C(N=C2N1C=C(C=C2)Cl)C3=CC=C(C=C3)Cl,"	Extensive hydroxylation, dealkylation, conjugation",
1576,LIverTox,Plicamycin,5284610,A[HD],1,1085.1,0.6,358.0,24,11,76,CC1C(C(CC(O1)OC2CC(OC(C2O)C)OC3=CC4=CC5=C(C(=O)C(C(C5)C(C(=O)C(C(C)O)O)OC)OC6CC(C(C(O6)C)O)OC7CC(C(C(O7)C)O)OC8CC(C(C(O8)C)O)(C)O)C(=C4C(=C3C)O)O)O)O,.,
2663,Xu,Furosemide,3440,Positive,1,330.74,2.0,131.0,7,3,21,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,	liver and kidney glucuronidation,
1407,LIverTox,Methsuximide,6476,E*,0,203.24,1.2,37.4,2,0,15,CC1(CC(=O)N(C1=O)C)C2=CC=CC=C2,Liver (demethylation and glucuronidation),
1862,LIverTox,Zepatier,91669168,C,1,1648.9,,388.0,21,6,119,CC(C)C(C(=O)N1CCCC1C2N=CC(=N2)C3=CC4=C(C=C3)C5=CC6=C(N5C(O4)C7=CC=CC=C7)C=CC(=C6)C8=CN=C(N8)C9CCCN9C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC.CC(C)(C)C1C(=O)N2CC(CC2C(=O)NC3(CC3C=C)C(=O)NS(=O)(=O)C4CC4)OC5=NC6=C(C=CC(=C6)OC)N=C5CCCCCC7CC7OC(=O)N1,.,
1568,LIverTox,Piperacillin-Tazobactam,9918881,B,1,817.9,,313.0,15,4,56,CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O.CC1(C(N2C(S1(=O)=O)CC2=O)C(=O)O)CN3C=CN=N3,.,
943,LIverTox,Brexanolone,92786,E,0,318.5,4.9,37.3,2,1,23,CC(=O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C,"Non-CYP450 keto-reduction via aldo-keto reductases AKR, glucuronidation via glucuronosyltransferases UGT, sulfation via sulfotransferases SULT",
2237,Greene,NaCl,5234,NE,0,58.44,,0.0,1,0,2,[Na+].[Cl-],.,
142,DILIrank,rabeprazole,5029,vLess-DILI-Concern,1,359.4,1.9,96.3,6,1,25,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCCCOC,"CYP2C19,CYP3A4",
771,DILIrank,tyramine,5610,vNo-DILI-Concern,0,137.18,1.1,46.2,2,2,10,C1=CC(=CC=C1CCN)O,"	CYP2D6, flavin-containing monooxygenase 3, monoamine oxidase A, monoamine oxidase B, phenylethanolamine N-methyltransferase, DBH, others",
429,DILIrank,bexarotene,82146,vMost-DILI-Concern,1,348.5,7.6,37.3,2,1,26,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C,CYP3A4,
2057,Greene,Dimercaprol,3080,HH,0,124.23,0.2,22.2,3,3,6,C(C(CS)S)O,,
3272,Liew,Carvedilol,2585,positive,1,406.5,4.2,75.7,5,3,30,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,,
456,DILIrank,budesonide,40000,vNo-DILI-Concern,0,430.5,2.5,93.1,6,2,31,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,CYP3A4,
147,DILIrank,benzbromarone,2333,vMost-DILI-Concern,1,424.1,5.7,50.4,3,1,22,CCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)Br)O)Br,.,
3368,Liew,Daptomycin,16129629,positive,1,1620.7,-5.1,702.0,28,22,115,CCCCCCCCCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC3C(OC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC3=O)CCCN)CC(=O)O)C)CC(=O)O)CO)C(C)CC(=O)O)CC(=O)C4=CC=CC=C4N)C,,
4045,Liew,Topiramate,5284627,positive,1,339.36,-0.8,124.0,9,1,22,CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C,Liver,
1635,LIverTox,Regorafenib,11167602,B,1,482.8,4.2,92.4,8,3,33,CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F,Hepatic UGT1A9-mediated,
964,LIverTox,Cannabidiol,644019,E*,0,314.5,6.5,40.5,2,2,23,CCCCCC1=CC(=C(C(=C1)O)C2C=C(CCC2C(=C)C)C)O,.,
724,DILIrank,ximelagatran,9574101,vMost-DILI-Concern,1,473.6,2.2,146.0,7,4,34,CCOC(=O)CNC(C1CCCCC1)C(=O)N2CCC2C(=O)NCC3=CC=C(C=C3)C(=NO)N,	to melagatran,
1372,LIverTox,Lovastatin,53232,B,1,404.5,4.3,72.8,5,1,29,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,Liver CYP3A and CYP2C8 substrate,
1828,LIverTox,Vandetanib,3081361,E*,0,475.4,4.9,59.5,7,1,30,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,"CYP3A4, FMO1, FMO3",
3234,Liew,Bethanechol,2370,negative,0,161.22,0.0,52.3,2,1,11,CC(C[N+](C)(C)C)OC(=O)N,,
3938,Liew,Rocuronium,441351,negative,0,609.7,,59.0,6,1,39,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C.[Br-],,
6,DILIrank,cyclophosphamide,2907,vLess-DILI-Concern,1,261.08,0.6,41.6,4,1,14,C1CNP(=O)(OC1)N(CCCl)CCCl,Liver,
254,DILIrank,prednisolone,5755,vLess-DILI-Concern,1,360.4,1.6,94.8,5,3,26,CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,.,
224,DILIrank,danazol,28417,vMost-DILI-Concern,1,337.5,3.8,46.3,3,1,25,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC5=C(CC34C)C=NO5,CYP3A4,
480,DILIrank,chloramphenicol,5959,vNo-DILI-Concern,1,323.13,1.1,115.0,5,3,20,C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-],Liver,
3967,Liew,Sparfloxacin,60464,positive,0,392.4,0.1,98.9,9,3,28,CC1CN(CC(N1)C)C2=C(C(=C3C(=C2F)N(C=C(C3=O)C(=O)O)C4CC4)N)F,Liver,
4012,Liew,Tertatolol,36920,negative,0,295.4,2.7,66.8,4,2,20,CC(C)(C)NCC(COC1=CC=CC2=C1SCCC2)O,,
3275,Liew,Cefadroxil,47965,positive,0,363.4,-2.1,158.0,7,4,25,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O,,
3782,Liew,Olsalazine,22419,positive,1,302.24,3.1,140.0,8,4,22,C1=CC(=C(C=C1N=NC2=CC(=C(C=C2)O)C(=O)O)C(=O)O)O,,
393,DILIrank,tamsulosin,129211,vLess-DILI-Concern,1,408.5,2.7,108.0,7,2,28,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,Liver,
3360,Liew,Cysteamine,6058,positive,1,77.15,-0.4,27.0,2,2,4,C(CS)N,,
1916,Greene,Arsenic Trioxide,261004,HH,1,197.841,,43.4,3,0,5,O=[As]O[As]=O,.,
3838,Liew,Phenindione,4760,positive,1,222.24,2.9,34.1,2,0,17,C1=CC=C(C=C1)C2C(=O)C3=CC=CC=C3C2=O,,
956,LIverTox,Butorphanol,5361092,ND,0,327.5,3.8,43.7,3,2,24,C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,hydroxylated & glucuronidated,
413,DILIrank,sildenafil,135398744,vLess-DILI-Concern,1,474.6,1.5,118.0,8,1,33,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,"Liver: CYP3A4 major route, CYP2C9 minor route",
716,DILIrank,cyanocobalamin,16212801,vNo-DILI-Concern,0,1355.4,,476.0,21,9,93,CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3],.,
3139,Liew,Acetaminophen,1983,positive,1,151.16,0.5,49.3,2,2,11,CC(=O)NC1=CC=C(C=C1)O,,
2731,Xu,Nefazodone,4449,Positive,1,470.0,4.3,51.6,5,0,33,CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl,"CYP3A4, CYP2D6",
714,DILIrank,pyridoxine,1054,vNo-DILI-Concern,0,169.18,-0.8,73.6,4,3,12,CC1=NC=C(C(=C1O)CO)CO,.,
3541,Liew,Fulvestrant,104741,negative,0,606.8,9.2,76.7,9,2,41,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F,,
186,DILIrank,mesalazine,4075,vLess-DILI-Concern,1,153.14,1.3,83.6,4,3,11,C1=CC(=C(C=C1N)C(=O)O)O,	Rapidly & extensively metabolized intestinal mucosal wall and the liver,
1755,LIverTox,Teriflunomide,54684141,D,1,270.21,3.3,73.1,6,2,19,CC(=C(C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F)O,.,
438,DILIrank,desloratadine,124087,vLess-DILI-Concern,1,310.8,4.5,24.9,2,1,22,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4,"UGT2B10, CYP2C8",
4060,Liew,Trifluridine,6256,negative,0,296.2,-0.5,99.1,8,3,20,C1C(C(OC1N2C=C(C(=O)NC2=O)C(F)(F)F)CO)O,Thymidine phosphorylase,
1076,LIverTox,Defibrotide,135565962,E,0,444.4,1.8,137.0,7,4,31,CC(C)C1=C(C=C(C(=C1)C2=NNC(=O)N2C3=CC4=C(C=C3)N(C=C4)C)O)OP(=O)(O)O,.,
2679,Xu,Imipramine HCl,3696,Positive,1,280.4,4.8,6.5,2,0,21,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31,"CYP1A2, CYP2C19, CYP2D6",
368,DILIrank,atracurium,47320,vNo-DILI-Concern,0,1243.5,,258.0,18,0,87,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-],	Hofmann elimination retro-Michael addition and ester hydrolysis by nonspecific esterases,
1921,Greene,atractyloside,442005,HH,1,726.8,1.2,267.0,16,5,48,CC(C)CC(=O)OC1C(C(C(OC1OC2CC(C3CCC45CC(CCC4C3(C2)C)C(=C)C5O)C(=O)O)CO)OS(=O)(=O)O)OS(=O)(=O)O,.,
976,LIverTox,Cariprazine,11154555,E*,0,427.4,4.3,38.8,3,1,28,CN(C)C(=O)NC1CCC(CC1)CCN2CCN(CC2)C3=C(C(=CC=C3)Cl)Cl,Liver via CYP3A4 and to a lesser extent CYP2D6,
766,DILIrank,exametazime,9552069,vNo-DILI-Concern,0,742.6,,179.0,12,8,40,CC(C(=NO)C)NCC(C)(C)CNC(C)C(=NO)C.CC(C(=NO)C)NCC(C)(C)CNC(C)C(=NO)C.[Tc].[Tc],.,
965,LIverTox,Capecitabine,60953,E*,0,359.35,0.6,121.0,7,3,25,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O,"liver, to 5'-DFCR, 5'-DFUR inactive; neoplastic tissue, 5'-DFUR to active fluorouracil",
464,DILIrank,cefaclor,51038,vLess-DILI-Concern,1,385.8,,139.0,7,4,25,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl.O,15% to 40%,
799,LIverTox,Afatinib,10184653,D,1,485.9,3.6,88.6,8,2,34,CN(C)CC=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OC4CCOC4,CYP not involved,
3406,Liew,Difluprednate,32037,negative,0,508.5,3.4,107.0,9,1,36,CCCC(=O)OC1(CCC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C(=O)COC(=O)C,,
3368,Liew,Daptomycin,16129629,positive,1,1620.7,-5.1,702.0,28,22,115,CCCCCCCCCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC3C(OC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC3=O)CCCN)CC(=O)O)C)CC(=O)O)CO)C(C)CC(=O)O)CC(=O)C4=CC=CC=C4N)C,,
464,DILIrank,cefaclor,51038,vLess-DILI-Concern,1,385.8,,139.0,7,4,25,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl.O,15% to 40%,
833,LIverTox,Amoxicillin-Clavulanate,6435924,A,1,564.6,,245.0,12,6,39,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C.C1C2N(C1=O)C(C(=CCO)O2)C(=O)O,.,
3270,Liew,Carprofen,2581,positive,1,273.71,4.0,53.1,2,2,19,CC(C1=CC2=C(C=C1)C3=C(N2)C=CC(=C3)Cl)C(=O)O,,
3628,Liew,Lenalidomide,216326,positive,1,259.26,-0.5,92.5,4,2,19,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,,
290,DILIrank,tilbroquinol,65592,vMost-DILI-Concern,1,238.08,3.1,33.1,2,1,13,CC1=CC(=C(C2=C1C=CC=N2)O)Br,.,
3659,Liew,Marimastat,119031,positive,0,331.41,0.5,128.0,5,5,23,CC(C)CC(C(C(=O)NO)O)C(=O)NC(C(=O)NC)C(C)(C)C,,
383,DILIrank,enoxaparin,772,vLess-DILI-Concern,1,1134.9,-10.8,652.0,38,15,70,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,.,
1321,LIverTox,Ivosidenib,71657455,E*,0,583.0,3.4,119.0,9,1,41,C1CC(=O)N(C1C(=O)N(C2=CC(=CN=C2)F)C(C3=CC=CC=C3Cl)C(=O)NC4CC(C4)(F)F)C5=NC=CC(=C5)C#N,.,
18,DILIrank,tetracycline,54685734,vLess-DILI-Concern,1,444.4,-2.0,182.0,9,6,32,CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O,Not metabolized,
817,LIverTox,Alprazolam,2118,D,1,308.8,2.1,43.1,3,0,22,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,"Liver, via cytochrome P450 3A4",
2659,Xu,Fluvastatin,446155,Negative,1,411.5,3.5,82.7,5,3,30,CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F,"	Liver: CYP2C9 75%, CYP3A4 20%, CYP2C8 5%",
789,LIverTox,Acarbose,444254,B,1,645.6,-8.5,321.0,19,14,44,CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO,Gastrointestinal tractglucosidasemaltogenic alpha-amylase and cyclomaltodextrinase from gut microbiome,
218,DILIrank,benoxaprofen,39941,vMost-DILI-Concern,1,301.72,4.1,63.3,4,1,21,CC(C1=CC2=C(C=C1)OC(=N2)C3=CC=C(C=C3)Cl)C(=O)O,.,
3816,Liew,Pemirolast,57697,positive,0,228.21,-0.3,87.1,5,1,17,CC1=CC=CN2C1=NC=C(C2=O)C3=NNN=N3,,
379,DILIrank,fenoldopam,3341,vNo-DILI-Concern,0,305.75,2.4,72.7,4,4,21,C1CNCC(C2=CC(=C(C(=C21)Cl)O)O)C3=CC=C(C=C3)O,	Liver CYP not involved,
1576,LIverTox,Plicamycin,5284610,A[HD],1,1085.1,0.6,358.0,24,11,76,CC1C(C(CC(O1)OC2CC(OC(C2O)C)OC3=CC4=CC5=C(C(=O)C(C(C5)C(C(=O)C(C(C)O)O)OC)OC6CC(C(C(O6)C)O)OC7CC(C(C(O7)C)O)OC8CC(C(C(O8)C)O)(C)O)C(=C4C(=C3C)O)O)O)O,.,
803,LIverTox,Alectinib,49806720,D,1,482.6,5.2,72.4,5,1,36,CCC1=CC2=C(C=C1N3CCC(CC3)N4CCOCC4)C(C5=C(C2=O)C6=C(N5)C=C(C=C6)C#N)(C)C,CYP3A4,
1710,LIverTox,Sorafenib,216239,B,1,464.8,4.1,92.4,7,3,32,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,Liver oxidation and glucuronidation CYP3A4 & UGT1A9-mediated,
3334,Liew,Clocortolone Pivalate,5282493,negative,0,495.0,4.5,80.7,6,1,34,CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1C(=O)COC(=O)C(C)(C)C)C)O)Cl)C)F,,
3323,Liew,Cimetidine,2756,positive,1,252.34,0.4,114.0,4,3,17,CC1=C(N=CN1)CSCCNC(=NC)NC#N,,
1243,LIverTox,Gilteritinib,49803313,E*,0,552.7,3.5,121.0,10,3,40,CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC(=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)OC)NC5CCOCC5,.,
425,DILIrank,frovatriptan,77992,vNo-DILI-Concern,0,243.3,1.2,70.9,2,3,18,CNC1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N,	Liver,
1957,Greene,buspirone,2477,NE,0,385.5,2.6,69.6,6,0,28,C1CCC2(C1)CC(=O)N(C(=O)C2)CCCCN3CCN(CC3)C4=NC=CC=N4,CYP3A4,
1905,Greene,amiodarone,2157,HH,1,645.3,7.6,42.7,4,0,31,CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I,Liver,
1040,LIverTox,Copanlisib,24989044,E*,0,480.5,-0.3,140.0,10,2,35,COC1=C(C=CC2=C1N=C(N3C2=NCC3)NC(=O)C4=CN=C(N=C4)N)OCCCN5CCOCC5,"CYP3A4/5 (?90%), CYP1A1 (?10%)",
3879,Liew,Probucol,4912,positive,0,516.8,11.3,91.1,4,2,35,CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)SC(C)(C)SC2=CC(=C(C(=C2)C(C)(C)C)O)C(C)(C)C,,
2270,Greene,Pargyline,4688,NE,0,159.23,2.1,3.2,1,0,12,CN(CC#C)CC1=CC=CC=C1,.,
2410,Greene,Ribavirin,37542,E*,0,244.2,-1.8,144.0,7,4,17,C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,liver and intracellularly,
193,DILIrank,corticorelin ovine triflutate,16186200,vNo-DILI-Concern,0,4757.0,-14.3,2050.0,72,67,333,CCC(C)C(C(=O)N)NC(=O)C(C(C)CC)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(=O)N)NC(=O)C(CO)NC(=O)C(CC1=CNC=N1)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)N)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)C(CCSC)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(C(C)C)NC(=O)C(CCC(=O)O)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CNC=N2)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(C(C)O)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(C(C)CC)NC(=O)C4CCCN4C(=O)C5CCCN5C(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CO)N,.,polypeptide
1294,LIverTox,Iloperidone,71360,E,0,426.5,4.1,64.8,7,0,31,CC(=O)C1=CC(=C(C=C1)OCCCN2CCC(CC2)C3=NOC4=C3C=CC(=C4)F)OC,Liver CYP2D6-mediated hydroxylation and CYP3A4-mediated O-demethylation,
3645,Liew,Lonidamine,39562,positive,0,321.2,4.3,55.1,3,1,21,C1=CC=C2C(=C1)C(=NN2CC3=C(C=C(C=C3)Cl)Cl)C(=O)O,,
3574,Liew,Halobetasol,5311167,negative,0,428.9,2.7,74.6,6,2,29,CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C)F,,
1511,LIverTox,Oxaliplatin,77994,A,1,397.29,,132.0,6,2,15,C1CCC(C(C1)N)N.C(=O)(C(=O)[O-])[O-].[Pt+2],.,
3200,Liew,Argatroban,440542,positive,0,508.6,1.3,189.0,8,5,35,CC1CCN(C(C1)C(=O)O)C(=O)C(CCCN=C(N)N)NS(=O)(=O)C2=CC=CC3=C2NCC(C3)C,,
3755,Liew,Nepafenac,151075,negative,0,254.28,1.9,86.2,3,2,19,C1=CC=C(C=C1)C(=O)C2=CC=CC(=C2N)CC(=O)N,,
186,DILIrank,mesalazine,4075,vLess-DILI-Concern,1,153.14,1.3,83.6,4,3,11,C1=CC(=C(C=C1N)C(=O)O)O,	Rapidly & extensively metabolized intestinal mucosal wall and the liver,
3820,Liew,Penfluridol,33630,negative,0,524.0,7.3,23.5,7,1,36,C1CN(CCC1(C2=CC(=C(C=C2)Cl)C(F)(F)F)O)CCCC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F,,
3337,Liew,Clofibrate,2796,positive,1,242.7,3.3,35.5,3,0,16,CCOC(=O)C(C)(C)OC1=CC=C(C=C1)Cl,,
2477,Greene,Uracil Mustard,6194,HH,1,252.09,0.5,61.4,3,2,15,C1=C(C(=O)NC(=O)N1)N(CCCl)CCCl,.,
637,DILIrank,niperotidine,3033952,vMost-DILI-Concern,1,434.5,2.9,130.0,9,2,30,CN(C)CC1=CC=C(O1)CSCCNC(=C[N+](=O)[O-])NCC2=CC3=C(C=C2)OCO3,.,
75,DILIrank,pseudoephedrine,7028,vNo-DILI-Concern,0,165.23,0.9,32.3,2,2,12,CC(C(C1=CC=CC=C1)O)NC,	10?30% liver,
3767,Liew,Nitisinone,115355,negative,0,329.23,2.3,97.0,8,0,23,C1CC(=O)C(C(=O)C1)C(=O)C2=C(C=C(C=C2)C(F)(F)F)[N+](=O)[O-],,
234,DILIrank,sunitinib,5329102,vMost-DILI-Concern,1,398.5,2.6,77.2,4,3,29,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,CYP3A4,
3416,Liew,Diphenidol,9175,negative,0,280.4,4.0,0.0,0,0,22,C1C=C2C=C3C=CC=CC3=CC2=C4C1C=C5C=CC=CC5=C4,,
1803,LIverTox,Triamterene,5546,D,1,253.26,1.0,130.0,7,3,19,C1=CC=C(C=C1)C2=NC3=C(N=C(N=C3N=C2N)N)N,hydroxylation to para-hydroxytriamterene,
1207,LIverTox,Flucytosine,3366,D,1,129.09,-0.9,67.5,3,2,9,C1=NC(=O)NC(=C1F)N,"minimal, in the GI tract",
3266,Liew,Carboprost,5281075,negative,0,368.5,2.9,98.0,5,4,26,CCCCCC(C)(C=CC1C(CC(C1CC=CCCCC(=O)O)O)O)O,,
3563,Liew,Goserelin,5311128,negative,1,1269.4,-1.5,496.0,16,17,91,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6,,
344,DILIrank,glycopyrrolate,3494,vNo-DILI-Concern,0,318.4,3.1,46.5,3,1,23,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C,.,
1623,LIverTox,Quinupristin-Dalfopristin,23724510,E*,0,1713.1,,441.0,25,6,121,CCC1C(=O)N2CCCC2C(=O)N(C(C(=O)N3CC(C(=O)CC3C(=O)NC(C(=O)OC(C(C(=O)N1)NC(=O)C4=C(C=CC=N4)O)C)C5=CC=CC=C5)CSC6CN7CCC6CC7)CC8=CC=C(C=C8)N(C)C)C.CCN(CC)CCS(=O)(=O)C1CCN2C1C(=O)OC(C(C=CC(=O)NCC=CC(=CC(CC(=O)CC3=NC(=CO3)C2=O)O)C)C)C(C)C,.,
393,DILIrank,tamsulosin,129211,vLess-DILI-Concern,1,408.5,2.7,108.0,7,2,28,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,Liver,
897,LIverTox,Azilsartan,135415867,E*,1,456.4,4.4,115.0,7,2,34,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NOC(=O)N5)C(=O)O,CYP2C9,
758,DILIrank,alaproclate,2081,vMost-DILI-Concern,1,255.74,2.8,52.3,3,1,17,CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N,.,
329,DILIrank,benzonatate,7699,vLess-DILI-Concern,1,603.7,2.4,121.0,12,1,42,CCCCNC1=CC=C(C=C1)C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC,.,
452,DILIrank,gadobenate dimeglumine,105124,vNo-DILI-Concern,0,667.7,,220.0,14,2,37,[H+].[H+].C1=CC=C(C=C1)COCC(C(=O)[O-])N(CCN(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3],.,
1661,LIverTox,Rolapitant,10311306,E,0,500.5,4.4,50.4,9,2,35,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OCC2(CCC3(CCC(=O)N3)CN2)C4=CC=CC=C4,CYP3A4,
3363,Liew,Dactinomycin,2019,positive,1,1255.4,3.8,356.0,18,5,90,CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)N)C,,
583,DILIrank,fosinopril,55891,vLess-DILI-Concern,1,563.7,6.2,110.0,7,1,39,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)O)C3CCCCC3,"liver, GIT mucosa to fosinoprilat",
6,DILIrank,cyclophosphamide,2907,vLess-DILI-Concern,1,261.08,0.6,41.6,4,1,14,C1CNP(=O)(OC1)N(CCCl)CCCl,Liver,
604,DILIrank,riboflavin,493570,vNo-DILI-Concern,0,376.4,-1.5,155.0,7,5,27,CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(CO)O)O)O,.,
3432,Liew,Doxepin,3158,positive,1,279.4,4.3,12.5,2,0,21,CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31,,
62,DILIrank,mefenamic acid,4044,vMost-DILI-Concern,1,241.28,5.1,49.3,3,2,18,CC1=C(C(=CC=C1)NC2=CC=CC=C2C(=O)O)C,CYP2C9,
1527,LIverTox,Pasireotide,9941444,E*,0,1047.2,4.7,281.0,11,9,77,C1C(CN2C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C2=O)CC3=CC=CC=C3)CC4=CC=C(C=C4)OCC5=CC=CC=C5)CCCCN)CC6=CNC7=CC=CC=C76)C8=CC=CC=C8)OC(=O)NCCN,.,
226,DILIrank,dimenhydrinate,10660,vNo-DILI-Concern,0,470.0,,81.8,5,1,33,CN1C2=C(C(=O)N(C1=O)C)NC(=N2)Cl.CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2,Liver,
3243,Liew,Bortezomib,387447,positive,1,384.2,,124.0,6,4,28,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,,
428,DILIrank,alpidem,54897,vMost-DILI-Concern,1,404.3,4.8,37.6,2,0,27,CCCN(CCC)C(=O)CC1=C(N=C2N1C=C(C=C2)Cl)C3=CC=C(C=C3)Cl,"	Extensive hydroxylation, dealkylation, conjugation",
727,DILIrank,dicloxacillin,18381,vLess-DILI-Concern,1,470.3,2.9,138.0,7,2,30,CC1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O,Liver,
2537,Xu,Biotin,171548,Negative,0,244.31,0.3,104.0,4,3,16,C1C2C(C(S1)CCCCC(=O)O)NC(=O)N2,.,
157,DILIrank,gabapentin,3446,vLess-DILI-Concern,1,171.24,-1.1,63.3,3,2,12,C1CCC(CC1)(CC(=O)O)CN,Not significantly metabolized,
344,DILIrank,glycopyrrolate,3494,vNo-DILI-Concern,0,318.4,3.1,46.5,3,1,23,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C,.,
1353,LIverTox,Levofloxacin,149096,A,1,361.4,-0.4,73.3,8,1,26,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,<5% desmethyl and N-oxide metabolites,
426,DILIrank,oxcarbazepine,34312,vLess-DILI-Concern,1,252.27,1.7,63.4,2,1,19,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N,Liver cytosolic enzymes and glucuronic acid,
3421,Liew,Disulfiram,3117,positive,1,296.5,3.9,121.0,4,0,16,CCN(CC)C(=S)SSC(=S)N(CC)CC,,
795,LIverTox,Acrivastine,5284514,E,0,348.4,1.6,53.4,4,1,26,CC1=CC=C(C=C1)C(=CCN2CCCC2)C3=CC=CC(=N3)C=CC(=O)O,.,
481,DILIrank,chlordiazepoxide,2712,vLess-DILI-Concern,1,299.75,2.4,48.2,3,1,21,CN=C1CN(C(=C2C=C(C=CC2=N1)Cl)C3=CC=CC=C3)O,Liver,
2755,Xu,Phenacetin,4754,Positive,1,179.22,1.6,38.3,2,1,13,CCOC1=CC=C(C=C1)NC(=O)C,,
4013,Liew,Testolactone,13769,negative,0,300.4,3.0,43.4,3,0,22,CC12CCC3C(C1CCC(=O)O2)CCC4=CC(=O)C=CC34C,Liver,
2741,Xu,Norgestrel,16051930,Positive,1,312.4,3.3,37.3,2,1,23,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,.,
902,LIverTox,Baloxavir,124081896,E,0,571.6,3.8,123.0,12,0,40,COC(=O)OCOC1=C2C(=O)N3CCOCC3N(N2C=CC1=O)C4C5=C(CSC6=CC=CC=C46)C(=C(C=C5)F)F,.,
3768,Liew,Nitrendipine,4507,positive,0,360.4,2.9,110.0,7,1,26,CCOC(=O)C1=C(NC(=C(C1C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OC)C)C,Liver,
1639,LIverTox,Resveratrol,445154,E,0,228.24,3.1,60.7,3,3,17,C1=CC(=CC=C1C=CC2=CC(=CC(=C2)O)O)O,.,
3782,Liew,Olsalazine,22419,positive,1,302.24,3.1,140.0,8,4,22,C1=CC(=C(C=C1N=NC2=CC(=C(C=C2)O)C(=O)O)C(=O)O)O,,
459,DILIrank,ezetimibe,150311,vLess-DILI-Concern,1,409.4,4.0,60.8,5,2,30,C1=CC(=CC=C1C2C(C(=O)N2C3=CC=C(C=C3)F)CCC(C4=CC=C(C=C4)F)O)O,"Intestinal wall, liver",
3149,Liew,Albuterol,2083,negative,0,239.31,0.3,72.7,4,4,17,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,,
3577,Liew,Histrelin,25077993,negative,0,1323.5,0.7,449.0,15,15,96,CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC2=CN(C=N2)CC3=CC=CC=C3)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8,,
1886,Greene,Acitretin,5284513,HH,1,326.4,6.1,46.5,3,1,24,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC,Liver,
1545,LIverTox,Peramivir,151164,E,0,328.41,0.0,151.0,5,5,23,CCC(CC)C(C1C(CC(C1O)C(=O)O)N=C(N)N)NC(=O)C,.,
2201,Greene,Mesoridazine Besylate,4078,HH,1,386.6,4.5,68.1,5,0,26,CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)C,	Liver/renal,
3585,Liew,Ibandronate,60852,positive,0,319.23,-4.1,139.0,8,5,19,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O,,
1717,LIverTox,Stiripentol,5311454,E,0,234.29,3.6,38.7,3,1,17,CC(C)(C)C(C=CC1=CC2=C(C=C1)OCO2)O,.,
1352,LIverTox,Levodopa,6047,E,0,197.19,-2.7,104.0,5,4,14,C1=CC(=C(C=C1CC(C(=O)O)N)O)O,Aromatic-l-amino-acid decarboxylase,
808,LIverTox,Aliskiren,5493444,C,1,551.8,3.5,146.0,7,4,39,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N,CYP3A4,
487,DILIrank,chlorothiazide,2720,vLess-DILI-Concern,1,295.7,-0.2,135.0,6,2,17,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2,	Nil,
1999,Greene,Ciclopirox,2749,NE,0,207.27,2.0,40.5,2,1,15,CC1=CC(=O)N(C(=C1)C2CCCCC2)O,.,
1482,LIverTox,Nizatidine,3033637,D,1,331.5,1.6,140.0,8,2,21,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C,Liver,
3836,Liew,Phendimetrazine,12460,negative,0,191.27,1.9,12.5,2,0,14,CC1C(OCCN1C)C2=CC=CC=C2,Liver,
4001,Liew,Temocillin,171758,negative,0,414.5,1.1,187.0,9,3,27,CC1(C(N2C(S1)C(C2=O)(NC(=O)C(C3=CSC=C3)C(=O)O)OC)C(=O)O)C,,
252,DILIrank,nystatin,14960,vNo-DILI-Concern,0,926.1,-0.2,320.0,18,12,65,CC1C=CC=CCCC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,None not extensively absorbed,
296,DILIrank,pipamazine,6761,vMost-DILI-Concern,1,402.0,4.4,74.9,4,1,27,C1CN(CCC1C(=O)N)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,.,
3006,Liew,Lomefloxacin,3948,negative,1,351.35,-0.8,72.9,8,2,25,CCN1C=C(C(=O)C2=CC(=C(C(=C21)F)N3CCNC(C3)C)F)C(=O)O,,
2009,Greene,Citicoline,11583971,NE,0,488.32,-4.0,214.0,11,4,31,C[N+](C)(C)CCOP(=O)(O)OP(=O)([O-])OCC1C(C(C(O1)N2C=CC(=NC2=O)N)O)O,.,
25,DILIrank,amphotericin b,14956,vLess-DILI-Concern,1,924.1,0.0,320.0,18,12,65,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,kidney,
3294,Liew,Celecoxib,2662,positive,1,381.4,3.4,86.4,7,1,26,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,,
1482,LIverTox,Nizatidine,3033637,D,1,331.5,1.6,140.0,8,2,21,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C,Liver,
169,DILIrank,verapamil,2520,vLess-DILI-Concern,1,454.6,3.8,64.0,6,0,33,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,liver,
4050,Liew,Tranilast,5282230,positive,1,327.3,3.2,84.9,5,2,24,COC1=C(C=C(C=C1)C=CC(=O)NC2=CC=CC=C2C(=O)O)OC,,
3681,Liew,Metergoline,28693,positive,0,403.5,3.8,46.5,3,1,30,CN1CC(CC2C1CC3=CN(C4=CC=CC2=C34)C)CNC(=O)OCC5=CC=CC=C5,,
1152,LIverTox,Enzalutamide,15951529,E,0,464.4,3.6,109.0,8,1,32,CC1(C(=O)N(C(=S)N1C2=CC(=C(C=C2)C(=O)NC)F)C3=CC(=C(C=C3)C#N)C(F)(F)F)C,"CYP2C8,CYP3A4",
3793,Liew,Oxatomide,4615,positive,0,426.6,4.1,38.8,3,1,32,C1CN(CCN1CCCN2C3=CC=CC=C3NC2=O)C(C4=CC=CC=C4)C5=CC=CC=C5,,
638,DILIrank,nitroglycerin,4510,vNo-DILI-Concern,0,227.09,1.6,165.0,9,0,15,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-],	Liver,
4056,Liew,Trichlormethiazide,5560,negative,0,380.7,0.6,135.0,7,3,20,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)NC(N2)C(Cl)Cl,,
574,DILIrank,fludarabine,657237,vNo-DILI-Concern,0,285.23,-0.6,140.0,9,4,20,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,.,
3516,Liew,Fluorescein,16850,negative,0,332.3,3.4,76.0,5,2,25,C1=CC=C2C(=C1)C(=O)OC23C4=C(C=C(C=C4)O)OC5=C3C=CC(=C5)O,,
4101,Liew,Xanomeline,60809,positive,0,281.42,3.3,66.5,5,0,19,CCCCCCOC1=NSN=C1C2=CCCN(C2)C,,
3791,Liew,Oxandrolone,5878,positive,1,306.4,3.7,46.5,3,1,22,CC12CCC3C(C1CCC2(C)O)CCC4C3(COC(=O)C4)C,Kidney,
331,DILIrank,dichlorphenamide,3038,vNo-DILI-Concern,0,305.2,0.3,137.0,6,2,16,C1=C(C=C(C(=C1S(=O)(=O)N)Cl)Cl)S(=O)(=O)N,.,
3770,Liew,Nitrofurazone,5447130,negative,0,198.14,0.2,126.0,5,2,14,C1=C(OC(=C1)[N+](=O)[O-])C=NNC(=O)N,,
1384,LIverTox,Mebendazole,4030,D,1,295.29,2.8,84.1,4,2,22,COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=CC=C3,Extensive liver,
2175,Greene,Leflunomide,3899,HH,1,270.21,2.5,55.1,6,1,19,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F,GI mucosa and liver,
1376,LIverTox,Lurasidone,213046,E,0,492.7,5.4,85.0,6,0,35,C1CCC(C(C1)CN2CCN(CC2)C3=NSC4=CC=CC=C43)CN5C(=O)C6C7CCC(C7)C6C5=O,CYP3A4,
3047,Liew,Nisoldipine,4499,negative,0,388.4,3.3,110.0,7,1,28,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,CYP3A4,
1928,Greene,Azathioprine,2265,HH,1,277.27,0.1,143.0,7,1,19,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],"	Activated non-enzymatically, deactivated mainly by xanthine oxidase",
3673,Liew,Mephobarbital,8271,positive,0,246.26,1.8,66.5,3,1,18,CCC1(C(=O)NC(=O)N(C1=O)C)C2=CC=CC=C2,,
1146,LIverTox,Encorafenib,50922675,E*,0,540.0,2.7,149.0,10,3,36,CC(C)N1C=C(C(=N1)C2=C(C(=CC(=C2)Cl)NS(=O)(=O)C)F)C3=NC(=NC=C3)NCC(C)NC(=O)OC,.,
2685,Xu,Kanamycin Sulfate,6032,Negative,0,484.5,-6.9,283.0,15,11,33,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)O)O)OC3C(C(C(C(O3)CO)O)N)O)N,	Unknown,
3500,Liew,Flavoxate,3354,negative,0,391.5,4.3,55.8,5,0,29,CC1=C(OC2=C(C1=O)C=CC=C2C(=O)OCCN3CCCCC3)C4=CC=CC=C4,,
2236,Greene,N-acetyl cysteine,12035,NE,0,163.2,0.4,67.4,4,3,10,CC(=O)NC(CS)C(=O)O,Liver,
604,DILIrank,riboflavin,493570,vNo-DILI-Concern,0,376.4,-1.5,155.0,7,5,27,CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(CO)O)O)O,.,
3483,Liew,Etretinate,5282375,positive,0,354.5,6.8,35.5,3,0,26,CCOC(=O)C=C(C)C=CC=C(C)C=CC1=C(C(=C(C=C1C)OC)C)C,,
3569,Liew,Guanethidine,3518,negative,0,198.31,0.5,67.6,2,2,14,C1CCCN(CCC1)CCN=C(N)N,,
3767,Liew,Nitisinone,115355,negative,0,329.23,2.3,97.0,8,0,23,C1CC(=O)C(C(=O)C1)C(=O)C2=C(C=C(C=C2)C(F)(F)F)[N+](=O)[O-],,
990,LIverTox,Ceritinib,57379345,D,1,558.1,6.4,114.0,8,3,38,CC1=CC(=C(C=C1C2CCNCC2)OC(C)C)NC3=NC=C(C(=N3)NC4=CC=CC=C4S(=O)(=O)C(C)C)Cl,CYP3A,
1551,LIverTox,Pexidartinib,25151352,B,1,417.8,4.5,66.5,7,2,29,C1=CC(=NC=C1CC2=CNC3=C2C=C(C=N3)Cl)NCC4=CN=C(C=C4)C(F)(F)F,.,
34,DILIrank,carboplatin,498142,vLess-DILI-Concern,1,371.25,,76.6,6,4,13,C1CC(C1)(C(=O)O)C(=O)O.[NH2-].[NH2-].[Pt],.,
1657,LIverTox,Rivaroxaban,6433119,A,1,435.9,2.5,116.0,6,1,29,C1COCC(=O)N1C2=CC=C(C=C2)N3CC(OC3=O)CNC(=O)C4=CC=C(S4)Cl,"CYP3A4, CYP2J2",
208,DILIrank,gamma hydroxybutyric acid,3037032,vNo-DILI-Concern,0,103.1,0.0,60.4,3,1,7,C(CC(=O)[O-])CO,"	95%, mainly liver, also in blood and tissues",
446,DILIrank,bendazac,2313,vMost-DILI-Concern,1,282.29,3.1,64.4,4,1,21,C1=CC=C(C=C1)CN2C3=CC=CC=C3C(=N2)OCC(=O)O,.,
3590,Liew,Iloprost,5311181,positive,0,360.5,2.8,77.8,4,3,26,CC#CCC(C)C(C=CC1C(CC2C1CC(=CCCCC(=O)O)C2)O)O,,
3918,Liew,Rapacuronium,5311398,negative,0,677.8,,55.8,6,0,44,CCC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)OC(=O)C)N5CCCCC5)C)C)[N+]6(CCCCC6)CC=C.[Br-],,
169,DILIrank,verapamil,2520,vLess-DILI-Concern,1,454.6,3.8,64.0,6,0,33,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,liver,
3784,Liew,Ondansetron,4595,positive,1,293.4,2.3,39.8,2,0,22,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,"CYP3A4, CYP1A2, CYP2D6",
3468,Liew,Eszopiclone,969472,negative,0,388.8,0.5,91.8,7,0,27,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,,
3169,Liew,Amdinocillin,36273,positive,0,325.4,2.1,98.5,5,1,22,CC1(C(N2C(S1)C(C2=O)N=CN3CCCCCC3)C(=O)O)C,,
3597,Liew,Iproniazid,3748,positive,1,179.22,0.4,54.0,3,2,13,CC(C)NNC(=O)C1=CC=NC=C1,,
3893,Liew,Propofol,4943,positive,1,178.27,3.8,20.2,1,1,13,CC(C)C1=C(C(=CC=C1)C(C)C)O,Liver,
3265,Liew,Carbimazole,31072,positive,1,186.23,0.7,64.9,3,0,12,CCOC(=O)N1C=CN(C1=S)C,,
2172,Greene,Lactose,6134,NE,0,342.3,-4.7,190.0,11,8,23,C(C1C(C(C(C(O1)OC2C(OC(C(C2O)O)O)CO)O)O)O)O,.,
3617,Liew,Ketorolac,3826,positive,1,255.27,1.9,59.3,3,1,19,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,,
1577,LIverTox,Pomalidomide,134780,D,1,273.24,0.2,110.0,5,2,20,C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)N,Liver mostly CYP1A2- and CYP3A4-mediated; some minor contributions by CYP2C19 and CYP2D6,
258,DILIrank,sulfathiazole,5340,vMost-DILI-Concern,1,255.3,0.1,122.0,6,2,16,C1=CC(=CC=C1N)S(=O)(=O)NC2=NC=CS2,.,
2436,Greene,tamoxifen,2733526,HH,1,371.5,7.1,12.5,2,0,28,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3,"CYP3A4, CYP2C9, CYP2D6",
2517,Xu,Amsacrine HCl,2179,Positive,1,393.5,4.0,88.7,6,2,28,COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=CC3=NC4=CC=CC=C42,,
3190,Liew,Anagrelide,135409400,negative,1,256.08,1.6,44.7,2,1,16,C1C2=C(C=CC(=C2Cl)Cl)N=C3N1CC(=O)N3,,
3612,Liew,Josamycin,5282165,positive,0,828.0,2.9,206.0,16,3,58,CC1CC=CC=CC(C(CC(C(C(C(CC(=O)O1)OC(=O)C)OC)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)OC(=O)CC(C)C)(C)O)N(C)C)O)CC=O)C)O,,
2073,Greene,Doxorubicin HCl,443939,HH,1,580.0,,206.0,12,7,40,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O.Cl,Liver,
3558,Liew,Gliclazide,3475,positive,1,323.4,1.5,86.9,4,2,22,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2,,
3974,Liew,Sucralfate,6398525,positive,0,1571.9,,624.0,55,28,83,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al],"Liver, GI",
1923,Greene,Aurothioglucose,6104,HH,1,392.18,,91.2,6,4,13,C(C1C(C(C(C(O1)[S-])O)O)O)O.[Au+],.,
3959,Liew,Silver sulfadiazine,441244,negative,0,357.14,,95.3,6,1,18,C1=CN=C(N=C1)[N-]S(=O)(=O)C2=CC=C(C=C2)N.[Ag+],,
2755,Xu,Phenacetin,4754,Positive,1,179.22,1.6,38.3,2,1,13,CCOC1=CC=C(C=C1)NC(=O)C,,
829,LIverTox,Amlodipine,2162,C,1,408.9,3.0,99.9,7,2,28,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,Liver,
481,DILIrank,chlordiazepoxide,2712,vLess-DILI-Concern,1,299.75,2.4,48.2,3,1,21,CN=C1CN(C(=C2C=C(C=CC2=N1)Cl)C3=CC=CC=C3)O,Liver,
4086,Liew,Vancomycin,14969,negative,1,1449.2,-2.6,531.0,26,19,101,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,,
3681,Liew,Metergoline,28693,positive,0,403.5,3.8,46.5,3,1,30,CN1CC(CC2C1CC3=CN(C4=CC=CC2=C34)C)CNC(=O)OCC5=CC=CC=C5,,
2534,Xu,Betamethasone,9782,Negative,0,392.5,1.9,94.8,6,3,28,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,CYP3A4,
1319,LIverTox,Ivabradine,132999,E,0,468.6,2.4,60.5,6,0,34,CN(CCCN1CCC2=CC(=C(C=C2CC1=O)OC)OC)CC3CC4=CC(=C(C=C34)OC)OC,"Liver first-pass >50%, CYP3A4",
3894,Liew,Propoxyphene,10100,positive,1,339.5,4.2,29.5,3,0,25,CCC(=O)OC(CC1=CC=CC=C1)(C2=CC=CC=C2)C(C)CN(C)C,CYP3A4,
3400,Liew,Dienestrol,667476,negative,0,266.3,5.4,40.5,2,2,20,CC=C(C1=CC=C(C=C1)O)C(=CC)C2=CC=C(C=C2)O,,
3555,Liew,Gemfibrozil,3463,positive,1,250.33,3.8,46.5,3,1,18,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,,
3379,Liew,Desipramine,2995,positive,1,266.4,4.9,15.3,2,1,20,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,,
3496,Liew,Fentanyl,3345,negative,0,336.5,4.0,23.6,2,0,25,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,,
254,DILIrank,prednisolone,5755,vLess-DILI-Concern,1,360.4,1.6,94.8,5,3,26,CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,.,
107,DILIrank,prednisone,5865,vLess-DILI-Concern,1,358.4,1.5,91.7,5,2,26,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,prednisolone liver,
3141,Liew,Acetophenazine,17676,positive,0,411.6,2.6,72.3,6,1,29,CC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN4CCN(CC4)CCO,,
1553,LIverTox,Phencyclidine,6468,C[HD],1,243.4,3.6,3.2,1,0,18,C1CCC(CC1)(C2=CC=CC=C2)N3CCCCC3,"Oxidative hydroxylation in liver by CYP450 enzymes, glucuronidation",
3266,Liew,Carboprost,5281075,negative,0,368.5,2.9,98.0,5,4,26,CCCCCC(C)(C=CC1C(CC(C1CC=CCCCC(=O)O)O)O)O,,
482,DILIrank,atazanavir,148192,vLess-DILI-Concern,1,704.9,5.6,171.0,9,5,51,CC(C)(C)C(C(=O)NC(CC1=CC=CC=C1)C(CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)C(C(C)(C)C)NC(=O)OC)O)NC(=O)OC,CYP3A4,
1546,LIverTox,Perampanel,9924495,E,0,349.4,3.4,57.0,3,0,27,C1=CC=C(C=C1)N2C=C(C=C(C2=O)C3=CC=CC=C3C#N)C4=CC=CC=N4,"Liver, mostly via CYP3A4 and/or CYP3A5",
2684,Xu,Isoxsuprine HCl,3783,Negative,0,301.4,2.8,61.7,4,3,22,CC(COC1=CC=CC=C1)NC(C)C(C2=CC=C(C=C2)O)O,.,
2725,Xu,Monocrotaline,9415,Positive,1,325.36,-0.7,96.3,7,2,23,CC1C(=O)OC2CCN3C2C(=CC3)COC(=O)C(C1(C)O)(C)O,.,
394,DILIrank,remifentanil,60815,vLess-DILI-Concern,1,376.4,1.9,76.2,6,0,27,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC,	cleaved by non-specific plasma and tissue esterases,
3361,Liew,Cytarabine,6253,positive,1,243.22,-2.1,129.0,5,4,17,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,,
724,DILIrank,ximelagatran,9574101,vMost-DILI-Concern,1,473.6,2.2,146.0,7,4,34,CCOC(=O)CNC(C1CCCCC1)C(=O)N2CCC2C(=O)NCC3=CC=C(C=C3)C(=NO)N,	to melagatran,
3868,Liew,Pranlukast,4887,positive,0,481.5,4.2,119.0,7,2,36,C1=CC=C(C=C1)CCCCOC2=CC=C(C=C2)C(=O)NC3=CC=CC4=C3OC(=CC4=O)C5=NNN=N5,CYP3A4,
3558,Liew,Gliclazide,3475,positive,1,323.4,1.5,86.9,4,2,22,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2,,
738,DILIrank,l-arginine,6322,vNo-DILI-Concern,0,174.2,-4.2,128.0,4,4,12,C(CC(C(=O)O)N)CN=C(N)N,.,
3704,Liew,Methyltestosterone,6010,positive,1,302.5,3.4,37.3,2,1,22,CC12CCC(=O)C=C1CCC3C2CCC4(C3CCC4(C)O)C,,
3222,Liew,Bendroflumethiazide,2315,positive,1,421.4,1.2,135.0,10,3,27,C1=CC=C(C=C1)CC2NC3=C(C=C(C(=C3)C(F)(F)F)S(=O)(=O)N)S(=O)(=O)N2,,
1446,LIverTox,Nabilone,5284592,E,0,372.5,6.4,46.5,3,1,27,CCCCCCC(C)(C)C1=CC(=C2C3CC(=O)CCC3C(OC2=C1)(C)C)O,.,
1743,LIverTox,Tedizolid,11234049,E*,0,370.3,1.4,106.0,8,1,27,CN1N=C(N=N1)C2=NC=C(C=C2)C3=C(C=C(C=C3)N4CC(OC4=O)CO)F,.,
2473,Greene,Troleandomycin,5284630,HH,1,814.0,4.3,184.0,16,0,57,CC1CC(C(C(O1)OC2C(CC3(CO3)C(=O)C(C(C(C(OC(=O)C(C(C2C)OC4CC(C(C(O4)C)OC(=O)C)OC)C)C)C)OC(=O)C)C)C)OC(=O)C)N(C)C,.,
2530,Xu,Benazepril,5362124,Negative,1,424.5,1.3,95.9,6,2,31,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O,Liver glucuronidation,
358,DILIrank,nitroprusside,11953895,vNo-DILI-Concern,0,297.95,,139.0,14,2,17,[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[N-]=O.O.O.[Na+].[Na+].[Fe+4],,complex
3180,Liew,Amitriptyline ,2160,positive,1,277.4,5.0,3.2,1,0,21,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,,
4047,Liew,Toremifene,3005573,positive,1,406.0,7.2,12.5,2,0,29,CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3,CYP3A4,
1700,LIverTox,Simvastatin,54454,A,1,418.6,4.7,72.8,5,1,30,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,.,
2685,Xu,Kanamycin Sulfate,6032,Negative,0,484.5,-6.9,283.0,15,11,33,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)O)O)OC3C(C(C(C(O3)CO)O)N)O)N,	Unknown,
944,LIverTox,Brexpiprazole,11978813,E,0,433.6,4.7,73.0,5,1,31,C1CN(CCN1CCCCOC2=CC3=C(C=C2)C=CC(=O)N3)C4=C5C=CSC5=CC=C4,Liver mainly mediated by CYP3A4 and CYP2D6,
1912,Greene,Amrinone,3698,HH,1,187.2,-0.2,68.0,3,2,14,C1=CN=CC=C1C2=CNC(=O)C(=C2)N,Liver,
62,DILIrank,mefenamic acid,4044,vMost-DILI-Concern,1,241.28,5.1,49.3,3,2,18,CC1=C(C(=CC=C1)NC2=CC=CC=C2C(=O)O)C,CYP2C9,
1580,LIverTox,Pralatrexate,148121,E*,0,477.5,-0.9,207.0,11,5,35,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,.,
3600,Liew,Isepamicin,3037209,positive,0,569.6,-6.9,298.0,16,12,39,CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(C(C(C(O3)CN)O)O)O)N)NC(=O)C(CN)O)O,,
1527,LIverTox,Pasireotide,9941444,E*,0,1047.2,4.7,281.0,11,9,77,C1C(CN2C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C2=O)CC3=CC=CC=C3)CC4=CC=C(C=C4)OCC5=CC=CC=C5)CCCCN)CC6=CNC7=CC=CC=C76)C8=CC=CC=C8)OC(=O)NCCN,.,
296,DILIrank,pipamazine,6761,vMost-DILI-Concern,1,402.0,4.4,74.9,4,1,27,C1CN(CCC1C(=O)N)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,.,
1475,LIverTox,Niraparib,24958200,E*,0,320.4,2.2,72.9,3,2,24,C1CC(CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N,Carboxylesterases,
1782,LIverTox,Tizanidine,5487,C,1,253.71,1.1,90.4,4,2,16,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl,"Liver CYP1A2, 95%",
3796,Liew,Oxiconazole,5361463,negative,0,429.1,6.1,39.4,3,0,26,C1=CC(=C(C=C1Cl)Cl)CON=C(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,,
1786,LIverTox,Tolcapone,4659569,C,1,273.24,3.3,103.0,5,2,20,CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-],Liver mainly glucuronidation,
2638,Xu,Eserine,5983,Negative,0,275.35,0.7,44.8,4,1,20,CC12CCN(C1N(C3=C2C=C(C=C3)OC(=O)NC)C)C,	Major metabolite: Eseroline,
1176,LIverTox,Etodolac,3308,C,1,287.35,2.8,62.3,3,2,21,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,liver,
3150,Liew,Alclometasone,5311000,negative,0,408.9,2.2,94.8,5,3,28,CC1CC2C3C(CC4=CC(=O)C=CC4(C3C(CC2(C1(C(=O)CO)O)C)O)C)Cl,,
3885,Liew,Progabide,5361323,positive,0,334.8,3.1,72.2,4,2,23,C1=CC(=CC=C1C(=C2C=C(C=CC2=O)F)NCCCC(=O)N)Cl,Liver,
1050,LIverTox,Cyproheptadine,2913,C,1,287.4,4.7,3.2,1,0,22,CN1CCC(=C2C3=CC=CC=C3C=CC4=CC=CC=C42)CC1,CYP3A4,
3199,Liew,Arbutamine,60789,negative,0,317.4,0.9,93.0,5,5,23,C1=CC(=CC=C1CCCCNCC(C2=CC(=C(C=C2)O)O)O)O,,
3539,Liew,Fotemustine,104799,positive,0,315.69,0.9,97.3,6,1,19,CCOP(=O)(C(C)NC(=O)N(CCCl)N=O)OCC,,
640,DILIrank,norfloxacin,4539,vLess-DILI-Concern,1,319.33,-1.0,72.9,7,2,23,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,Liver,
394,DILIrank,remifentanil,60815,vLess-DILI-Concern,1,376.4,1.9,76.2,6,0,27,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC,	cleaved by non-specific plasma and tissue esterases,
3175,Liew,Aminohippuric acid,2148,negative,0,194.19,-0.9,92.4,4,3,14,C1=CC(=CC=C1C(=O)NCC(=O)O)N,,
453,DILIrank,atomoxetine,54841,vMost-DILI-Concern,1,255.35,3.7,21.3,2,1,19,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2,CYP2D6,
750,DILIrank,mepazine,6075,vMost-DILI-Concern,1,310.5,5.6,31.8,3,0,22,CN1CCCC(C1)CN2C3=CC=CC=C3SC4=CC=CC=C42,.,
3815,Liew,Pefloxacin,51081,positive,0,333.36,0.3,64.1,7,1,24,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCN(CC3)C)F)C(=O)O,Liver,
1435,LIverTox,Molindone,23897,D,1,276.37,1.7,45.3,3,1,20,CCC1=C(NC2=C1C(=O)C(CC2)CN3CCOCC3)C,Liver,
3660,Liew,Mazindol,4020,negative,0,284.74,2.2,35.8,2,1,20,C1CN2C(=N1)C3=CC=CC=C3C2(C4=CC=C(C=C4)Cl)O,,
3562,Liew,Gonadorelin,638793,negative,0,1182.3,-2.4,475.0,15,16,85,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)CNC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6,,
3575,Liew,Halofantrine,37393,positive,0,500.4,8.6,23.5,5,1,33,CCCCN(CCCC)CCC(C1=C2C=CC(=CC2=C3C=C(C=C(C3=C1)Cl)Cl)C(F)(F)F)O,,
345,DILIrank,metyrapone,4174,vNo-DILI-Concern,0,226.27,2.0,42.8,3,0,17,CC(C)(C1=CN=CC=C1)C(=O)C2=CN=CC=C2,.,
63,DILIrank,meloxicam,54677470,vLess-DILI-Concern,1,351.4,3.0,136.0,7,2,23,CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O,"CYP2C9,3A4",
259,DILIrank,terbinafine,1549008,vMost-DILI-Concern,1,291.4,5.6,3.2,1,0,22,CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21,liver,
3181,Liew,Amlexanox,2161,negative,0,298.29,3.1,103.0,6,2,22,CC(C)C1=CC2=C(C=C1)OC3=NC(=C(C=C3C2=O)C(=O)O)N,,
3545,Liew,Gabexate,3447,positive,0,321.37,1.4,117.0,5,2,23,CCOC(=O)C1=CC=C(C=C1)OC(=O)CCCCCN=C(N)N,,
3904,Liew,Quazepam,4999,negative,0,386.8,4.0,47.7,6,0,25,C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F,Liver,
1413,LIverTox,Metronidazole,4173,C,1,171.15,0.0,83.9,4,1,12,CC1=NC=C(N1CCO)[N+](=O)[O-],Liver,
1428,LIverTox,Mirtazapine,4205,C,1,265.35,3.3,19.4,3,0,20,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,"CYP1A2, CYP2D6, CYP3A4",
1152,LIverTox,Enzalutamide,15951529,E,0,464.4,3.6,109.0,8,1,32,CC1(C(=O)N(C(=S)N1C2=CC(=C(C=C2)C(=O)NC)F)C3=CC(=C(C=C3)C#N)C(F)(F)F)C,"CYP2C8,CYP3A4",
746,DILIrank,glafenine,3474,vMost-DILI-Concern,1,372.8,3.5,91.7,6,3,26,C1=CC=C(C(=C1)C(=O)OCC(CO)O)NC2=C3C=CC(=CC3=NC=C2)Cl,.,
3022,Liew,Metolazone,4170,positive,1,365.8,4.1,101.0,5,2,24,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,,
2111,Greene,Flufenamic Acid (Flufenamate),3371,WE,1,281.23,5.2,49.3,6,2,20,C1=CC=C(C(=C1)C(=O)O)NC2=CC=CC(=C2)C(F)(F)F,"	Hydroxylation, glucuronidation",
415,DILIrank,acebutolol,1978,vLess-DILI-Concern,1,336.4,1.7,87.7,5,3,24,CCCC(=O)NC1=CC(=C(C=C1)OCC(CNC(C)C)O)C(=O)C,LIver,
3945,Liew,Roxatidine,91276,positive,0,306.4,1.5,61.8,4,2,22,C1CCN(CC1)CC2=CC(=CC=C2)OCCCNC(=O)CO,Liver,
435,DILIrank,levothyroxine,5819,vLess-DILI-Concern,1,776.87,2.4,92.8,5,3,24,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,"	Mainly in liver, kidneys, brain and muscles",
1569,LIverTox,Pirfenidone,40632,D,1,185.22,1.9,20.3,1,0,14,CC1=CN(C(=O)C=C1)C2=CC=CC=C2,"Liver 70?80% CYP1A2-mediated; minor contributions from CYP2C9, CYP2C19, CYP2D6 and CYP2E1",
1787,LIverTox,Tolmetin,5509,D,1,257.28,2.8,59.3,3,1,19,CC1=CC=C(C=C1)C(=O)C2=CC=C(N2C)CC(=O)O,.,
2172,Greene,Lactose,6134,NE,0,342.3,-4.7,190.0,11,8,23,C(C1C(C(C(C(O1)OC2C(OC(C(C2O)O)O)CO)O)O)O)O,.,
75,DILIrank,pseudoephedrine,7028,vNo-DILI-Concern,0,165.23,0.9,32.3,2,2,12,CC(C(C1=CC=CC=C1)O)NC,	10?30% liver,
1641,LIverTox,Revefenacin,11753673,E,0,597.7,4.1,108.0,6,2,44,CN(CCN1CCC(CC1)OC(=O)NC2=CC=CC=C2C3=CC=CC=C3)C(=O)C4=CC=C(C=C4)CN5CCC(CC5)C(=O)N,.,
2500,Xu,Acetylcholine Chloride,187,Negative,0,146.21,0.2,26.3,2,0,10,CC(=O)OCC[N+](C)(C)C,ACH,
3500,Liew,Flavoxate,3354,negative,0,391.5,4.3,55.8,5,0,29,CC1=C(OC2=C(C1=O)C=CC=C2C(=O)OCCN3CCCCC3)C4=CC=CC=C4,,
1243,LIverTox,Gilteritinib,49803313,E*,0,552.7,3.5,121.0,10,3,40,CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC(=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)OC)NC5CCOCC5,.,
945,LIverTox,Brigatinib,68165256,E*,0,584.1,4.6,85.9,9,2,40,CN1CCN(CC1)C2CCN(CC2)C3=CC(=C(C=C3)NC4=NC=C(C(=N4)NC5=CC=CC=C5P(=O)(C)C)Cl)OC,.,
897,LIverTox,Azilsartan,135415867,E*,1,456.4,4.4,115.0,7,2,34,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NOC(=O)N5)C(=O)O,CYP2C9,
195,DILIrank,sirolimus,5284616,vLess-DILI-Concern,1,914.2,6.0,195.0,13,3,65,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC,Liver,
3546,Liew,Gadodiamide,153921,negative,0,573.7,,188.0,11,2,30,CNC(=O)CN(CCN(CCN(CC(=O)NC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3],,
132,DILIrank,glipizide,3478,vLess-DILI-Concern,1,445.5,1.9,139.0,6,3,31,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,Liver hydroxylation,
3562,Liew,Gonadorelin,638793,negative,0,1182.3,-2.4,475.0,15,16,85,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)CNC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6,,
208,DILIrank,gamma hydroxybutyric acid,3037032,vNo-DILI-Concern,0,103.1,0.0,60.4,3,1,7,C(CC(=O)[O-])CO,"	95%, mainly liver, also in blood and tissues",
3812,Liew,Paromomycin,441375,negative,1,713.7,,430.0,23,15,47,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N.OS(=O)(=O)O,,
3721,Liew,Miglustat,51634,negative,0,219.28,-0.6,84.2,5,4,15,CCCCN1CC(C(C(C1CO)O)O)O,,
276,DILIrank,eltrombopag olamine,9846180,vMost-DILI-Concern,1,442.5,4.5,111.0,7,3,33,CC1=C(C=C(C=C1)N2C(=O)C(=C(N2)C)NN=C3C=CC=C(C3=O)C4=CC(=CC=C4)C(=O)O)C,	extensive liver through CYP1A2 and CYP2C8,
707,DILIrank,rosuvastatin,446157,vLess-DILI-Concern,1,481.5,1.6,149.0,10,3,33,CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,Liver: CYP2C9 major and CYP2C19-mediated; ~10% metabolized,
3221,Liew,Bendamustine,65628,negative,0,358.3,2.9,58.4,4,1,23,CN1C2=C(C=C(C=C2)N(CCCl)CCCl)N=C1CCCC(=O)O,,
1032,LIverTox,Cobimetinib,16222096,D,1,531.3,3.9,64.6,7,3,30,C1CCNC(C1)C2(CN(C2)C(=O)C3=C(C(=C(C=C3)F)F)NC4=C(C=C(C=C4)I)F)O,Intestinal and low Liver clearance mostly CYP3A4 oxidation and UGT2B7 glucuronidation,
4063,Liew,Trimeprazine,5574,positive,0,298.4,4.7,31.8,3,0,21,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)CN(C)C,Liver,
2648,Xu,Fenoprofen Sodium,3342,Positive,1,242.27,3.3,46.5,3,1,18,CC(C1=CC(=CC=C1)OC2=CC=CC=C2)C(=O)O,,
250,DILIrank,neomycin,8378,vNo-DILI-Concern,0,614.6,-9.0,353.0,19,13,42,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N,,
4061,Liew,Trihexyphenidyl,5572,negative,0,301.5,4.5,23.5,2,1,22,C1CCC(CC1)C(CCN2CCCCC2)(C3=CC=CC=C3)O,,
3280,Liew,Cefmenoxime,9570757,positive,0,511.6,0.0,270.0,14,3,33,CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O,,
1983,Greene,Ceftazidime,5481173,WE,1,546.6,0.4,245.0,12,3,37,CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],	negligible,
1189,LIverTox,Felbamate,3331,B,1,238.24,0.6,105.0,4,2,17,C1=CC=C(C=C1)C(COC(=O)N)COC(=O)N,Liver,
3204,Liew,Atenolol,2249,negative,1,266.34,0.2,84.6,4,3,19,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,,
3756,Liew,Netilmicin,41859,positive,0,475.6,-4.2,200.0,12,8,33,CCNC1CC(C(C(C1OC2C(C(C(CO2)(C)O)NC)O)O)OC3C(CC=C(O3)CN)N)N,,
3325,Liew,Cinoxacin,2762,positive,0,262.22,2.1,88.4,7,1,19,CCN1C2=CC3=C(C=C2C(=O)C(=N1)C(=O)O)OCO3,,
3917,Liew,Ranolazine,56959,negative,1,427.5,2.7,74.3,6,2,31,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O,"CYP3A, CYP2D6",
137,DILIrank,atorvastatin,60823,vMost-DILI-Concern,1,558.6,5.0,112.0,6,4,41,CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,CYP3A4,
383,DILIrank,enoxaparin,772,vLess-DILI-Concern,1,1134.9,-10.8,652.0,38,15,70,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,.,
2731,Xu,Nefazodone,4449,Positive,1,470.0,4.3,51.6,5,0,33,CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl,"CYP3A4, CYP2D6",
77,DILIrank,rifabutin,6323490,vLess-DILI-Concern,1,847.0,6.3,206.0,14,5,61,CC1C=CC=C(C(=O)NC2=C3C(=NC4(N3)CCN(CC4)CC(C)C)C5=C(C2=O)C(=C(C6=C5C(=O)C(O6)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)C,liver,
3875,Liew,Prilocaine,4906,negative,0,220.31,2.1,41.1,2,2,16,CCCNC(C)C(=O)NC1=CC=CC=C1C,"Liver, Kidney",
1944,Greene,Bezafibrate,39042,NE,0,361.8,3.8,75.6,4,2,25,CC(C)(C(=O)O)OC1=CC=C(C=C1)CCNC(=O)C2=CC=C(C=C2)Cl,.,
426,DILIrank,oxcarbazepine,34312,vLess-DILI-Concern,1,252.27,1.7,63.4,2,1,19,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N,Liver cytosolic enzymes and glucuronic acid,
3243,Liew,Bortezomib,387447,positive,1,384.2,,124.0,6,4,28,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,,
3715,Liew,Mibefradil,60662,negative,0,568.5,,67.4,6,3,38,CC(C)C1C2=C(CCC1(CCN(C)CCCC3=NC4=CC=CC=C4N3)OC(=O)COC)C=C(C=C2)F.Cl.Cl,,
2762,Xu,phenytoin,1775,Positive,1,252.27,2.5,58.2,2,2,19,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,Liver,
1969,Greene,carbamazepine,2554,HH,1,236.27,2.5,46.3,1,1,18,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,CYP3A4,
145,DILIrank,quetiapine,5002,vLess-DILI-Concern,1,383.5,2.1,73.6,5,1,27,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,Liver via CYP3A4-catalysed sulfoxidation to its active metabolite norquetiapine N-desalkylquetiapine,
3609,Liew,Itraconazole,55283,positive,1,705.6,5.7,101.0,9,0,49,CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,,
3838,Liew,Phenindione,4760,positive,1,222.24,2.9,34.1,2,0,17,C1=CC=C(C=C1)C2C(=O)C3=CC=CC=C3C2=O,,
1078,LIverTox,Delafloxacin,487101,E*,0,440.8,2.7,120.0,11,3,30,C1C(CN1C2=C(C=C3C(=C2Cl)N(C=C(C3=O)C(=O)O)C4=C(C=C(C(=N4)N)F)F)F)O,.,
1973,Greene,carbon tetrachloride (2),5943,HH,1,153.8,2.8,0.0,0,0,5,C(Cl)(Cl)(Cl)Cl,.,
1450,LIverTox,Naldemedine,54732242,E,0,570.6,3.2,141.0,9,4,42,CC(C)(C1=NC(=NO1)C2=CC=CC=C2)NC(=O)C3=C(C4C56CCN(C(C5(C3)O)CC7=C6C(=C(C=C7)O)O4)CC8CC8)O,primarily CYP3A4,
3511,Liew,Flumethasone,16490,negative,0,410.5,1.9,94.8,7,3,29,CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C)F,,
2014,Greene,Clindamycin HCl,446598,HH,1,425.0,2.2,128.0,7,4,27,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl,Liver,
633,DILIrank,nalbuphine,5311304,vNo-DILI-Concern,0,357.4,0.2,73.2,5,3,26,C1CC(C1)CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O,	Liver glucuronidation,
833,LIverTox,Amoxicillin-Clavulanate,6435924,A,1,564.6,,245.0,12,6,39,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C.C1C2N(C1=O)C(C(=CCO)O2)C(=O)O,.,
3181,Liew,Amlexanox,2161,negative,0,298.29,3.1,103.0,6,2,22,CC(C)C1=CC2=C(C=C1)OC3=NC(=C(C=C3C2=O)C(=O)O)N,,
3374,Liew,Delapril,5362116,positive,0,452.5,1.7,95.9,6,2,33,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N(CC(=O)O)C2CC3=CC=CC=C3C2,,
681,DILIrank,sulcotidil,5354,vMost-DILI-Concern,1,337.6,5.8,57.6,3,2,23,CCCCCCCCNC(C)C(C1=CC=C(C=C1)SC(C)C)O,.,
3707,Liew,Metoclopramide,4168,negative,1,299.79,2.6,67.6,4,2,20,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,,
6,DILIrank,cyclophosphamide,2907,vLess-DILI-Concern,1,261.08,0.6,41.6,4,1,14,C1CNP(=O)(OC1)N(CCCl)CCCl,Liver,
500,DILIrank,cloxacillin,6098,vLess-DILI-Concern,1,435.9,2.4,138.0,7,2,29,CC1=C(C(=NO1)C2=CC=CC=C2Cl)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O,.,
1652,LIverTox,Rimantadine,5071,E,0,179.3,2.6,26.0,1,1,13,CC(C12CC3CC(C1)CC(C3)C2)N,Liver hydroxylation and glucuronidation,
3006,Liew,Lomefloxacin,3948,negative,1,351.35,-0.8,72.9,8,2,25,CCN1C=C(C(=O)C2=CC(=C(C(=C21)F)N3CCNC(C3)C)F)C(=O)O,,
2009,Greene,Citicoline,11583971,NE,0,488.32,-4.0,214.0,11,4,31,C[N+](C)(C)CCOP(=O)(O)OP(=O)([O-])OCC1C(C(C(O1)N2C=CC(=NC2=O)N)O)O,.,
1573,LIverTox,Plazomicin,42613186,E,0,592.7,-6.2,269.0,15,11,41,CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CC=C(O3)CNCCO)N)N)NC(=O)C(CCN)O)O,.,
941,LIverTox,Bosutinib,5328940,D,1,530.4,5.4,82.9,8,1,36,CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC,"By CYP3A4, to inactive metabolites",
2545,Xu,Calcium Pantothenate,988,Negative,0,219.23,-1.1,107.0,5,4,15,CC(C)(CO)C(C(=O)NCCC(=O)O)O,.,
3429,Liew,Doxacurium,60169,negative,0,1035.2,7.4,163.0,16,0,74,C[N+]1(CCC2=CC(=C(C(=C2C1CC3=CC(=C(C(=C3)OC)OC)OC)OC)OC)OC)CCCOC(=O)CCC(=O)OCCC[N+]4(CCC5=CC(=C(C(=C5C4CC6=CC(=C(C(=C6)OC)OC)OC)OC)OC)OC)C,,
3875,Liew,Prilocaine,4906,negative,0,220.31,2.1,41.1,2,2,16,CCCNC(C)C(=O)NC1=CC=CC=C1C,"Liver, Kidney",
3243,Liew,Bortezomib,387447,positive,1,384.2,,124.0,6,4,28,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,,
1034,LIverTox,Codeine,5284371,E,0,299.4,1.1,41.9,4,1,22,CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O,"Liver: CYP2D6 to morphine, CYP3A4 to norcodeine, UGT2B7 to 3- and 6-glucuronides of codeine, norcodeine, and morphine",
142,DILIrank,rabeprazole,5029,vLess-DILI-Concern,1,359.4,1.9,96.3,6,1,25,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCCCOC,"CYP2C19,CYP3A4",
1146,LIverTox,Encorafenib,50922675,E*,0,540.0,2.7,149.0,10,3,36,CC(C)N1C=C(C(=N1)C2=C(C(=CC(=C2)Cl)NS(=O)(=O)C)F)C3=NC(=NC=C3)NCC(C)NC(=O)OC,.,
3453,Liew,Epalrestat,1549120,positive,1,319.4,3.8,115.0,5,1,21,CC(=CC1=CC=CC=C1)C=C2C(=O)N(C(=S)S2)CC(=O)O,,
1375,LIverTox,Lubiprostone,157920,E,0,390.5,4.0,83.8,7,2,27,CCCCC(C1(CCC2C(O1)CC(=O)C2CCCCCCC(=O)O)O)(F)F,"Extensive, CYP not involved",
1374,LIverTox,Loxapine,3964,D,1,327.8,3.1,28.1,3,0,23,CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl,"Extensive Liver; active metabolites include amoxapine and 8-hydroxyloxapine. Inhibits P-gp and is a substrate of CYP1A2, CYP3A4 and CYP2D6",
3396,Liew,Dibucaine,3025,negative,0,343.5,4.4,54.5,4,1,25,CCCCOC1=NC2=CC=CC=C2C(=C1)C(=O)NCCN(CC)CC,,
3533,Liew,Fosaprepitant,219090,positive,0,614.4,1.0,124.0,14,3,41,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)N(N3)P(=O)(O)O)C4=CC=C(C=C4)F,,
3472,Liew,Ethchlorvynol,5281077,positive,0,144.6,1.5,20.2,1,1,9,CCC(C=CCl)(C#C)O,,
3306,Liew,Chlormezanone,2717,positive,1,273.74,1.1,62.8,3,0,17,CN1C(S(=O)(=O)CCC1=O)C2=CC=C(C=C2)Cl,,
4064,Liew,Trimethaphan,23576,negative,0,365.5,3.6,24.6,1,0,26,C1CC2C3C(C[S+]2C1)N(C(=O)N3CC4=CC=CC=C4)CC5=CC=CC=C5,,
3563,Liew,Goserelin,5311128,negative,1,1269.4,-1.5,496.0,16,17,91,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6,,
2365,Greene,phenothiazine,7108,HH,1,199.27,4.2,37.3,2,1,14,C1=CC=C2C(=C1)NC3=CC=CC=C3S2,.,
2498,Xu,Acetazolamide,1986,Positive,1,222.3,-0.3,152.0,7,2,13,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,	None,
1225,LIverTox,Fostamatinib,11671467,E*,0,580.5,1.6,187.0,15,4,40,CC1(C(=O)N(C2=C(O1)C=CC(=N2)NC3=NC(=NC=C3F)NC4=CC(=C(C(=C4)OC)OC)OC)COP(=O)(O)O)C,"Gut ALP to tamatinib Liver tamatinib metabolite by CYP3A4, UGT1A9",
407,DILIrank,candesartan,2541,vLess-DILI-Concern,1,440.5,4.1,119.0,7,2,33,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,Candesartan cilexetil: intestinal wall; candesartan: Hepatic CYP2C9,
250,DILIrank,neomycin,8378,vNo-DILI-Concern,0,614.6,-9.0,353.0,19,13,42,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N,,
1009,LIverTox,Cholic Acid,221493,D[HD],1,408.6,3.6,98.0,5,4,29,CC(CCC(=O)O)C1CCC2C1(C(CC3C2C(CC4C3(CCC(C4)O)C)O)O)C,.,
3201,Liew,Aripiprazole,60795,negative,1,448.4,4.6,44.8,4,1,30,C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl,Liver mostly via CYP3A4 and 2D6,
3101,Liew,Teriparatide,16132393,negative,0,4118.0,-18.7,1800.0,62,60,289,CCC(C)C(C(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(CCSC)C(=O)NC(CC1=CN=CN1)C(=O)NC(CC(=O)N)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CC2=CN=CN2)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)N)C(=O)NC(CO)C(=O)NC(CCSC)C(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(C(C)C)C(=O)NC(CC5=CN=CN5)C(=O)NC(CC(=O)N)C(=O)NC(CC6=CC=CC=C6)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CO)N,,
3262,Liew,Captopril,44093,positive,1,217.29,0.3,58.6,4,2,14,CC(CS)C(=O)N1CCCC1C(=O)O,,
3411,Liew,Diltiazem,39186,positive,1,414.5,3.1,84.4,6,0,29,CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC,,
1033,LIverTox,Cocaine,446220,A[HD],1,303.35,2.3,55.8,5,0,22,CN1C2CCC1C(C(C2)OC(=O)C3=CC=CC=C3)C(=O)OC,CYP3A4,
3803,Liew,Oxyphencyclimine,4642,negative,0,344.4,2.9,62.1,4,1,25,CN1CCCN=C1COC(=O)C(C2CCCCC2)(C3=CC=CC=C3)O,,
415,DILIrank,acebutolol,1978,vLess-DILI-Concern,1,336.4,1.7,87.7,5,3,24,CCCC(=O)NC1=CC(=C(C=C1)OCC(CNC(C)C)O)C(=O)C,LIver,
409,DILIrank,rizatriptan,5078,vNo-DILI-Concern,0,269.34,1.7,49.7,3,1,20,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3,	By monoamine oxidase,
464,DILIrank,cefaclor,51038,vLess-DILI-Concern,1,385.8,,139.0,7,4,25,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl.O,15% to 40%,
1198,LIverTox,Fidaxomicin,10034073,E,0,1058.0,6.4,267.0,18,7,72,CCC1C=C(C(CC=CC=C(C(=O)OC(CC=C(C=C(C1OC2C(C(C(C(O2)(C)C)OC(=O)C(C)C)O)O)C)C)C(C)O)COC3C(C(C(C(O3)C)OC(=O)C4=C(C(=C(C(=C4O)Cl)O)Cl)CC)O)OC)O)C,.,
3892,Liew,Propiomazine,4940,negative,0,340.5,4.8,48.8,4,0,24,CCC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CC(C)N(C)C,,
3535,Liew,Fosfomycin,446987,positive,1,138.06,-1.4,70.1,4,2,8,CC1C(O1)P(=O)(O)O,,
1602,LIverTox,Propylthiouracil,657298,A,1,170.23,0.8,73.2,2,2,11,CCCC1=CC(=O)NC(=S)N1,.,
1399,LIverTox,Meropenem,441130,D,1,383.5,-2.4,136.0,7,3,26,CC1C2C(C(=O)N2C(=C1SC3CC(NC3)C(=O)N(C)C)C(=O)O)C(C)O,.,
3601,Liew,Isocarboxazid,3759,positive,0,231.25,1.5,67.2,4,2,17,CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2,,
3936,Liew,Rivastigmine,77991,negative,1,250.34,2.3,32.8,3,0,18,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C,Liver,
60,DILIrank,labetalol,3869,vMost-DILI-Concern,1,328.4,3.1,95.6,4,4,24,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O,"Liver pass metabolism,",
2833,Xu,Warfarin,54678486,Negative,1,308.3,2.7,63.6,4,1,23,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O,"Liver: CYP2C9, 2C19, 2C8, 2C18, 1A2,3A4",
2416,Greene,Rosiglitazone,77999,WE,1,357.4,3.1,96.8,6,1,25,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,CYP2C8,
3938,Liew,Rocuronium,441351,negative,0,609.7,,59.0,6,1,39,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C.[Br-],,
157,DILIrank,gabapentin,3446,vLess-DILI-Concern,1,171.24,-1.1,63.3,3,2,12,C1CCC(CC1)(CC(=O)O)CN,Not significantly metabolized,
3870,Liew,Prazepam,4890,negative,0,324.8,3.6,32.7,2,0,23,C1CC1CN2C(=O)CN=C(C3=C2C=CC(=C3)Cl)C4=CC=CC=C4,Liver,
3145,Liew,Adapalene,60164,negative,0,412.5,7.7,46.5,3,1,31,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5,,
1347,LIverTox,Letermovir,45138674,E,0,572.5,4.6,77.8,10,1,41,COC1=C(C=C(C=C1)C(F)(F)F)N2C(C3=C(C(=CC=C3)F)N=C2N4CCN(CC4)C5=CC(=CC=C5)OC)CC(=O)O,glucuronidation UGT1A1/1A3 to a minor extent,
1083,LIverTox,Desflurane,42113,C,1,168.04,2.6,9.2,7,0,10,C(C(F)(F)F)(OC(F)F)F,Not metabolized,
630,DILIrank,moxisylyte,4260,vMost-DILI-Concern,1,279.37,3.2,38.8,4,0,20,CC1=CC(=C(C=C1OC(=O)C)C(C)C)OCCN(C)C,.,
492,DILIrank,ramelteon,208902,vNo-DILI-Concern,0,259.34,2.7,38.3,2,1,19,CCC(=O)NCCC1CCC2=C1C3=C(C=C2)OCC3,"Liver CYP1A2 major, CYP2C,CYP3A4 minor",
1786,LIverTox,Tolcapone,4659569,C,1,273.24,3.3,103.0,5,2,20,CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-],Liver mainly glucuronidation,
794,LIverTox,Aclidinium,11519741,E,0,564.6,,112.0,7,1,34,C1C[N+]2(CCC1C(C2)OC(=O)C(C3=CC=CS3)(C4=CC=CS4)O)CCCOC5=CC=CC=C5.[Br-],Ester hydrolysis,
3513,Liew,Flunisolide,82153,negative,0,434.5,2.5,93.1,7,2,31,CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C,,
3784,Liew,Ondansetron,4595,positive,1,293.4,2.3,39.8,2,0,22,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,"CYP3A4, CYP1A2, CYP2D6",
630,DILIrank,moxisylyte,4260,vMost-DILI-Concern,1,279.37,3.2,38.8,4,0,20,CC1=CC(=C(C=C1OC(=O)C)C(C)C)OCCN(C)C,.,
2816,Xu,Ticlopidine,5472,Positive,1,263.8,3.6,31.5,2,0,17,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl,Liver,
3841,Liew,Phenoxybenzamine,4768,negative,0,303.8,4.4,12.5,2,0,21,CC(COC1=CC=CC=C1)N(CCCl)CC2=CC=CC=C2,,
4094,Liew,Vigabatrin,5665,positive,1,129.16,-2.2,63.3,3,2,9,C=CC(CCC(=O)O)N,,
956,LIverTox,Butorphanol,5361092,ND,0,327.5,3.8,43.7,3,2,24,C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,hydroxylated & glucuronidated,
1803,LIverTox,Triamterene,5546,D,1,253.26,1.0,130.0,7,3,19,C1=CC=C(C=C1)C2=NC3=C(N=C(N=C3N=C2N)N)N,hydroxylation to para-hydroxytriamterene,
46,DILIrank,diflunisal,3059,vMost-DILI-Concern,1,250.2,4.4,57.5,5,2,18,C1=CC(=C(C=C1C2=C(C=C(C=C2)F)F)C(=O)O)O,Liver,
2760,Xu,Phenylbutazone,4781,Positive,1,308.4,3.2,40.6,2,0,23,CCCCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3,,
692,DILIrank,ebrotidine,65869,vMost-DILI-Concern,1,477.4,1.5,198.0,7,3,26,C1=CC(=CC=C1S(=O)(=O)NC=NCCSCC2=CSC(=N2)N=C(N)N)Br,.,
1451,LIverTox,Nalmefene,5284594,E,0,339.4,2.7,52.9,4,2,25,C=C1CCC2(C3CC4=C5C2(C1OC5=C(C=C4)O)CCN3CC6CC6)O,Liver,
3450,Liew,Enoxacin,3229,positive,0,320.32,-0.2,85.8,8,2,23,CCN1C=C(C(=O)C2=CC(=C(N=C21)N3CCNCC3)F)C(=O)O,,
1641,LIverTox,Revefenacin,11753673,E,0,597.7,4.1,108.0,6,2,44,CN(CCN1CCC(CC1)OC(=O)NC2=CC=CC=C2C3=CC=CC=C3)C(=O)C4=CC=C(C=C4)CN5CCC(CC5)C(=O)N,.,
3335,Liew,Clofarabine,119182,positive,1,303.68,0.9,119.0,8,3,20,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N,,
2740,Xu,Norethindrone,6230,Positive,1,298.4,3.0,37.3,2,1,22,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,"	Mainly CYP3A4 liver; also 5??-/5??-reductase, 3??-Tooltip 3??-hydroxysteroid dehydrogenase/3??-HSDTooltip 3??-hydroxysteroid dehydrogenase, and aromatase",
3262,Liew,Captopril,44093,positive,1,217.29,0.3,58.6,4,2,14,CC(CS)C(=O)N1CCCC1C(=O)O,,
353,DILIrank,pentagastrin,9853654,vNo-DILI-Concern,0,767.9,1.5,276.0,10,8,54,CC(C)(C)OC(=O)NCCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CCSC)C(=O)NC(CC(=O)O)C(=O)NC(CC3=CC=CC=C3)C(=O)N,.,
133,DILIrank,pemoline,4723,vMost-DILI-Concern,1,176.17,0.9,64.7,2,1,13,C1=CC=C(C=C1)C2C(=O)N=C(O2)N,	Liver,
1416,LIverTox,Midostaurin,9829523,E*,0,570.6,4.8,77.7,4,1,43,CC12C(C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)N(C)C(=O)C9=CC=CC=C9)OC,.,
102,DILIrank,venlafaxine,5656,vLess-DILI-Concern,1,277.4,2.9,32.7,3,1,20,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,"	Extensively metabolised by the liver, primarily via CYP2D6",
3476,Liew,Etidocaine,37497,negative,0,276.4,3.7,32.3,2,1,20,CCCN(CC)C(CC)C(=O)NC1=C(C=CC=C1C)C,,
3625,Liew,Latanoprost,5311221,negative,0,432.6,4.3,87.0,5,3,31,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O,,
3401,Liew,Diethylcarbamazine,3052,negative,1,199.29,0.3,26.8,2,0,14,CCN(CC)C(=O)N1CCN(CC1)C,,
1959,Greene,Butoconazole Nitrate,47472,NE,0,411.8,6.4,43.1,2,0,25,C1=CC(=C(C(=C1)Cl)SC(CCC2=CC=C(C=C2)Cl)CN3C=CN=C3)Cl,,
1826,LIverTox,Valsartan,60846,D,1,435.5,4.4,112.0,6,2,32,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O,.,
2117,Greene,Fluspirilene,3396,HH,1,475.6,5.6,35.6,5,1,35,C1CN(CCC12C(=O)NCN2C3=CC=CC=C3)CCCC(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F,,
567,DILIrank,fipexide,3351,vMost-DILI-Concern,1,388.8,3.2,51.2,5,0,27,C1CN(CCN1CC2=CC3=C(C=C2)OCO3)C(=O)COC4=CC=C(C=C4)Cl,.,
3555,Liew,Gemfibrozil,3463,positive,1,250.33,3.8,46.5,3,1,18,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,,
1797,LIverTox,Trametinib,11707110,E*,0,615.4,3.4,102.0,6,2,37,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5,.,
4087,Liew,Vardenafil,110634,positive,0,488.6,2.5,118.0,7,1,34,CCCC1=NC(=C2N1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC)C,CYP3A4,
3401,Liew,Diethylcarbamazine,3052,negative,1,199.29,0.3,26.8,2,0,14,CCN(CC)C(=O)N1CCN(CC1)C,,
3583,Liew,Hydroxyurea,3657,positive,1,76.055,-1.8,75.4,2,3,5,C(=O)(N)NO,,
3335,Liew,Clofarabine,119182,positive,1,303.68,0.9,119.0,8,3,20,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N,,
3281,Liew,Cefmetazole,42008,positive,0,471.5,-0.6,239.0,12,2,30,CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)(NC(=O)CSCC#N)OC)SC2)C(=O)O,,
806,LIverTox,Alfuzosin,2092,C,1,389.4,1.7,112.0,8,2,28,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,CYP3A4,
356,DILIrank,calcitonin salmon,16133812,vNo-DILI-Concern,0,3431.9,-16.6,1560.0,55,52,239,CC(C)CC1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)N1)CC(=O)N)CO)N)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC2=CNC=N2)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(C(C)O)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)N4CCCC4C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CO)C(=O)NCC(=O)NC(C(C)O)C(=O)N5CCCC5C(=O)N)C(C)O)CO,.,
588,DILIrank,gemcitabine,60750,vMost-DILI-Concern,1,263.2,-1.5,108.0,6,3,18,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,.,
1372,LIverTox,Lovastatin,53232,B,1,404.5,4.3,72.8,5,1,29,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,Liver CYP3A and CYP2C8 substrate,
3858,Liew,Piretanide,4849,positive,0,362.4,2.2,118.0,7,2,25,C1CCN(C1)C2=C(C(=CC(=C2)C(=O)O)S(=O)(=O)N)OC3=CC=CC=C3,,
258,DILIrank,sulfathiazole,5340,vMost-DILI-Concern,1,255.3,0.1,122.0,6,2,16,C1=CC(=CC=C1N)S(=O)(=O)NC2=NC=CS2,.,
4017,Liew,Tetrahydrozoline,5419,negative,0,200.28,1.8,24.4,1,1,15,C1CC(C2=CC=CC=C2C1)C3=NCCN3,,
3224,Liew,Benoxinate,4633,negative,0,308.4,3.1,64.8,5,1,22,CCCCOC1=C(C=CC(=C1)C(=O)OCCN(CC)CC)N,,
746,DILIrank,glafenine,3474,vMost-DILI-Concern,1,372.8,3.5,91.7,6,3,26,C1=CC=C(C(=C1)C(=O)OCC(CO)O)NC2=C3C=CC(=CC3=NC=C2)Cl,.,
1983,Greene,Ceftazidime,5481173,WE,1,546.6,0.4,245.0,12,3,37,CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],	negligible,
3037,Liew,Mycophenolic acid,446541,positive,1,320.3,3.2,93.1,6,2,23,CC1=C2COC(=O)C2=C(C(=C1OC)CC=C(C)CCC(=O)O)O,,
3828,Liew,Perazine,4744,positive,0,339.5,4.1,35.0,4,0,24,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=CC=CC=C42,,
3280,Liew,Cefmenoxime,9570757,positive,0,511.6,0.0,270.0,14,3,33,CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O,,
3734,Liew,Moxalactam,47499,positive,0,520.5,-0.6,232.0,13,4,36,CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)(NC(=O)C(C4=CC=C(C=C4)O)C(=O)O)OC)OC2)C(=O)O,,
3990,Liew,Talinolol,68770,positive,0,363.5,2.6,82.6,4,4,26,CC(C)(C)NCC(COC1=CC=C(C=C1)NC(=O)NC2CCCCC2)O,,
2665,Xu,Gallamine Triethiodide,6172,Negative,0,891.5,,27.7,6,0,39,CC[N+](CC)(CC)CCOC1=C(C(=CC=C1)OCC[N+](CC)(CC)CC)OCC[N+](CC)(CC)CC.[I-].[I-].[I-],.,
3880,Liew,Procainamide,4913,positive,1,235.33,0.9,58.4,3,2,17,CCN(CC)CCNC(=O)C1=CC=C(C=C1)N,CYP2D6,
118,DILIrank,isoproterenol,3779,vNo-DILI-Concern,0,211.26,-0.6,72.7,4,4,15,CC(C)NCC(C1=CC(=C(C=C1)O)O)O,.,
1518,LIverTox,Oxycodone,5284603,E,0,315.4,1.2,59.0,5,1,23,CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O,"Liver: mainly CYP3A, and, to a much lesser extent, CYP2D6 ~5%; 95% metabolized i.e., 5% excreted unchanged",
4019,Liew,Theophylline,2153,negative,0,180.16,0.0,69.3,3,1,13,CN1C2=C(C(=O)N(C1=O)C)NC=N2,hepatic,
2679,Xu,Imipramine HCl,3696,Positive,1,280.4,4.8,6.5,2,0,21,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31,"CYP1A2, CYP2C19, CYP2D6",
2153,Greene,indacrinone,42266,HH,1,365.2,4.5,63.6,4,1,24,CC1(CC2=CC(=C(C(=C2C1=O)Cl)Cl)OCC(=O)O)C3=CC=CC=C3,.,
3283,Liew,Cefonicid,43594,positive,0,542.6,-1.9,264.0,13,4,35,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)O)C(=O)O)CSC4=NN=NN4CS(=O)(=O)O,,
1342,LIverTox,Lavender,702,E,0,46.07,-0.1,20.2,1,1,3,CCO,.,
3323,Liew,Cimetidine,2756,positive,1,252.34,0.4,114.0,4,3,17,CC1=C(N=CN1)CSCCNC(=NC)NC#N,,
500,DILIrank,cloxacillin,6098,vLess-DILI-Concern,1,435.9,2.4,138.0,7,2,29,CC1=C(C(=NO1)C2=CC=CC=C2Cl)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O,.,
3274,Liew,Cefaclor,51039,positive,1,367.8,-1.8,138.0,6,3,24,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,,
1416,LIverTox,Midostaurin,9829523,E*,0,570.6,4.8,77.7,4,1,43,CC12C(C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)N(C)C(=O)C9=CC=CC=C9)OC,.,
252,DILIrank,nystatin,14960,vNo-DILI-Concern,0,926.1,-0.2,320.0,18,12,65,CC1C=CC=CCCC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,None not extensively absorbed,
3278,Liew,Cefdinir,6915944,positive,1,395.4,0.0,212.0,10,4,26,C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O,,
2088,Greene,Estrone,5870,HH,1,270.4,3.1,37.3,2,1,20,CC12CCC3C(C1CCC2=O)CCC4=C3C=CC(=C4)O,.,
3521,Liew,Fluphenazine,3372,positive,1,437.5,4.4,55.2,8,1,30,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO,,
1138,LIverTox,Eluxadoline,11250029,C,1,569.6,0.9,165.0,7,4,42,CC1=CC(=CC(=C1CC(C(=O)N(CC2=CC(=C(C=C2)OC)C(=O)O)C(C)C3=NC=C(N3)C4=CC=CC=C4)N)C)C(=O)N,.,
1547,LIverTox,Pergolide,47811,E*,0,314.5,4.2,44.3,2,1,22,CCCN1CC(CC2C1CC3=CNC4=CC=CC2=C34)CSC,Extensively Liver,
1852,LIverTox,Vortioxetine,9966051,E*,0,298.4,4.2,40.6,3,1,21,CC1=CC(=C(C=C1)SC2=CC=CC=C2N3CCNCC3)C,"Liver, primarily CYP2D6-mediated oxidation",
3144,Liew,Acyclovir,2022,positive,1,225.2,-1.6,115.0,4,3,16,C1=NC2=C(N1COCCO)NC(=NC2=O)N,,
3529,Liew,Folic acid,6037,negative,0,441.4,-1.1,209.0,9,6,32,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N,,
3511,Liew,Flumethasone,16490,negative,0,410.5,1.9,94.8,7,3,29,CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C)F,,
3413,Liew,Dinoprost,5280363,negative,0,354.5,2.7,98.0,5,4,25,CCCCCC(C=CC1C(CC(C1CC=CCCCC(=O)O)O)O)O,,
2701,Xu,maleic acid,444266,Positive,1,116.07,-0.3,74.6,4,2,8,C(=CC(=O)O)C(=O)O,.,
1588,LIverTox,Pretomanid,456199,D,1,359.26,2.8,91.3,9,0,25,C1C(COC2=NC(=CN21)[N+](=O)[O-])OCC3=CC=C(C=C3)OC(F)(F)F,.,
1787,LIverTox,Tolmetin,5509,D,1,257.28,2.8,59.3,3,1,19,CC1=CC=C(C=C1)C(=O)C2=CC=C(N2C)CC(=O)O,.,
3480,Liew,Etonogestrel,21729469,positive,0,324.5,3.3,37.3,2,1,24,CCC12CC(=C)C3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,,
3325,Liew,Cinoxacin,2762,positive,0,262.22,2.1,88.4,7,1,19,CCN1C2=CC3=C(C=C2C(=O)C(=N1)C(=O)O)OCO3,,
1375,LIverTox,Lubiprostone,157920,E,0,390.5,4.0,83.8,7,2,27,CCCCC(C1(CCC2C(O1)CC(=O)C2CCCCCCC(=O)O)O)(F)F,"Extensive, CYP not involved",
1782,LIverTox,Tizanidine,5487,C,1,253.71,1.1,90.4,4,2,16,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl,"Liver CYP1A2, 95%",
3835,Liew,Phenacemide,4753,positive,0,178.19,0.9,72.2,2,2,13,C1=CC=C(C=C1)CC(=O)NC(=O)N,,
2500,Xu,Acetylcholine Chloride,187,Negative,0,146.21,0.2,26.3,2,0,10,CC(=O)OCC[N+](C)(C)C,ACH,
3893,Liew,Propofol,4943,positive,1,178.27,3.8,20.2,1,1,13,CC(C)C1=C(C(=CC=C1)C(C)C)O,Liver,
1352,LIverTox,Levodopa,6047,E,0,197.19,-2.7,104.0,5,4,14,C1=CC(=C(C=C1CC(C(=O)O)N)O)O,Aromatic-l-amino-acid decarboxylase,
1210,LIverTox,Fluorouracil,3385,A,1,130.08,-0.9,58.2,3,2,9,C1=C(C(=O)NC(=O)N1)F,Intracellular and liver CYP-mediated,
126,DILIrank,testosterone,6013,vMost-DILI-Concern,1,288.4,3.3,37.3,2,1,21,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C,	Liver mainly reduction and conjugation,
2675,Xu,Hydrocortisone,5754,Negative,0,362.5,1.6,94.8,5,3,26,CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,"	11??-HSDsTooltip 11??-Hydroxysteroid dehydrogenases, others",
764,DILIrank,tenofovir,5481350,vLess-DILI-Concern,1,519.4,1.6,185.0,14,1,35,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C,Ester hydrolysis,
2452,Greene,tianeptine,68870,HH,1,437.0,1.2,95.1,6,2,29,CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O,Liver by ??-oxidation,
598,DILIrank,hydroxyzine,3658,vNo-DILI-Concern,0,374.9,3.7,35.9,4,1,26,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Liver,
3152,Liew,Alendronate,2088,positive,1,249.1,-6.5,161.0,8,6,14,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,,
3333,Liew,Clobetasol,5311051,negative,0,410.9,2.5,74.6,5,2,28,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C,,
1736,LIverTox,Tafenoquine,115358,E,0,463.5,5.4,78.6,9,2,33,CC1=CC(=NC2=C1C(=C(C=C2NC(C)CCCN)OC)OC3=CC=CC(=C3)C(F)(F)F)OC,.,
3416,Liew,Diphenidol,9175,negative,0,280.4,4.0,0.0,0,0,22,C1C=C2C=C3C=CC=CC3=CC2=C4C1C=C5C=CC=CC5=C4,,
1559,LIverTox,Phenyltoloxamine,7077,E,0,255.35,3.9,12.5,2,0,19,CN(C)CCOC1=CC=CC=C1CC2=CC=CC=C2,.,
3406,Liew,Difluprednate,32037,negative,0,508.5,3.4,107.0,9,1,36,CCCC(=O)OC1(CCC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C(=O)COC(=O)C,,
2549,Xu,Carbidopa,34359,Negative,0,226.23,-2.2,116.0,6,5,16,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)NN,"	7 metabolites known, not metabolized extensively",
4047,Liew,Toremifene,3005573,positive,1,406.0,7.2,12.5,2,0,29,CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3,CYP3A4,
1248,LIverTox,Glatiramer Acetate,3081884,B,1,623.7,,374.0,18,12,43,CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N,.,
83,DILIrank,streptomycin,19649,vNo-DILI-Concern,0,581.6,-8.0,336.0,15,12,40,CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O,.,
265,DILIrank,clevidipine,153994,vNo-DILI-Concern,0,456.3,4.3,90.9,7,1,30,CCCC(=O)OCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,Blood and tissue esterases,
3955,Liew,Sertraline,68617,positive,1,306.2,4.8,12.0,1,1,20,CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,"CYP2B6(major), CYP2C19",
1405,LIverTox,Methocarbamol,4107,E,0,241.24,0.6,91.0,5,2,17,COC1=CC=CC=C1OCC(COC(=O)N)O,Liver,
285,DILIrank,ecallantide,118984459,vNo-DILI-Concern,0,7054.0,-27.9,3120.0,110,100,492,CCC(C)C1C(=O)NC(C(=O)NCC(=O)NCC(=O)NC2CSSCC3C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N4CCCC4C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)N5CCCC5C(=O)N3)CC(=O)O)CC(=O)O)C)CCCCN)CC6=CC=CC=C6)C)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CO)NC(=O)C(CC8=CN=CN8)NC(=O)C(CCSC)NC(=O)C(C)NC(=O)C(CCC(=O)O)N)C(=O)NC(C(C)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(=O)O)C(=O)O)CCSC)CCCCN)CCCCN)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC2=O)CCC(=O)O)CC(=O)N)CCC(=O)N)CC(=O)N)CCCNC(=N)N)CC9=CC=CC=C9)CCC(=O)O)CO)CC(C)C)CCC(=O)O)CCC(=O)O)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CC1=CC=CC=C1)CCC(=O)O)CCC(=O)O)CCC(=O)N)CCCNC(=N)N)C(C)O)CC1=CC=CC=C1)C(C)CC)CC(=O)N)CC1=CC=CC=C1)CC1=CC=CC=C1)CC1=CNC2=CC=CC=C21)CCCNC(=N)N)CC1=CN=CN1)C)C)CCCNC(=N)N)CC1=CC=C(C=C1)O,.,protein
1745,LIverTox,Telbivudine,159269,E,0,242.23,-1.2,99.1,5,3,17,CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)O,Nil,
3922,Liew,Repaglinide,65981,negative,1,452.6,5.2,78.9,5,2,33,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,CYP3A4,
2206,Greene,Methapyrilene,4098,HH,1,261.39,2.6,47.6,4,0,18,CN(C)CCN(CC1=CC=CS1)C2=CC=CC=N2,,
3628,Liew,Lenalidomide,216326,positive,1,259.26,-0.5,92.5,4,2,19,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,,
3870,Liew,Prazepam,4890,negative,0,324.8,3.6,32.7,2,0,23,C1CC1CN2C(=O)CN=C(C3=C2C=CC(=C3)Cl)C4=CC=CC=C4,Liver,
2441,Greene,Temafloxacin,60021,HH,1,417.4,0.6,72.9,9,2,30,CC1CN(CCN1)C2=C(C=C3C(=C2)N(C=C(C3=O)C(=O)O)C4=C(C=C(C=C4)F)F)F,.,
3949,Liew,Salsalate,5161,positive,1,258.23,3.0,83.8,5,2,19,C1=CC=C(C(=C1)C(=O)OC2=CC=CC=C2C(=O)O)O,,
3810,Liew,Papaverine,4680,positive,1,339.4,3.9,49.8,5,0,25,COC1=C(C=C(C=C1)CC2=NC=CC3=CC(=C(C=C32)OC)OC)OC,Liver,
373,DILIrank,rubidium chloride rb-82,71357,vNo-DILI-Concern,0,117.37,,0.0,1,0,2,[Cl-].[Rb+],.,
3403,Liew,Diethylstilbestrol,448537,positive,0,268.3,5.1,40.5,2,2,20,CCC(=C(CC)C1=CC=C(C=C1)O)C2=CC=C(C=C2)O,,
1929,Greene,Azithromycin,55185,WE,1,749.0,4.0,180.0,14,5,52,CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O,LIver,
3273,Liew,Caspofungin,468682,positive,1,1093.3,0.3,412.0,18,16,77,CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2C(CCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)O)NCCN)O,,
3753,Liew,Nelfinavir,64143,positive,1,567.8,5.7,127.0,6,4,40,CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O,,
2416,Greene,Rosiglitazone,77999,WE,1,357.4,3.1,96.8,6,1,25,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,CYP2C8,
3981,Liew,Sulfapyridine,5336,positive,0,249.29,0.0,93.5,5,2,17,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N,,
2816,Xu,Ticlopidine,5472,Positive,1,263.8,3.6,31.5,2,0,17,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl,Liver,
2726,Xu,montelukast,5281040,Negative,1,586.2,7.7,95.7,5,2,41,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O,"CYP2C8, CYP3A4, CYP2C9",
3521,Liew,Fluphenazine,3372,positive,1,437.5,4.4,55.2,8,1,30,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO,,
2177,Greene,Leucovorin Calcium,6006,NE,0,473.4,-1.2,216.0,9,7,34,C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,.,
4101,Liew,Xanomeline,60809,positive,0,281.42,3.3,66.5,5,0,19,CCCCCCOC1=NSN=C1C2=CCCN(C2)C,,
778,DILIrank,levomefolate calcium,444412,vNo-DILI-Concern,0,459.5,-0.5,199.0,9,7,33,CN1C(CNC2=C1C(=O)N=C(N2)N)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,.,
3307,Liew,Chloroprocaine,8612,negative,0,270.75,2.9,55.6,4,1,18,CCN(CC)CCOC(=O)C1=C(C=C(C=C1)N)Cl,,
3418,Liew,Dipyridamole,3108,negative,0,504.6,0.7,145.0,12,4,36,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,,
1138,LIverTox,Eluxadoline,11250029,C,1,569.6,0.9,165.0,7,4,42,CC1=CC(=CC(=C1CC(C(=O)N(CC2=CC(=C(C=C2)OC)C(=O)O)C(C)C3=NC=C(N3)C4=CC=CC=C4)N)C)C(=O)N,.,
3664,Liew,Medrysone,247839,negative,0,344.5,2.7,54.4,3,1,25,CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)CC4)C)O)C)C(=O)C,,
290,DILIrank,tilbroquinol,65592,vMost-DILI-Concern,1,238.08,3.1,33.1,2,1,13,CC1=CC(=C(C2=C1C=CC=N2)O)Br,.,
4013,Liew,Testolactone,13769,negative,0,300.4,3.0,43.4,3,0,22,CC12CCC3C(C1CCC(=O)O2)CCC4=CC(=O)C=CC34C,Liver,
2701,Xu,maleic acid,444266,Positive,1,116.07,-0.3,74.6,4,2,8,C(=CC(=O)O)C(=O)O,.,
3978,Liew,Sulfacytine,5322,positive,0,294.33,0.1,113.0,4,2,20,CCN1C=CC(=NC1=O)NS(=O)(=O)C2=CC=C(C=C2)N,,
1719,LIverTox,Streptozocin,29327,D,1,265.22,-1.4,152.0,8,5,18,CN(C(=O)NC1C(C(C(OC1O)CO)O)O)N=O,"Liver, Kidney",
133,DILIrank,pemoline,4723,vMost-DILI-Concern,1,176.17,0.9,64.7,2,1,13,C1=CC=C(C=C1)C2C(=O)N=C(O2)N,	Liver,
2678,Xu,Idoxuridine,5905,Positive,1,354.1,-1.0,99.1,5,3,17,C1C(C(OC1N2C=C(C(=O)NC2=O)I)CO)O,.,
1641,LIverTox,Revefenacin,11753673,E,0,597.7,4.1,108.0,6,2,44,CN(CCN1CCC(CC1)OC(=O)NC2=CC=CC=C2C3=CC=CC=C3)C(=O)C4=CC=C(C=C4)CN5CCC(CC5)C(=O)N,.,
1755,LIverTox,Teriflunomide,54684141,D,1,270.21,3.3,73.1,6,2,19,CC(=C(C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F)O,.,
1557,LIverTox,Phentermine-Topiramate,56842108,E*,0,488.6,,150.0,10,2,33,CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C.CC(C)(CC1=CC=CC=C1)N,.,
1225,LIverTox,Fostamatinib,11671467,E*,0,580.5,1.6,187.0,15,4,40,CC1(C(=O)N(C2=C(O1)C=CC(=N2)NC3=NC(=NC=C3F)NC4=CC(=C(C(=C4)OC)OC)OC)COP(=O)(O)O)C,"Gut ALP to tamatinib Liver tamatinib metabolite by CYP3A4, UGT1A9",
3337,Liew,Clofibrate,2796,positive,1,242.7,3.3,35.5,3,0,16,CCOC(=O)C(C)(C)OC1=CC=C(C=C1)Cl,,
739,DILIrank,pyridostigmine,4991,vNo-DILI-Concern,0,181.21,0.7,33.4,2,0,13,C[N+]1=CC=CC(=C1)OC(=O)N(C)C,.,
3709,Liew,Metoprolol,4171,positive,1,267.36,1.9,50.7,4,2,19,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,,
3893,Liew,Propofol,4943,positive,1,178.27,3.8,20.2,1,1,13,CC(C)C1=C(C(=CC=C1)C(C)C)O,Liver,
1160,LIverTox,Eribulin,11354606,E*,0,729.9,1.1,146.0,12,2,52,CC1CC2CCC3C(=C)CC(O3)CCC45CC6C(O4)C7C(O6)C(O5)C8C(O7)CCC(O8)CC(=O)CC9C(CC(C1=C)O2)OC(C9OC)CC(CN)O,.,
4027,Liew,Tibolone,444008,negative,1,312.4,2.4,37.3,2,1,23,CC1CC2=C(CCC(=O)C2)C3C1C4CCC(C4(CC3)C)(C#C)O,"Liver, Intestine",
3835,Liew,Phenacemide,4753,positive,0,178.19,0.9,72.2,2,2,13,C1=CC=C(C=C1)CC(=O)NC(=O)N,,
3514,Liew,Fluocinolone,91488,negative,0,412.4,1.1,115.0,8,4,29,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CC(C4=CC(=O)C=CC43C)F)F)O,,
3571,Liew,Gusperimus,55362,negative,0,387.5,-2.0,181.0,6,7,27,C(CCCN=C(N)N)CCC(=O)NC(C(=O)NCCCCNCCCN)O,,
1568,LIverTox,Piperacillin-Tazobactam,9918881,B,1,817.9,,313.0,15,4,56,CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O.CC1(C(N2C(S1(=O)=O)CC2=O)C(=O)O)CN3C=CN=N3,.,
941,LIverTox,Bosutinib,5328940,D,1,530.4,5.4,82.9,8,1,36,CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC,"By CYP3A4, to inactive metabolites",
943,LIverTox,Brexanolone,92786,E,0,318.5,4.9,37.3,2,1,23,CC(=O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C,"Non-CYP450 keto-reduction via aldo-keto reductases AKR, glucuronidation via glucuronosyltransferases UGT, sulfation via sulfotransferases SULT",
3590,Liew,Iloprost,5311181,positive,0,360.5,2.8,77.8,4,3,26,CC#CCC(C)C(C=CC1C(CC2C1CC(=CCCCC(=O)O)C2)O)O,,
1832,LIverTox,Vemurafenib,42611257,E*,0,489.9,5.0,100.0,7,2,33,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)C4=CC=C(C=C4)Cl)F,.,
779,DILIrank,sitaxsentan,216235,vMost-DILI-Concern,1,454.9,3.7,144.0,9,1,29,CC1=CC2=C(C=C1CC(=O)C3=C(C=CS3)S(=O)(=O)NC4=C(C(=NO4)C)Cl)OCO2,"CYP2C9,CYP3A4",
2642,Xu,Ethynodiol Diacetate,9270,Positive,1,384.5,3.9,52.6,4,0,28,CC(=O)OC1CCC2C3CCC4(C(C3CCC2=C1)CCC4(C#C)OC(=O)C)C,.,
831,LIverTox,Amoxapine,2170,E,0,313.8,2.6,36.9,3,1,22,C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl,Liver cytochrome P450 system,
428,DILIrank,alpidem,54897,vMost-DILI-Concern,1,404.3,4.8,37.6,2,0,27,CCCN(CCC)C(=O)CC1=C(N=C2N1C=C(C=C2)Cl)C3=CC=C(C=C3)Cl,"	Extensive hydroxylation, dealkylation, conjugation",
157,DILIrank,gabapentin,3446,vLess-DILI-Concern,1,171.24,-1.1,63.3,3,2,12,C1CCC(CC1)(CC(=O)O)CN,Not significantly metabolized,
1243,LIverTox,Gilteritinib,49803313,E*,0,552.7,3.5,121.0,10,3,40,CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC(=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)OC)NC5CCOCC5,.,
672,DILIrank,riluzole,5070,vMost-DILI-Concern,1,234.2,3.6,76.4,7,1,15,C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N,CYP1A2,
50,DILIrank,famotidine,3325,vLess-DILI-Concern,1,337.5,-0.6,238.0,8,4,20,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,.,
1666,LIverTox,Rotigotine,57537,E,0,315.5,4.9,51.7,3,1,22,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O,CYP450,
3176,Liew,Aminolevulinic acid,137,positive,1,131.13,-3.8,80.4,4,2,9,C(CC(=O)O)C(=O)CN,,
990,LIverTox,Ceritinib,57379345,D,1,558.1,6.4,114.0,8,3,38,CC1=CC(=C(C=C1C2CCNCC2)OC(C)C)NC3=NC=C(C(=N3)NC4=CC=CC=C4S(=O)(=O)C(C)C)Cl,CYP3A,
3760,Liew,Niclosamide,4477,negative,0,327.12,4.0,95.2,4,2,21,C1=CC(=C(C=C1[N+](=O)[O-])Cl)NC(=O)C2=C(C=CC(=C2)Cl)O,,
1581,LIverTox,Pramipexole,119570,E,0,211.33,1.9,79.2,4,2,14,CCCNC1CCC2=C(C1)SC(=N2)N,.,
523,DILIrank,polymyxin b sulfate,5702105,vNo-DILI-Concern,0,1301.6,,574.0,22,20,90,CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O,.,
2365,Greene,phenothiazine,7108,HH,1,199.27,4.2,37.3,2,1,14,C1=CC=C2C(=C1)NC3=CC=CC=C3S2,.,
2801,Xu,Sulfasalazine,5339,Positive,1,398.4,-0.7,150.0,9,3,28,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N=NC3=CC(=C(C=C3)O)C(=O)O,.,
764,DILIrank,tenofovir,5481350,vLess-DILI-Concern,1,519.4,1.6,185.0,14,1,35,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C,Ester hydrolysis,
2076,Greene,Edrophonium Chloride,8307,NE,0,201.69,,20.2,2,1,13,CC[N+](C)(C)C1=CC(=CC=C1)O.[Cl-],.,
3165,Liew,Amantadine,2130,positive,0,151.25,2.4,26.0,1,1,11,C1C2CC3CC1CC(C2)(C3)N,,
3250,Liew,Buclizine,6729,negative,0,433.0,7.1,6.5,2,0,31,CC(C)(C)C1=CC=C(C=C1)CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=C(C=C4)Cl,,
133,DILIrank,pemoline,4723,vMost-DILI-Concern,1,176.17,0.9,64.7,2,1,13,C1=CC=C(C=C1)C2C(=O)N=C(O2)N,	Liver,
2500,Xu,Acetylcholine Chloride,187,Negative,0,146.21,0.2,26.3,2,0,10,CC(=O)OCC[N+](C)(C)C,ACH,
3891,Liew,Proparacaine,4935,negative,0,294.39,2.7,64.8,5,1,21,CCCOC1=C(C=C(C=C1)C(=O)OCCN(CC)CC)N,,
1923,Greene,Aurothioglucose,6104,HH,1,392.18,,91.2,6,4,13,C(C1C(C(C(C(O1)[S-])O)O)O)O.[Au+],.,
3476,Liew,Etidocaine,37497,negative,0,276.4,3.7,32.3,2,1,20,CCCN(CC)C(CC)C(=O)NC1=C(C=CC=C1C)C,,
327,DILIrank,meclizine,4034,vNo-DILI-Concern,0,390.9,5.8,6.5,2,0,28,CC1=CC(=CC=C1)CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=C(C=C4)Cl,Liver,
1402,LIverTox,Metformin,4091,B,1,129.16,-1.3,91.5,1,3,9,CN(C)C(=N)N=C(N)N,Not by liver,
157,DILIrank,gabapentin,3446,vLess-DILI-Concern,1,171.24,-1.1,63.3,3,2,12,C1CCC(CC1)(CC(=O)O)CN,Not significantly metabolized,
1755,LIverTox,Teriflunomide,54684141,D,1,270.21,3.3,73.1,6,2,19,CC(=C(C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F)O,.,
3870,Liew,Prazepam,4890,negative,0,324.8,3.6,32.7,2,0,23,C1CC1CN2C(=O)CN=C(C3=C2C=CC(=C3)Cl)C4=CC=CC=C4,Liver,
3396,Liew,Dibucaine,3025,negative,0,343.5,4.4,54.5,4,1,25,CCCCOC1=NC2=CC=CC=C2C(=C1)C(=O)NCCN(CC)CC,,
1077,LIverTox,Degarelix,16136245,E,0,1632.3,3.5,513.0,18,17,117,CC(C)CC(C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)NC(=O)N)NC(=O)C(CC3=CC=C(C=C3)NC(=O)C4CC(=O)NC(=O)N4)NC(=O)C(CO)NC(=O)C(CC5=CN=CC=C5)NC(=O)C(CC6=CC=C(C=C6)Cl)NC(=O)C(CC7=CC8=CC=CC=C8C=C7)NC(=O)C,Subject to common peptidic degradation during passage through the hepato-biliary system; not a substrate for the human CYP450 system,
1366,LIverTox,Lopinavir,92727,D,1,628.8,5.9,120.0,5,4,46,CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O,Liver,
3756,Liew,Netilmicin,41859,positive,0,475.6,-4.2,200.0,12,8,33,CCNC1CC(C(C(C1OC2C(C(C(CO2)(C)O)NC)O)O)OC3C(CC=C(O3)CN)N)N,,
36,DILIrank,chlorcyclizine,2710,vLess-DILI-Concern,1,300.8,4.5,6.5,2,0,21,CN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,.,
2175,Greene,Leflunomide,3899,HH,1,270.21,2.5,55.1,6,1,19,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F,GI mucosa and liver,
2630,Xu,Donepezil,3152,Negative,1,379.5,4.3,38.8,4,0,28,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,"	CYP2D6, CYP3A4, and glucuronidation.Four major metabolites, two of which are active.",
3852,Liew,Pipecuronium,65332,negative,0,762.7,,59.1,8,0,45,CC(=O)OC1CC2CCC3C(C2(CC1N4CC[N+](CC4)(C)C)C)CCC5(C3CC(C5OC(=O)C)N6CC[N+](CC6)(C)C)C.[Br-].[Br-],,
601,DILIrank,l-methionine,6137,vNo-DILI-Concern,0,149.21,-1.9,88.6,4,2,9,CSCCC(C(=O)O)N,.,
487,DILIrank,chlorothiazide,2720,vLess-DILI-Concern,1,295.7,-0.2,135.0,6,2,17,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2,	Nil,
2684,Xu,Isoxsuprine HCl,3783,Negative,0,301.4,2.8,61.7,4,3,22,CC(COC1=CC=CC=C1)NC(C)C(C2=CC=C(C=C2)O)O,.,
3239,Liew,Bimatoprost,5311027,positive,0,415.6,2.8,89.8,4,4,30,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O,,
296,DILIrank,pipamazine,6761,vMost-DILI-Concern,1,402.0,4.4,74.9,4,1,27,C1CN(CCC1C(=O)N)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,.,
3785,Liew,Opipramol,9417,positive,1,363.5,3.6,30.0,4,1,27,C1CN(CCN1CCCN2C3=CC=CC=C3C=CC4=CC=CC=C42)CCO,CYP2D6,
3637,Liew,Levorphanol,5359272,negative,0,257.37,3.1,23.5,2,1,19,CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)O,,
3990,Liew,Talinolol,68770,positive,0,363.5,2.6,82.6,4,4,26,CC(C)(C)NCC(COC1=CC=C(C=C1)NC(=O)NC2CCCCC2)O,,
646,DILIrank,oxacillin,6196,vLess-DILI-Concern,1,401.4,2.4,138.0,7,2,28,CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O,.,
1555,LIverTox,Phenobarbital,4763,B,1,232.23,1.5,75.3,3,2,17,CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2,CYP2C19,
1489,LIverTox,Obeticholic Acid,447715,B,1,420.6,5.7,77.8,4,3,30,CCC1C2CC(CCC2(C3CCC4(C(C3C1O)CCC4C(C)CCC(=O)O)C)C)O,.,
3234,Liew,Bethanechol,2370,negative,0,161.22,0.0,52.3,2,1,11,CC(C[N+](C)(C)C)OC(=O)N,,
3384,Liew,Desvenlafaxine,125017,negative,1,263.37,2.6,43.7,3,2,19,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O,,
1009,LIverTox,Cholic Acid,221493,D[HD],1,408.6,3.6,98.0,5,4,29,CC(CCC(=O)O)C1CCC2C1(C(CC3C2C(CC4C3(CCC(C4)O)C)O)O)C,.,
1733,LIverTox,Tacrine,1935,A,1,198.26,2.7,38.9,2,1,15,C1CCC2=NC3=CC=CC=C3C(=C2C1)N,CYP1A2,
3941,Liew,Ropivacaine,175805,negative,0,274.4,2.9,32.3,2,1,20,CCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,CYP1A2,
505,DILIrank,darunavir,213039,vMost-DILI-Concern,1,547.7,2.9,149.0,9,3,38,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N,CYP3A4,
1719,LIverTox,Streptozocin,29327,D,1,265.22,-1.4,152.0,8,5,18,CN(C(=O)NC1C(C(C(OC1O)CO)O)O)N=O,"Liver, Kidney",
2222,Greene,mianserin,4184,HH,1,264.4,3.4,6.5,2,0,20,CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42,"	Liver CYP2D6; via aromatic hydroxylation, N-oxidation, N-demethylation",
3191,Liew,Anastrozole,2187,positive,1,293.4,2.1,78.3,4,0,22,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,,
237,DILIrank,methylnaltrexone bromide,5361918,vNo-DILI-Concern,0,356.4,1.6,66.8,4,2,26,C[N+]1(CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O)CC6CC6,	Liver,
1662,LIverTox,Romidepsin,5352062,C,1,540.7,2.2,193.0,8,4,36,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,CYP3A4,
2186,Greene,Loperamide HCl,3955,NE,0,477.0,5.0,43.8,3,1,34,CN(C)C(=O)C(CCN1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,	Liver extensive,
1028,LIverTox,Clopidogrel,60606,B,1,321.8,3.8,57.8,4,0,21,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,Liver,
1973,Greene,carbon tetrachloride (2),5943,HH,1,153.8,2.8,0.0,0,0,5,C(Cl)(Cl)(Cl)Cl,.,
3177,Liew,4-Aminosalicylic acid,4649,positive,1,153.14,1.3,83.6,4,3,11,C1=CC(=C(C=C1N)O)C(=O)O,,
1018,LIverTox,Clemastine,26987,E,0,343.9,5.0,12.5,2,0,24,CC(C1=CC=CC=C1)(C2=CC=C(C=C2)Cl)OCCC3CCCN3C,Liver,
3151,Liew,Aldrin,2087,positive,0,364.9,4.5,0.0,0,0,18,C1C2C=CC1C3C2C4(C(=C(C3(C4(Cl)Cl)Cl)Cl)Cl)Cl,,
779,DILIrank,sitaxsentan,216235,vMost-DILI-Concern,1,454.9,3.7,144.0,9,1,29,CC1=CC2=C(C=C1CC(=O)C3=C(C=CS3)S(=O)(=O)NC4=C(C(=NO4)C)Cl)OCO2,"CYP2C9,CYP3A4",
3940,Liew,Ropinirole,5095,negative,1,260.37,2.7,32.3,2,1,19,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,CYP1A2,
2739,Xu,nomifensine,4528,Positive,1,238.33,2.6,29.3,2,1,18,CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3,.,
830,LIverTox,Amodiaquine,2165,A,1,355.9,2.6,48.4,4,2,25,CCN(CC)CC1=C(C=CC(=C1)NC2=C3C=CC(=CC3=NC=C2)Cl)O,.,
1581,LIverTox,Pramipexole,119570,E,0,211.33,1.9,79.2,4,2,14,CCCNC1CCC2=C(C1)SC(=N2)N,.,
3832,Liew,Perindopril,107807,negative,0,368.5,0.9,95.9,6,2,26,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O,Kidney,
3656,Liew,Malathion,4004,negative,0,330.4,2.4,128.0,8,0,19,CCOC(=O)CC(C(=O)OCC)SP(=S)(OC)OC,,
2663,Xu,Furosemide,3440,Positive,1,330.74,2.0,131.0,7,3,21,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,	liver and kidney glucuronidation,
3531,Liew,Formestane,11273,negative,0,302.4,2.6,54.4,3,1,22,CC12CCC(=O)C(=C1CCC3C2CCC4(C3CCC4=O)C)O,,
3505,Liew,Floxuridine,5790,positive,1,246.19,-1.2,99.1,6,3,17,C1C(C(OC1N2C=C(C(=O)NC2=O)F)CO)O,,
1458,LIverTox,Nebivolol,71301,E,0,405.4,3.0,71.0,7,3,29,C1CC2=C(C=CC(=C2)F)OC1C(CNCC(C3CCC4=C(O3)C=CC(=C4)F)O)O,CYP2D6,
1973,Greene,carbon tetrachloride (2),5943,HH,1,153.8,2.8,0.0,0,0,5,C(Cl)(Cl)(Cl)Cl,.,
4065,Liew,Trimethobenzamide,5577,positive,1,388.5,2.3,69.3,6,1,28,CN(C)CCOC1=CC=C(C=C1)CNC(=O)C2=CC(=C(C(=C2)OC)OC)OC,,
936,LIverTox,Bleomycin,5460769,D,1,1415.6,-7.5,685.0,31,20,96,CC1=C(N=C(N=C1N)C(CC(=O)N)NCC(C(=O)N)N)C(=O)NC(C(C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)NC(C)C(C(C)C(=O)NC(C(C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O,.,
3366,Liew,Dapiprazole,3033538,negative,0,325.5,2.4,37.2,4,0,24,CC1=CC=CC=C1N2CCN(CC2)CCC3=NN=C4N3CCCC4,,
3450,Liew,Enoxacin,3229,positive,0,320.32,-0.2,85.8,8,2,23,CCN1C=C(C(=O)C2=CC(=C(N=C21)N3CCNCC3)F)C(=O)O,,
3774,Liew,Norepinephrine,439260,negative,0,169.18,-1.2,86.7,4,4,12,C1=CC(=C(C=C1C(CN)O)O)O,,
2760,Xu,Phenylbutazone,4781,Positive,1,308.4,3.2,40.6,2,0,23,CCCCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3,,
1428,LIverTox,Mirtazapine,4205,C,1,265.35,3.3,19.4,3,0,20,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,"CYP1A2, CYP2D6, CYP3A4",
3171,Liew,Amikacin,37768,positive,0,585.6,-7.9,332.0,17,13,40,C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N,,
3552,Liew,Gatifloxacin,5379,positive,0,375.4,-0.7,82.1,8,2,27,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F,,
1342,LIverTox,Lavender,702,E,0,46.07,-0.1,20.2,1,1,3,CCO,.,
1863,LIverTox,Zidovudine,35370,B,1,267.24,0.0,93.2,6,2,19,CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-],Liver,
1546,LIverTox,Perampanel,9924495,E,0,349.4,3.4,57.0,3,0,27,C1=CC=C(C=C1)N2C=C(C=C(C2=O)C3=CC=CC=C3C#N)C4=CC=CC=N4,"Liver, mostly via CYP3A4 and/or CYP3A5",
3740,Liew,Nafarelin,25077649,negative,0,1322.5,0.8,475.0,15,16,96,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)C(CC2=CC3=CC=CC=C3C=C2)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8,,
1101,LIverTox,Diphenoxylate,13505,ND,0,452.6,5.7,53.3,4,0,34,CCOC(=O)C1(CCN(CC1)CCC(C#N)(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC=CC=C4,.,
3633,Liew,Levobunolol,39468,negative,0,291.4,2.4,58.6,4,2,21,CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O,,
186,DILIrank,mesalazine,4075,vLess-DILI-Concern,1,153.14,1.3,83.6,4,3,11,C1=CC(=C(C=C1N)C(=O)O)O,	Rapidly & extensively metabolized intestinal mucosal wall and the liver,
3257,Liew,Butenafine,2484,negative,0,317.5,6.3,3.2,1,0,24,CC(C)(C)C1=CC=C(C=C1)CN(C)CC2=CC=CC3=CC=CC=C32,,
634,DILIrank,esomeprazole Sodium,9579578,vLess-DILI-Concern,1,345.4,2.2,96.3,6,1,24,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,"	Liver CYP2C19, CYP3A4",
1650,LIverTox,Rilpivirine,6451164,D,1,366.4,4.5,97.4,6,2,28,CC1=CC(=CC(=C1NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C)C=CC#N,CYP3A4,
1555,LIverTox,Phenobarbital,4763,B,1,232.23,1.5,75.3,3,2,17,CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2,CYP2C19,
674,DILIrank,ritonavir,392622,vMost-DILI-Concern,1,720.9,6.0,202.0,9,4,50,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,Liver,
4087,Liew,Vardenafil,110634,positive,0,488.6,2.5,118.0,7,1,34,CCCC1=NC(=C2N1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC)C,CYP3A4,
3098,Liew,Sumatriptan,5358,negative,0,295.4,0.9,73.6,4,2,20,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,MAO,
25,DILIrank,amphotericin b,14956,vLess-DILI-Concern,1,924.1,0.0,320.0,18,12,65,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,kidney,
439,DILIrank,zoledronate,68740,vLess-DILI-Concern,1,272.09,-4.3,153.0,8,5,16,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O,	Nil,
357,DILIrank,pentetic acid,3053,vNo-DILI-Concern,0,393.35,-8.5,196.0,13,5,27,C(CN(CC(=O)O)CC(=O)O)N(CCN(CC(=O)O)CC(=O)O)CC(=O)O,.,
3257,Liew,Butenafine,2484,negative,0,317.5,6.3,3.2,1,0,24,CC(C)(C)C1=CC=C(C=C1)CN(C)CC2=CC=CC3=CC=CC=C32,,
1342,LIverTox,Lavender,702,E,0,46.07,-0.1,20.2,1,1,3,CCO,.,
2901,Liew,Ciprofibrate,2763,positive,1,289.15,3.4,46.5,3,1,18,CC(C)(C(=O)O)OC1=CC=C(C=C1)C2CC2(Cl)Cl,,
4097,Liew,Voglibose,444020,positive,0,267.28,-4.1,154.0,8,8,18,C1C(C(C(C(C1(CO)O)O)O)O)NC(CO)CO,,
>>>>>>> 772863a274eb6a0a836c8f6db049ba9b99d86e02
